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Summary  
Asthma is a chronic respiratory disease with a prevalence that has increased 
worldwide over the past 40 years. Longitudinal cohort studies have been 
designed to determine associations between early life events and asthma 
prevalence.  One such cohort is the Merthyr Allergy Prevention Study 
(MAPS). 
  
MAPS recruited high risk subjects, before birth, from a deprived population in 
South Wales. The original study was a randomised controlled trial (RCT) of 
either normal diet for the first four months of life, or a cows’ milk protein 
exclusion diet with soya formula milk supplementation if subjects were not 
breast fed. Subjects were subsequently followed up as part of a cohort study.  
The findings presented are based on the final follow up at age 23 years. 
  
While there was a significant protective effect of breast feeding on wheeze at 
age 1, there was no evidence of an association with wheeze at age 23 years.  
The intervention arm of the RCT was associated with an increased risk of 
asthma and sensitisation at age 23 years.   
 
There was tracking of both total serum IgE and positive skin prick test results 
over the years but there was no clear relationship between these two measures 
of allergy.  Although the prevalence of atopy was low in childhood, there was 
still a clear association with this and wheeze later in life.  Wheeze at age 3 
years or older was an important determinant of asthma at age 23 years.  There 
was a significant association between those who wheeze from age of 3 to age 
23 years and atopic status at age 7 years.   
7 
 
 
In conclusion we have investigated a birth cohort from a relatively deprived 
area of South Wales and found characteristics in the first 7 years of life are 
critical in determining if asthma develops in early adulthood. 
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Chapter One 
Background 
1.0 General introduction  
Asthma is an inflammatory disease of the airways that may commence at any 
age, but most often does so in childhood
1
. Before puberty it is more likely to 
affect boys than girls, with a gender ratio of approximately 2:1, male:female. 
Following puberty, asthma incidence is greater in females
2
.    It may become 
quiescent in adolescence but can then recur in later life.  It is common and 
approximately 5.4 million individuals (8%) in the UK are receiving treatment 
for asthma
3
.  Asthma has a small but significant mortality; 20 per million 
population died from asthma in England and Wales in 2012
4
.  It is also a 
significant cause of disability and a history of childhood asthma is now known 
to be a risk factor for chronic obstructive pulmonary disease (COPD) in 
adults
5
.  In addition to these factors the prevalence of asthma has increased 
worldwide in recent decades, especially in developing countries
6,7
.  There is a 
considerable economic burden, in both health service resources and days of 
work lost. The annual cost associated with asthma in the UK is estimated at 
£2.5 billion, of which £900 million is directly related to the money spent in the 
National Health Service (NHS).  In addition twenty million working days are 
lost per year due to illness from asthma
8
.   
 
Despite the worldwide significance of asthma, there is still no single test to 
diagnose it.  Asthma is defined by the Global Initiative for Asthma (GINA) as:  
‘...a heterogeneous disease, usually characterised by chronic airway 
inflammation.  It is defined by the history of respiratory symptoms such as 
23 
 
wheeze, shortness of breath, chest tightness and cough that vary over time and 
in intensity, together with variable expiratory airflow limitation.’9  
This clinical definition, however, is not used to define asthma in 
epidemiological studies.  As yet there is no consensus on asthma diagnosis in 
research.  Indeed, one study found that there were 60 different definitions of 
asthma across 122 research papers on paediatric asthma
10
.  Over the past 20 
years two groups have sought to standardize the methodology on the study of 
asthma: the International Study of Asthma and Allergy in Children (ISAAC)
11
 
and the European Community Respiratory Health Study (ECRHS)
12
.  They 
have produced validated questionnaires, standardized practical procedures 
such as skin prick testing and facilitated international collaboration. The aim 
has been to develop an epidemiological definition of asthma that has 
international validity.  
 
1.1 Validation of asthma definition in epidemiological questionnaires 
Wheeze is the sound made when there is turbulent air flow through an airway, 
and is usually described as a high pitched sound coming from the chest.    
Wheeze is therefore a condition that can be used to compare many different 
cohorts.  The International Union against Tuberculosis and Lung Disease 
(IUATLD) found that questions related to wheeze in the past 12 months and 
asthma ever or asthma in the past 12 months were repeatable and up to 96% 
sensitive in predicting a positive bronchial provocation test for bronchial 
hyper-reactivity (BHR) with histamine (proxy for asthma) in European 
subjects
13
.  These questions therefore became part of the core questions used 
for defining asthma for the different phases of the ISAAC study.  However the 
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way that they are formulated is not always consistent. Van Wonderen et al 
showed that in epidemiological studies there were at least 60 different 
definitions of asthma in 122 studies.  They also found that where doctor 
diagnosis of asthma has been used to define asthma, 19% have used current 
doctor diagnosis of asthma, while 28% have used ever doctor diagnosis of 
asthma and the rest have not  specified when the doctor diagnosis was made
10
.  
The validated ISAAC phase II questionnaire which was also used in phase III 
studies defined current asthma as a previous doctor diagnosis of asthma ever 
and symptoms of asthma in the preceding 12 months.  Further development 
from this questionnaire has led to the core questions in the ISAAC manual 
which are related to asthma symptoms in the past twelve months and ever 
having had asthma (see appendix 10).  In this way epidemiological studies 
have addressed content, construct and predictive validity with regards to the 
appropriate questions for questionnaires defining asthma in epidemiological 
studies. 
It is important to note that this definition will not identify subjects who have 
only a cough or chest tightness as their symptom of asthma, but it should 
include the majority of cases and gives a clear guide for international 
comparison.  Wheeze is a distinct entity from asthma and is not 
interchangeable with asthma, but it is not open to different interpretations as 
the diagnosis of asthma is
10
.   
Bronchial provocation testing for bronchial hyper-reactivity (BHR) is also 
undertaken in many studies to define asthma
10
.  Generally it is agreed that in 
field work BHR is consistent and gives good specificity
14
 but validated 
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questionnaires give the best sensitivity for identifying asthma, without losing 
specificity, compared to a questionnaire in combination with measured BHR
15
.    
 
ISAAC state that two key concepts guided the development of these specific 
questions. Firstly, the principle of using symptoms rather than diagnosis for 
international comparisons, and secondly, the recognition that there were 
several dimensions to asthma severity: frequency of attacks, intensity of 
attacks, and persistence of symptoms
16
. The phase three ISAAC questionnaire 
is given in the appendix for both age 6-7 and 13-14 years and is sourced at the 
following website 
http://isaac.auckland.ac.nz/resources/tools.php?menu=tools1.  As can be seen 
ISAAC only considers symptoms and not current diagnosis as there is 
evidence that symptoms rather than diagnosed and treated asthma gives a 
clearer view of prevalence as suggested in one adult study undertaken by 
ECRHS
17
.  A number of studies have used these validated ISAAC 
questionnaires to undertake epidemiological studies on asthma. 
 
1.2 Epidemiology of asthma 
ISAAC and ECRHS have undertaken multicentre international cross-sectional 
studies which have led to a greater understanding of asthma in both children 
and adults.  They have reported on international prevalence
18
, late onset of 
asthma
19
, and the role of certain environmental factors on the development of 
asthma, including breast feeding
20
, early Paracetamol use
21
,  the presence of 
siblings and  early day care
22
 and pet keeping
23
.   ISAAC and ECRHS have 
each developed systems, techniques and international collaboration through 3 
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phases of studies spanning approximately 5 year periods, from the 1990s to 
the current day.  The focus of ISAAC is on children worldwide, while ECRHS 
is primarily concerned with adults in Europe.   
 
ISAAC has undertaken worldwide cross-sectional studies on children age 6-7 
years and 13-14 years.  In early ISAAC studies, countries that had a 
prevalence of wheeze in the past 12 months (current wheeze) of less than 10% 
were mainly in Asia, Northern Africa, Eastern Europe and the Eastern 
Mediterranean regions.  Those with wheeze rates greater than 20% were 
mainly in the UK, Australasia, North America and Latin America
11
.  As part 
of an international ISAAC study between 1996-8, centres worldwide were 
recruited by professional collaboration provided the researchers agreed to use 
the ISAAC protocol
24
.   The twelve month prevalence of self-reported asthma 
symptoms from written questionnaires in different centres, during this period, 
is shown by the points on the graph in figure 1.1.  Using similar methods and 
criteria for definition, there was great variation between countries, and also 
there was great variation within some countries.  Lai et al, reported on the 
2003 phase III ISAAC study, that the prevalence of current wheeze ranged 
from 2.4% in Jodhpur (India) to 37.6% in Costa Rica in 6–7 year olds, and 
from 0.8% in Tibet (China) to 32.6% in Wellington (New Zealand) in 13–14 
year olds
18
. Asthma symptoms became more common in children from 1993 
to 2003 in many low- and middle-income countries which previously had low 
levels. However, in most high-prevalence countries, the prevalence of asthma 
changed little and even declined in a few countries. What has happened to the 
prevalence and severity of asthma since 2003 is not clear as there have been 
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no further worldwide studies in children
25
.  However a European Community 
Respiratory Health Survey (ECRHS) 10 year review of 11168 European 
subjects suggested that there was a plateauing of symptoms up to 2003 in 
young adults (age 20-44 years), although there was evidence of an increase in 
treated asthma
17
.   
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Figure 1.1 Asthma prevalence in centres around the world 
 
 
Taken from Beasley,  worldwide variation in twelve month prevalence of self-
reported asthma symptoms from written questionnaires: ISAAC 1996-8
24
.  
Results from different centres in the same country are marked separately. 
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1.3 Changes in asthma prevalence  
In 1997 Woolcock and Peat reviewed data from a wide range of countries 
where cross-sectional studies have taken place on more than one occasion and 
found the prevalence of asthma had risen significantly all over the world.  In 
Australia the prevalence of ‘asthma ever diagnosed’ in 8-11 year olds 
increased  from 12.9% in 1982 to 29.7% in 1992 and Taiwan’s rate of current 
asthma in 7-15 year olds increased from 1.3% in 1974 to 5.8% in 1991
26
.  In a 
second large cross-sectional postal survey among young adults in Melbourne 
in 1998, compared to a previous survey that had taken place in 1990, there was 
a significant rise in doctor diagnosed asthma from 12% to 17% p<0.001 over 
the 8 year period
27
.  In cross-sectional studies of 11-12 year olds,  in New 
Zealand in 1989 and again in 2000, Wickens et al showed a similar increase in 
asthma ever being diagnosed from 17% to 37% between the two studies
28
. 
Asthma prevalence has increased in countries considered to have a low 
prevalence as well.  Haahtela et al investigated the records of serial military 
recruits in Finland including records of call up examinations and records of 
conscripts discharged because of poor health between 1966 and 1989, and 
compared them to records collected between 1926 and 1961
29
.  During 1926-
61 the prevalence of asthma remained steady at between 0.02% and 0.08%. 
However, between 1966 and 1989, there was a  continuous, linear increase in 
prevalence, from 0.29% in 1966 to 1.79% in 1989- a six fold increase or a 
twenty fold increase compared to 1926
29
. Brogger et al undertook two cross-
sectional studies of subjects aged 15–70 years in Oslo, Norway, in 1972 and 
again in 1998–1999.  The prevalence of ever having had a doctor’s diagnosis 
of asthma increased from 3.4 to 9.3% and the prevalence of wheezing 
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increased from 17.8 to 25.8%
30
.  ISAAC studies suggest that the rise in asthma 
prevalence continues but is relatively greater in those countries that had low 
prevalence in earlier phases (and would be considered developing countries).  
The prevalence in those countries where it was previously highest may have 
now plateaued
7
.  However, this is not the experience in the UK where the 
prevalence appears to continue to rise. 
 
1.4 The prevalence of asthma in the UK  
Anderson et al
31
 showed that in the UK the prevalence of asthma rose from 
1965 through to the 1990s with a plateauing in prevalence from the 1990s.  
However, Figure 1.2 (taken from Anderson et al) does show a rise in 
prevalence of asthma diagnosis ever (shown on a log scale), among children in 
studies in the UK over the past 50 years and suggests that the rate of increase 
in prevalence was still increasing up to 2004. 
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Figure 1.2 Trends in the prevalence of a diagnosis of asthma ever in children 
in the UK, presented on a log scale
31
. 
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 Figure 1.3 is also taken from Anderson et al
31
 and shows that there has been 
an increase in the rate of patients consulting their general practitioners for 
asthma over the past 50 years in the UK, although this does appear to be 
levelling off in the 21
st
 century.   
 
Figure 1.3 Patients consulting general practitioners for asthma per 10 000 
population, England and Wales 1955-1998.  Data from the General Practice 
Database (GPRD) and Morbidity Statistics in General Practice (MSGP)
31
 
 
 
1.4a The prevalence of asthma in Wales 
The ECRHS reported in 1996 that the highest adult worldwide prevalence of 
wheeze in the preceding year (used as a proxy for current asthma) was in 
Wales
12
 where there are currently 10% asthma sufferers compared to 9% in 
the rest of the UK
3
.   The phase III ISAAC study showed that the prevalence 
of asthma symptoms in children in Wales was still among the highest in the 
world
18
.  Studies by Burr in schoolchildren aged 11 years in South Wales 
showed that the percentage reporting they had ever suffered from asthma 
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increased from 5% in 1973 to 12% in 1988 and 27% in 2003
32
. Findings of the 
Welsh Health Survey (2009) state that there were 4,000 hospital admissions 
for asthma (1.3 per 1000 population per year) a rate which is nearly 30% 
higher than the rest of the UK
31
.   The evidence suggests that the worldwide 
burden of asthma continues to rise, although in the West there may be a 
plateauing of this rise.   However, Wales may be an exception and there still 
may be a rising prevalence here.   
 
1.5 Atopy and atopic diseases  
The term “atopy” has been applied to allergic conditions that occur in families 
(hay fever, asthma, and atopic dermatitis).  Since immunoglobulin E was first 
discovered in the 1960s
33
, the understanding of its importance in allergic 
disease has grown and now we describe atopy as ‘a genetic propensity to 
develop immunoglobulin E antibodies in response to exposure to allergens’34, 
This is known as sensitisation
35
, which is usually defined on the basis of a 
positive skin prick test
36, 37
 or a raised level of specific IgE
38, 39
 to a 
perennial allergen such as dust mites, pet dander, pollen or mould.  A portion 
of the allergen called the antigen combines with specific IgE on mast cells to 
cause the release of histamine. Atopy is known to be associated with eczema
40
, 
asthma
41
 and hay fever
42
.  When investigating the rising prevalence of asthma 
we must consider atopy since it too is rising in prevalence
43
 and there is much 
evidence that atopy is associated with asthma.  However, sensitisation to an 
allergen does not necessarily mean disease, since up to 40% of children
44
 and 
adults
45
 who are sensitised may have no evidence of clinically relevant 
symptoms.  There is evidence that atopy defined as either a positive skin prick 
34 
 
test or raised specific IgE, is associated with asthma in children
46
, airway 
hyper responsiveness in children
47
 and asthma in adults
38, 48
.  Asthma is often 
found in association with atopy and there is evidence that an association with 
atopy can increase the likelihood that asthma becomes chronic
49
.  
 
1.6 Theory to explain the increased prevalence of asthma and other atopic 
diseases -The Hygiene Hypothesis  
In 1989 Strachan reported that hay fever was less likely in 11 year olds if they 
had siblings, especially older ones
50
.  He found that the prevalence of hay-
fever at ages 11 and 23 years  was inversely related to the number of children 
in the household at age 11, with older siblings having a greater influence on 
this relationship than younger siblings.  His hypothesis was that early life 
infections, to which subjects with siblings were more likely to be exposed, 
formed some sort of protection against hay-fever and other allergic diseases. 
The biological basis for this, the hygiene hypothesis was founded on murine 
models and suggested the Th1/Th2 paradigm i.e. two mutually exclusive T 
helper cell phenotypes develop from a common ancestor cell and one type of 
cell (T-helper type 1, Th1) produces chemical mediators and fights infections 
while the other cell type (T-helper type 2, Th2) produces another set of 
chemical mediators and these induce B cell clones to produce IgE 
51, 52
.   
 
Matricardi et al showed that compared to non-atopic Italian cadets (not 
sensitised on skin prick testing and specific IgE tests), atopic Italian cadets 
(sensitised) were significantly less likely to have antibodies to orofeacal and 
food borne infections (Toxoplasma gondii, Helicobacter pylori and Hepatitis 
35 
 
A virus)
53
.  Shirakawa et al showed that among Japanese schoolchildren, there 
was a strong inverse association between delayed hypersensitivity to 
‘Mycobacterium tuberculosis’and atopy (sensitised). Positive tuberculin 
responses predicted a lower incidence of asthma, lower serum IgE levels, and 
cytokine profiles biased toward Th1 type response
54
.    These and other 
subsequent clinical studies have reinforced the hygiene hypothesis, making it a 
plausible explanation for why there has been an increase in asthma over the 
past few decades worldwide. 
 
1.7 Other theories linked to the rise in prevalence of asthma 
The rise in asthma prevalence has been linked to the change in diet over the 
past 30 years, mainly due to the ‘fast food’ culture in modern Western society.  
A Mediterranean diet in preschool children has been found to protect against 
wheeze
55
. A large ISAAC study undertaken in New Zealand showed that those 
children who ate hamburgers regularly were more likely to suffer with wheeze 
than those who never did
56
.  In a recent international ISAAC study there was 
an increased risk of severe asthma in adolescents and children associated with 
the consumption of fast food ≥3 times per week57.  Fast food has a higher salt 
content and is depleted in important trace elements and vitamins.  High salt 
intake may be one factor that is increasing the prevalence of asthma and a 
reduction of salt intake for as little as two weeks significantly improved 
pulmonary function tests in subjects with exercise induced asthma
58
.  A 
greater imbalance of antioxidants has also been found in asthmatic children 
compared to normal children
59
.   Allen et al undertook a meta-analysis of 40 
studies investigating antioxidants in diet and found that relatively low dietary 
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intakes of vitamins A and C were associated with increased odds of asthma 
and wheeze
60
.   A diet high in Vitamin E which has antioxidant properties was 
protective against developing asthma in adult women
61
.  These studies are 
consistent with the assertion that changes in diet may also be a factor in the 
rise in asthma prevalence.   
Poor diet can also lead to obesity which has increased in the Western world 
over the past few decades.  The speculation that the growth in the prevalence 
of obesity may be the cause for the growth in prevalence of asthma has been 
fuelled by the finding that prevalence of both have increased at a similar rate 
in the USA as shown in figure 1.4 taken from Sin et al
62
.   
 
 
1.8a) Aetiological factors associated with asthma but not clearly linked to a 
rise in prevalence 
Some longitudinal aetiological factors have not increased in prevalence in line 
with asthma but there is evidence that they may be associated with asthma 
inception.  Those factors include pollution and viral infection and will be 
briefly discussed here.   
Figure 1.4 
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It has been known for many decades that asthma exacerbations are more 
frequent when the concentration of outdoor pollutants such as nitrogen 
dioxide, sulphur dioxide and particulate matter in the air increases.  One study 
from Seattle USA found that the risk of a visit to an emergency room for 
asthma was associated with mean PM10 levels (particulate matter up to 10µm) 
over the four  days preceding the emergency visit
63
.  There is a perception that 
pollution in cities is increasing although this is not true in the West.  Since 
‘Clean air legislation’ was passed in 1970 in the USA64 and in 1956 in the UK,  
there have been lower levels of pollution, especially over the past 30 years
65
.  
Unfortunately in developing countries outdoor pollution continues to 
increase
66
 but asthma prevalence has not yet been linked to this.   
 
1.8b) Respiratory Syncytial Virus (RSV) 
The largest body of evidence regarding viral infections and association with 
asthma inception exists for Respiratory Syncytial Virus (RSV). RSV is a 
common childhood respiratory infection in Europe.  Many children suffer 
from it and premature babies are at increased risk of more severe RSV 
infections which require hospitalisation
67
.  There has been no evidence of an 
increase in prevalence of RSV infection over the past 10-15 years and 
therefore this cannot explain the rising prevalence of asthma
67
.  However, 
there is evidence of a link between RSV infection and asthma inception. One 
study from the  Avon Longitudinal Study of Parents and Children (ALSPAC) 
showed there was a positive association between being admitted to hospital 
with bronchiolitis with a positive test for RSV before the age of 12 months, 
and having asthma at the age of 7 years
68
.  A further longitudinal study from 
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the Tucson Children’s Respiratory Study (TCRS) also showed that children 
who had an RSV-confirmed infection before the age of 3 years were at 
increased risk of frequent wheeze up to the age of 11, though the odds ratios 
decreased from 4.3 at age 6 to 2.4 at age 11; by age 13 the increased risk was 
small and not statistically significant
69
.   
 
A further study reported on RSV infection in 46 infants who were admitted to 
hospital with the illness and 92 controls followed up to the age of 18.  They 
found there was an association of infant RSV and atopic asthma
70
.  Evidence 
from these studies supports the hypothesis that RSV is associated with 
childhood asthma, but causation cannot be proven.  RSV is the most common 
cause of hospital admission in the winter season during the first year of life, 
and severe RSV bronchiolitis has been shown to be associated with an 
increase in subsequent rates of early wheezing
71
.  However, although these 
studies may show an association, the questions still remains:  Is RSV infection 
the cause of asthma or does it just occur in lungs that later go on to develop 
asthma.  In an attempt to answer this question Blanken et al undertook a 
randomised controlled study of Palivizumab in healthy preterm babies, who 
were at increased risk of RSV infection.  Palivizumab is a monoclonal 
antibody which has already been shown to have efficacy in preventing severe 
RSV infection in high risk infants.  At 1 year, treatment with Palivizumab was 
associated with a reduced risk of wheeze
72
.   These one year results suggest 
that preventing RSV infection may reduce the risk of wheeze and therefore 
asthma, suggesting that RSV may be a cause of asthma.  However follow up 
results are awaited. 
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1.9 Longitudinal studies and the aetiology of asthma 
Longitudinal studies give the clearest evidence on aetiological factors in 
asthma, especially if data on risk factors are gathered prospectively.  This is 
supported by one study that showed that recall bias can account for large 
differences between prospectively collected data and retrospectively collected 
data (for example 40% of parents who agreed that their child had doctor 
diagnosed asthma, denied this when asked retrospectively)
73
.  A number of 
longitudinal studies have been established over the past 30-40 years to try to 
answer some basic questions related to the inception of asthma.  Some of the 
longest running studies are the Dunedin study, Tucson Children Respiratory 
Study (TCRS), the German Multicentre Allergy Study (German MAS), 
Tasmanian Allergy Study (TAS), Avon Longitudinal Study of Parents and 
Children (ALSPAC).  Table 1.1 gives a brief overview of each study, and 
others not mentioned here. Some have recruited at birth (or pre-birth)
74
, some 
in childhood
75
.  Some longitudinal studies are based on unselected population 
studies
76
 while others are taken from high risk populations
77
.  
 
Table 1.1 shows that a number of early life factors are associated with asthma 
and allergy.  There are some factors that are associated with increased risk in 
some cohorts but not in others.  This disparity may be due to varied definitions 
of asthma, or it may be related to confounding factors associated with 
differing environmental conditions as yet unidentified, or due to the ways in 
which the risk factors were measured.  Nevertheless prospective cohort studies 
have provided a useful tool for the investigation of the natural history of 
40 
 
asthma, and have identified a large number of credible associations between 
environmental variables and asthma onset in childhood.  However as yet we 
have been unable to identify modifiable causal risk factors that are amenable 
to intervention for primary or secondary prevention of disease
78
.    
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Table 1.1 Longitudinal studies regarding the inception of asthma 
Study Name 
(Sample 
studied) 
Country Sample at 
recruitment 
When 
subjects 
recruited  
Age of 
subjects 
at entry 
Important findings 
TAS (general 
population) 
Australia 8,583 1968 
Born -
1961 
7 years 
of age 
Childhood eczema increases 
risk of adult asthma
79
 
Dunedin 
Study (general 
population) 
New 
Zealand 
1037 1972-73 3 years 
of age 
Remodelling, defined as loss of 
reversibility of obstruction, 
begins in childhood and 
continues into adulthood
80
   
Breast feeding associated with 
increased risk of asthma
75
 
TCRS 
(HMO†=gene
ral 
population)  
USA 1246 1980-84 Birth Breast feeding no effect unless 
mother asthmatic, then 
increases risk
81
 
Day-care protects
82
   
 
German MAS 
(general 
population 
with nested 
high risk) 
Germany 1314 1990 Birth House dust mite exposure not 
related to development of 
asthma
83
 
Eczema in infancy is 
associated with wheeze age 7 
years
84
 
Repeated upper respiratory 
tract infections associated with 
a reduced risk of asthma
85
 
ALSPAC UK 11 534 1991-92 Birth Maternal use of Paracetamol
86
 
increases risk 
Breast feeding
87
 and mode of 
delivery
88
 no effect on 
development of asthma 
MAAS 
(unselected 
population) 
UK 1085 1995 Birth Latent class analysis of 
sensitisation phenotypes-
multiple early sensitisations 
strong association with 
asthma
89
. 
PIAMA 
(unselected 
population) 
Netherla
nds 
4146‡  1996/7 Birth Breast feeding protective90.  
Consumption of food 
containing milk fat reduces 
risk of asthma
91
 
†Health Maintenance Organisation-only subjects with health insurance included 
‡ Approximately 50% of the invited women (n=4146) agreed to participate and gave written 
informed consent. The mothers were allocated to the intervention arm (n=855) or to the 
‘‘natural history’’ arm (n=3291) of the PIAMA study. Only allergic mothers were included in 
the intervention study, while in the natural history study allergic (n=472) and non-allergic 
(n=2819) mothers were included. 
Abbreviations TAS= Tasmanian Allergy Study. TCRS= Tucson Children’s Respiratory 
Study, German MAS= German Multicentre Allergy Study, MAAS= Manchester Asthma and 
Allergy Study, ALSPAC= Avon Longitudinal Study of Parents and Children, PIAMA= the 
Prevention and Incidence of Asthma and Mite Allergy  
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1.10 Natural history of asthma and childhood wheeze phenotypes 
Since airways are small in childhood, wheeze is more common in children and 
not every wheeze in childhood is the beginning of asthma.  The TCRS 
reported that 30% of children wheeze before the age of 3 years, showing that 
early wheeze is common
92
.  Later the ALSPAC study reported that over 70% 
of children who wheeze in the first 6 months of life do not wheeze 3 years 
later, suggesting that early wheeze may not be a prequel to childhood 
asthma
93
. It is important to classify these early patterns of wheezing, in order 
to understand the natural history of asthma.  However, the question of how to 
categorize early wheeze remains controversial.  In 1995 the TCRS published 
on the first 6 years follow up of subjects and their patterns of wheeze.  They 
categorised subjects based on wheezing in the first 3 years of life, and at age 6 
years, into  
 those who did not wheeze at any time point up to age 6 years (No 
wheeze NW),  
 those who wheezed up to age 3 but not in the year of 6th birthday 
(transient early wheeze TEW),  
 those who wheezed in the year of 6th birthday but not up to age 3 (late 
onset wheeze LOW) and 
 those who wheezed up to age 3 years and in the year of 6th birthday 
(persistent wheeze PW).   
 
Since this publication, many longitudinal studies have used modified TCRS 
phenotypes to define their study group with respect to early wheeze as shown 
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in table 1.2.  The rationale is usually similar to that of Tucson but modified to 
take account of ages at which data were collected in each study. 
 
Not all longitudinal cohorts have used these four categories. One study 
categorised wheeze with infection as wheezy bronchitis
94
, while ALSPAC 
defined 6 categories of childhood wheeze phenotype using latent class 
analysis
76
.   
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Table 1.2 Early wheeze phenotypes categories used in named longitudinal 
studies 
Study No wheeze 
(NW) 
Transient 
Early 
Wheeze 
(TEW) 
Late onset 
wheeze 
(LOW) 
Persistent 
Wheeze (PW) 
BAMSE
95
  
seen age 
2months 1 
year, 2 
years and 4 
years 
No wheeze age 
2 months to 4 
years 
Three 
episodes of 
wheeze 
between 3 
months and 
2 years 
No wheeze 
2 months to 
2 years and 
wheeze at 
age 4 
Wheeze 2 
months to 2 
years and 
wheeze at age 4 
years 
German 
MAS
96
§  
Never wheeze 
up to age 7 
Wheeze at 
least once 
before 3 and 
not in past 
year age 7 
No wheeze 
before 3 but 
wheeze in 
the past 
year age 7 
Wheeze at least 
once before age 
3 and in past 
year age 7 
Jamtland 
Sweden
97
 
No wheeze age 
0-4 years  
Wheeze 0-1 
years only 
Wheeze 2-4 
only 
Wheeze age 1 
and age 4 
MAAS
98
 
seen at age 
3 years and 
5 years 
No wheeze up 
to 3 years and 
no wheeze in 
past year at age 
5 
Any wheeze 
up to age 3 
years but 
none in past 
year at age 5 
No wheeze 
up to age 3 
years and 
wheeze in 
past year at 
age 5 
Wheeze up to 
age 3 years and 
wheeze in past 
year age 5 
SIDRIA
99
  
seen age 7 
years 
No wheeze 
between 0-7 
years by 
parental recall 
Wheeze 0-2 
years by 
parental  
recall 
Wheeze 2-7 
years and 
not before 
by parental 
recall  
Wheeze present 
at age 7 and 
parental  recall 
for wheeze 
before age 2 
TCRS
92
 
seen 0-3 
then at age 
6 
0-6 years, no 
wheeze up to 
age 3 and no 
wheeze age 6 
Any wheeze 
up to age 3 
none at age 6 
Wheeze 
only at age 
6 
Wheeze up to 3 
and at age 6 
Key to studies- TCRS- Tucson Children’s Respiratory Study, SIDRIA (Italian 
Studies of Respiratory Disorders in Chidhood and the Environment), 
Jamtland-Swedish cohort,  BAMSE-Swedish no translation, MAAS-
Manchester Asthma and Allergy study 
§ German MAS were reviewed at ages 1, 3, 6, 12 and 18 months, then yearly, 
within 3 months of their birthday, up to 7 years of age 
 
 
Although there have been a number of longitudinal studies,  a number of 
questions still remain regarding the natural history of asthma.  It was therefore 
considered appropriate to investigate the natural history of a cohort from a 
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deprived area in the South Wales Valleys who could provide a relatively stable 
population, since movement of subjects is not as great as in a city. The 
incidence and prevalence of asthma are known to be higher in deprived areas 
and therefore the end point of asthma was considered to be more likely to 
occur in this study group.  In addition they were high risk compared to 
subjects from the general population. 
 
1.11 The Merthyr Allergy Prevention study (MAPS) 
The Merthyr Allergy Prevention study (MAPS) aimed to investigate which 
environmental features, especially those in early life, predispose high risk 
individuals to develop asthma.  In the 1980s there had been 3 randomised 
trials investigating the withholding of cows’ milk and replacing it with soya-
based feed in order to reduce the development of allergy in children.  All three 
studies had methodological deficiencies;  one was too small, another was 
invalidated by noncompliance and the third was not a double blind study in 
that the investigator was aware of which children had which diets
100
.    Burr et 
al recruited pregnant women between 1982 and 1984, with a history of atopy 
in either themselves, their partner or older siblings of the unborn infant.  They 
established a randomised controlled trial (RCT) to investigate if avoidance of 
cows’ milk during infancy could be a useful strategy to avoid allergy and 
asthma in later life, in these high risk infants
100
.   The main outcome measure 
in the first years of life was wheeze in the preceding year and doctor 
diagnosed asthma.  The RCT turned into a cohort study over the years, with 
the last follow-up at age 23. The purpose of this thesis is to use data from this 
study to examine associations between wheeze, asthma and atopy in early 
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adulthood and a number of predictors in childhood.  The hope is that finding 
such early life factors may lead to prevention rather than treatment of asthma. 
 
1.12a) Hypothesis and aims 
The hypothesis of this cohort study is that early life exposure is associated 
with asthma, wheeze and atopy in early adulthood. 
The aim of this study was to investigate the association of wheeze and other 
outcomes at age 23 with inherited, immunological, early life environmental 
and host factors.  Special interest is paid to the natural history of childhood 
wheeze and the development of wheeze and asthma in early adult years.   
 
 
1.12b) Objectives of thesis   
 
To describe the methods, and review the main findings from previous 
publications on this study with particular emphasis on those matters that are 
relevant to the follow up of subjects at age 23 years.  
 
To describe the demographics of the population with a discussion on the 
representativeness of the follow up cohort at age 23 with respect to the 
original birth cohort.  Associations between the outcomes of wheeze and 
asthma at age 23 years and family history and childhood and adult BMI will 
be investigated. 
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To investigate the relationship between atopy, defined using the results of skin 
prick tests, and outcomes at age 23.  We will also investigate the utility of total 
IgE as a measure of atopy and its association with skin prick test results. 
Longitudinal relations between atopy and both wheeze and asthma will be 
estimated.   
 
To analyse outcomes at age 23 years in relation to the randomisation groups in 
the original randomised controlled trial.  We will investigate the association of 
neonatal diet, including breast feeding, with adult outcomes.   
 
To investigate the associations between early environmental factors and 
outcomes at age 23 years.   
 
To investigate the natural history of wheeze and explore the use of different 
phenotypes to classify children.   
 
To summarise the findings and reflect on how these findings contribute to our 
understanding of how asthma develops in children and young adults..
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Chapter Two 
 
Description of original cohort and methods  
2.0 Original study design 
The Merthyr allergy prevention study (MAPS) was designed as a randomised 
controlled trial (RCT) to test the hypothesis that infants who do not receive 
cow’s milk during the first four months of life are less likely to develop 
allergic diseases in early childhood than those who receive a normal diet.  
Participants were recruited from a socially deprived community in the South 
Wales valleys because there was evidence that asthma prevalence
101, 102
 and 
severity
103
 were directly associated with poorer economic circumstances and 
therefore it was thought that asthma incidence and prevalence would be 
greater in this population.  The subjects were infants born within a defined 
geographical area (the catchment area of Prince Charles Hospital, Merthyr 
Tydfil) and they had to have a first-degree relative with a history of eczema, 
asthma, or hay fever.  Their mothers were identified between 1982-1984 at 
their first antenatal clinic appointment at Prince Charles Hospital, Merthyr or 
Aberdare General Hospital, Aberdare.   
 
Written informed consent was obtained from pregnant women before entering 
into the study.  Those who gave consent had their new-borns randomised to 
the intervention group or the control group.  The intervention group had a 
cows’ milk exclusion diet with soya milk substitute.  Randomisation was 
undertaken by a computer-generated list that was inserted into numbered 
envelopes and each envelope was opened in turn on recruitment of a pregnant 
woman.  Pregnant women in the intervention group were asked to restrict their 
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own cows’ milk intake to half a pint (284 ml) daily during the remainder of 
the pregnancy and while they breast fed.  They were also asked not to give 
cow’s milk, or any food made from cows’ milk, to the child for at least the 
first four months of the child’s life.  A soya preparation, as an alternative to 
cows’ milk or cows’ milk based formula, was supplied for mothers in the 
intervention arm who did not wish to breast feed or who wanted to supplement 
breast feeding.  Those in the control group who did not wish to breast feed 
were given the cow’s milk formulation normally supplied while in hospital, 
after which they purchased their preferred formulation.   
 
A total of 527 pregnant women consented to participate in the study.  As there 
were 3 sets of twins, there were 533 possible births. Of these 46 (9%) did not 
participate for the following reasons: eight were born outside the study area; 
five had a birth-weight less than 2kg ( a stated exclusion criterion); 9 pregnant 
women were unwilling to cooperate in the study despite giving consent; 14 
babies were either still born or aborted; and errors occurred in the 
randomisation of 10 babies and consequently they were excluded
100
.  A total 
of 487 children, 238 (119 male) in the intervention group and 249 (137 male) 
in the control group entered the RCT.  The recruitment process is summarised 
in figure 2.1.     
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Figure 2.1 Subjects entered into study and those excluded.  
 
 
 
2.1a) Follow up age 0-1 year 
On recruitment of a pregnant woman, baseline information was gathered 
including the woman’s smoking habits during the pregnancy, the type of 
housing the family occupied and features of the housing, such as visible mould 
on walls and damp.  Information on mode of delivery of the infant, was taken 
from the hospital notes.  The data collection forms used at the initial interview 
and before birth are shown in Appendix 2a, 2b and 2c.  These questionnaires 
were based on validated ISAAC questionnaires as were all the questionnaires 
in this study.   Evidence of validation of the ISAAC questions used to define 
527 women 
recruited, 6 twins 
533 Possible Births 
487 (91%) 
Admitted to trial 
46(9%) Excluded 
10 (2%) Uncertain 
randomisation 
9 (2%) non- 
cooperation 
14 (3%)  Stillbirths 
or Abortions 
8 (2%) Moved 
away from area 
5 (1%) birth weight 
<2000g 
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asthma compared to a respiratory physician diagnosis of asthma was given in 
1996 by Jenkins and Clarke
15
.  In this way content, construct and predictive 
validity have been addressed with regards to the appropriate questions for 
questionnaires defining asthma in epidemiological studies. 
 
During the first 6 months of life, a dietitian visited families weekly at home 
and examined diaries in which details of the infants’ diets were recorded by 
the mother.  A doctor, who was blind to the randomisation, examined the 
infants at 3 months of age (see appendix 3a/b), 6 months of age (see appendix 
4a/b) and 1 year (see appendix 5a/b).  Blood was taken for immunoglobulins 
at birth from the umbilical cord (cord blood) and at 3 months.  Skin prick 
testing was undertaken at age 6 months and 1 year to validated standards that 
were developed in the 1980s-1990 by the ISAAC team of which Dr Burr was a 
member.  The full methods including validation for included centres is given 
in the phase II module handbook published in 1998.  The relevant pages are 
pages 37-45 and the manual can be found at 
http://isaac.auckland.ac.nz/phases/phasetwo/phasetwomodules.pdf.  The 
relevant section is copied and given in appendix 11.   
 
2.1b) Follow up of the cohort age 7 years 
The subjects were followed up as they grew older, creating a cohort.  Each 
year from age 2 to 6 years, around their birthday, a short questionnaire was 
sent to the mother asking whether the child had wheezed or been treated by a 
doctor for eczema during the preceding year (appendix 6).   
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Parents of subjects were invited to bring their child to a research clinic at age 
7.  At this clinic subjects were reviewed by a consultant paediatrician who was 
unaware of the children’s allocation in the randomised trial.  A structured 
history was taken and a clinical examination conducted; details of the data 
recorded are shown in appendices 7a/b/c/d.  Blood was taken for measurement 
of total IgE and an assay comprising specific IgE to 12 aero-allergens 
(AlaTOP). Skin prick tests were performed for common allergens.    An 
exercise challenge test was conducted by measuring peak expiratory flow rate 
(PEFR) five times at the beginning of the study, then asking the child to run 
for 6 minutes.  After 5 minutes of rest the PEFR was measured again.  Further 
information was obtained about housing conditions.  
 
2.1c) Follow up of the cohort age 15 years 
At age 15, subjects were sent a detailed postal questionnaire on current 
symptoms and treatment, severity of wheezing and active and passive smoking 
(appendix 8a/b), but subjects were not clinically assessed. A total of 363 
subjects completed and returned the questionnaire.  
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Table 2.1 Summary of investigations undertaken at different ages. 
Age  (N -% 
of total) 
Questionnaire  Diet Examination Total I gE Skin 
prick test 
Antenatal  Baseline 
information, 
Appendix 2a 
  Mother  
At birth  487-
100% 
Birth and 
perinatal period  
Appendix 2b, 2c 
Weekly visits 
from dietitian. 
Diet Diary  
 Cord blood  
3 months 482-
99% 
Appendix 3a, b Weekly visits 
from dietitian. 
Diet Diary  
By 
paediatrician  
Yes Yes 
6 months 476-
98% 
Appendix 4a, b Weekly visits 
from dietitian. 
Diet Diary  
By 
paediatrician  
 Yes 
1 year  475 -
98% 
Appendix 5a, b  By 
paediatrician  
Yes but too 
few 
samples to 
analyse  
Yes 
2 years-6 
years 
468-
96% 
Birthday card 
and short  
questionnaire  
Appendix 6 
    
7 years   (453 -
93%) 
Full 
questionnaire 
and results of 
examination.  
Appendix 7a, b, 
c, d 
 By 
paediatrician 
Exercise test 
undertaken  
Yes Yes 
15 years   (363 -
75%) 
Postal 
questionnaire 
only  Appendix 
8a, b 
    
 
2.2 Findings at one year  
Evidence of compliance with the randomised intervention was provided by the 
mothers’ weekly diet diaries and confirmed by serum IgG4 antibodies at 3 
months: cows’ milk antibodies were detected in 37% of the intervention group 
and 70% of the controls at 3 months
100
.  This suggested that at least 37% of 
the intervention group had had some exposure to cows’ milk at age 3 months.  
There was an association between the randomisation group and the prevalence 
of breast feeding with 32.8% ever breast fed (breast fed for even one week) in 
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the intervention group and 41.8% ever breast fed in the control group. During 
the first year of life, 34% of the infants wheezed at some time.  There was no 
association between wheeze in the first year and randomisation to the 
intervention group or the control group.  Napkin rash, diarrhoea and oral 
thrush were more common in the intervention group, especially during the first 
three months.  The incidence of wheeze during the first year of life in subjects 
who were breast-fed for any length of time was about half that in those who 
were never breast fed (22.0% and 41.9% respectively –see chapter 5).  It was 
concluded that withholding cow’s milk conferred no clear benefit during 
infancy.  Breast feeding, however was associated with a significant reduction 
in wheeze at age 1
104
.  The incidence of wheeze was higher in boys than in 
girls, and in babies born during the autumn; it was also higher with a greater 
number of siblings
105
.  Levels of der p 1 in the samples of dust from the child's 
mattress, the mother's mattress, and the carpet on which the child was most 
frequently placed were not associated with wheeze at age 1
105
.   
 
 
 
2.3 Findings at age 7 years 
When the subjects were 7 years old, 30% had wheezed during the preceding 
year, and 32% were considered by the paediatrician to have had asthma at 
some time over the past 7 years.  In 25% of the children at least one skin prick 
test was positive; and about half of the atopic subjects had wheezed in the 
preceding year, suggesting a strong association between wheeze and atopy.  At 
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age 7 years there was no association between wheeze and the original 
randomisation. 
 
Mean PEFR adjusted for height
106
 was significantly lower in subjects with 
wheeze compared to those with no wheeze in the preceding year.  The PEFR 
after exercise as a percentage of the initial value was lower in those who were 
atopic with wheeze compared to those who were not atopic, whether they had 
a wheeze or not.  Pet ownership in infancy was negatively associated with 
atopy at age 7.  Wheeze in the non-atopic subjects was associated with passive 
smoking (especially when the mother was a smoker).  In addition being from 
an employed family compared to being from an unemployed family reduced 
the risk of wheeze in non-atopic subjects: OR 0.38 (95% Confidence Interval 
0.21 to 0.70)
107
.    
Subjects who had ever been breast fed had a lower risk of wheeze at age 7 but 
only if they were not atopic.  Figure 2.2 shows graphs of odds ratios of the 
association of breast feeding and wheeze at ages 1-7 years.  Atopic and non-
atopic subjects are plotted separately (taken from Burr et al
107
).  There is no 
clear association between breast feeding and wheeze in subjects who are 
atopic, but in the non-atopic group there is a clear association with an OR less 
than 1 at age 6 and 7 years, suggesting protection against wheeze at these ages.  
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Figure 2.2 Association between wheeze and breastfeeding, by age and atopic 
status (odds ratios, with 95% CIs, for the) 
 
 
2.4 Findings at age 15 years 
At 15 years of age wheeze was present in 31% of those who responded to the 
postal questionnaire. There was no association between wheeze and the 
original randomisation.  A third of those with wheeze had severe wheeze, 
defined by ISAAC criteria: i.e. the symptoms were sufficiently severe to 
restrict speech to one or two words on occasion or to disturb sleep at least 
once a week.  Half the subjects in the severe wheeze subgroup were receiving 
inadequate treatment (no inhaled corticosteroids during the past 12 months) or 
no treatment at all.  Many wheezy children, including some with severe 
symptoms, were unaware that they had ever suffered from asthma.  About a 
quarter of those taking inhaled corticosteroids used them only when they were 
wheezy rather than at regular intervals.  In this cohort it was common for 
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asthma to be undiagnosed in adolescence and treated inadequately or not at 
all
108
. 
 
 
2.5a) Current study-collection of data at age 23 years 
The final phase of follow up was undertaken when the subjects were 
approximately 23 years of age.  This final phase forms the basis of the thesis 
as outlined below.  It was supported by a grant from the Welsh Office of 
Research and Development in 2006 (now renamed as National Institute for 
Social Care and Health Research (NISCHR)). 
 
The questionnaire used at age 23 was based on questions from previous 
ISAAC studies
109
  (See appendix 9).  Subjects were excluded if they had been 
unwilling to participate at earlier stages of the study, if they were known to 
have moved out of the area or were deceased.  A total of 438 subjects were 
eligible to be included in this stage of the study.  Figure 2.3 shows the number 
who entered this follow up phase of the study and the numbers who were 
excluded, including two further subjects who were later found to be deceased. 
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Figure 2.3 Flow diagram of subject recruitment at age 23 years 
 
 
 
2.5b) Recruitment at age 23 years 
 Each subject was sent a letter inviting him/her to participate in the follow up 
study.  Those who did not reply were sent a further letter.  If they again did not 
reply, they were contacted by telephone and finally they were approached at 
home.  In this way we were able to ascertain if individuals were still living at 
their recorded address.  Those not living at the recorded address were searched 
for on the Electoral Roll.  We also asked Health Solutions Wales (a provider 
of information, information technology, telecommunications and consultancy 
services to the NHS) to help us find addresses using the NHS administrative 
438 within sampling 
frame for current 
study 
361 subjects Located 
304 subjects answered 
questionnaire 
124 attended 
research clinic for 
clinical 
measurements 
180 refused to 
attend research 
clinic 
57 unwilling to 
participate, or 
complete 
questionnaire, 10 
refused, 47 
repeatedly did not 
attend 
75 subjects could not be 
located 
2 subjects deceased 
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register, and finally, we searched death certificate records for Aberdare and 
Merthyr Tydfil.  After four unsuccessful attempts at contact, subjects were 
excluded from the study population.   
 
Participants were invited to attend a research clinic at Prince Charles Hospital, 
Merthyr.  They were reviewed by a technician who was blinded to the 
randomisation.  If the subjects did not attend at the scheduled time they were 
contacted and offered a further appointment.  Occasionally participants made 
as many as 5 appointments that they did not attend.   Subjects who were 
contactable and who did not wish to attend the clinic were asked if they would 
complete the questionnaire by post or over the phone (appendix 9a-e).    
 
2.6 Definitions 
Definitions are based on earlier ISAAC studies and are therefore validated, 
and can be found in the ISAAC phase one manual
110
. 
 
2.6a) Atopy  
2.6a) Atopy  
Assessment of atopy and allergy was made by skin prick testing with 
commercially prepared antigen extracts (Diagenics U.K.).  Atopy was defined 
as having one or more positive skin prick tests to a set of perennial allergens 
(house dust mite, grass, tree, moulds, cat, dog, peanut, milk and egg); a 
positive control (histamine) and a negative control (saline) were also included.  
The technique used involved puncturing the skin with a calibrated lancet (1 
mm) held vertically through a drop of diluted allergen
111
.    Weal size was 
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measured 15 minutes after pricking the subcutaneous layer of skin at 45 
degrees through a drop of antigen extract using an ALK lancet. The test was 
regarded as positive if the skin prick test to the given allergen formed a weal at 
least 3mm greater than the control (no allergen, just base mixture that carries 
allergen). Although there is diurnal variation in skin prick reactivity we were 
unable to keep all skin prick test appointments to the morning and some skin 
prick testing was undertaken in the afternoon.   
 
2.6b) Wheeze  
Wheeze was defined as answering yes to the question “Have you had 
wheezing or whistling in the chest in the past 12 months?”   Subjects were 
informed that a wheeze was a high pitched sound heard from the chest.   
 
2.6c) Severe Wheeze 
Severe wheeze is the symptom considered to signify severe asthma in 
epidemiological studies.  In this study and in line with previous ISAAC 
studies
18
, severe wheeze was defined as wheeze that limits speech or disturbs 
sleep at least once a week, i.e. answering yes to either of the questions:  ‘Do 
you have wheeze that limits speech’ or ‘Do you have wheeze that disturbs 
your sleep at least once a week’.   
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2.6di) Asthma  
Asthma at age 23 years was defined as a previous history of asthma, as 
reported by the subject and answering yes to the question ‘Have you had a 
wheeze in the past year’.  These asthma defining questions were based on the 
core questions developed by ISAAC as shown in appendix 10.  The ISAAC 
phase II manual addressed content, construct and predictive validity of the 
core questions and Dr Burr in the writing of the questionnaire for the final 
phase of this study used the ISACC questions on wheeze and severe wheeze 
(see appendix 9 and 10) 
 
2.6dii) Atopic asthma  
It has not been possible to show that asthma is associated with sensitivity to 
specific allergens, but for the purpose of this thesis we have defined asthma in 
subjects who are concurrently atopic, as atopic asthma.  
 
  
2.6e) Social Class  
Social class was recorded when the subject was age 1 and age 7 using the 
Registrar General’s classification of occupations (see Appendix 1).  It was 
based on the occupation of the father if he was employed and a member of the 
household.  Otherwise it was based on the occupation of the mother.    Those 
in social class I, II or III non-manual were grouped together as non-manual 
workers, while those in social classes III manual, IV, V and unemployed were 
grouped together as manual workers.  At age 23 years information on 
deprivation was based on homeownership compared to rented accommodation 
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or council housing.  In addition information on unemployment was available 
and used as a proxy for social class. 
 
2.7 Outcome measures 
The principal outcome measures for this study were the presence or not of 
wheeze and of asthma as defined above.  Other outcomes were based on 
physiological measurements at age 23 which included skin prick test results 
and total IgE.  
 
Lung function was assessed by spirometry.  The machine used to undertake 
the measurement was a Vitalograph model alpha made by Vitalograph, 
Buckingham, UK.  Forced expiratory volume in 1 second (FEV1) and Forced 
Vital Capacity (FVC) were both recorded pre and 15 minutes post 
bronchodilator administration (2 puffs of Salbutamol 100ug via a large volume 
spacer) as absolute measures and as percentages of change from the baseline 
value
112
.  Reversibility was calculated as the percentage change in FEV1 
between pre- and post-bronchodilator.  Participants with an FEV1 of ≤ 80% of 
predicted
106
 with at least 15% reversibility were considered to display features 
of asthma. Those with an FEV1 of ≤ 80% with limited or no reversibility were 
considered to display features of chronic obstructive airways disease (COAD).  
Any individual whose FEV1 was below 80% predicted or who had significant 
symptoms was advised to see their GP regarding probable asthma. 
 
2.8 Statistical methods 
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The majority of the analyses in this work were performed by a small set of 
standard methods described here; more specialised ones are described in the 
relevant chapters.  The majority of the outcomes are binary and were modelled 
using logistic regression, with effect sizes summarised by odds ratios, and 
95% confidence intervals used to quantify uncertainty.  Analyses were 
adjusted for confounders.  It is never simple to choose the set of confounders 
but those used here generally included the original randomisation, gender, 
social class, parental allergy and breast feeding history.  These were based on 
evidence in the literature on confounders.  Exceptions were required on 
occasions; for example analyses of breast feeding were not adjusted for breast 
feeding.  The adjustments made are referred to in the results sections of each 
chapter. 
 
Continuous variables were modelled using linear regression and were 
compared between two groups using a t-test when the variables were 
approximately normally distributed, or the Mann-Whitney test when the 
assumption of normality was not reasonable.  Associations were summarised 
by correlation coefficients.  Pearson’s correlation coefficient was used where 
the distribution was normal; otherwise Spearman’s coefficient was used.   
Associations between categorical variables were investigated using the chi-
squared test.  Time to event data were summarised by Kaplan-Meier estimates 
of survival and hazard functions and were modelled using Cox-s proportional 
hazards model.  Analyses were carried out using SPSS version 18; the 
significance level in hypothesis testing was taken as 5%.  Representativeness 
of the population under study will be discussed further in chapter 3. 
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Chapter 3 
 
Response rate and effect of social class, family history and obesity on 
asthma, wheeze and atopy, at age 23 years 
3.0 Early life events and outcomes in early adulthood 
Before examining early life events and associations with specific outcomes, 
we will investigate the participation rate at age 23 years, and how this may 
impact on the results of any associations found in this thesis. The prevalence 
of wheeze, rhinitis and eczema at age 23 years will be examined as well as 
socio-economic status, familial disposition and raised BMI with reference to 
wheeze, asthma and atopy at age 23 years.    
 
3.1 Response rate in longitudinal studies 
All cohort studies involve a loss to follow-up and this may lead to bias.  
Cochrane argued that high follow up rates are essential to reduce the risk of 
bias
113
 although these are rarely achievable in a birth cohort study extending to 
early adulthood
114
.  For example, the British 1958 Birth Cohort (National 
Child Development Study) is a longitudinal study of all people in England, 
Scotland, and Wales born in one week in March 1958. Of the 18,559 subjects 
who entered the study, data up to age 16 years was provided by only 29% of 
the original population
115
.  The German MAS study recruited 1314 infants at 
birth; data up to age 13 years was available for 58% of the original 
population
49
.  A birth cohort of 1,037 born in Dunedin in New Zealand and 
followed up at regular intervals, had data available up to age 26 for 59% of 
those who originally entered the study
116
 .  The TCRS enrolled 1,246 subjects 
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at birth and there was follow up data at age 22 years for 68% of subjects
117
.  
Thus it is unrealistic to expect a follow up rate to adulthood much greater than 
two thirds. 
 
 
Loss to follow up without differentiation may reduce the power of a study, but 
differential loss to follow-up can introduce bias and reduce generalisability of 
the study
118
.  Follow up rates are often lower in those who are most troubled 
by illness
119, 120
 and in those of lower socio-economic status
121
. Follow-up at 
age 6 in the longitudinal birth cohort German MAS study varied with socio-
economic status (SES) of the family:  low, middle and high SES participation 
rates, of the original cohort, were 62%, 77% and 80% respectively
122
.    In the 
TCRS those children who had full data collected by age 6 years were more 
likely to have better educated, non-smoking, non-ethnic, white parents 
compared to the children with incomplete information
92
.   Differential follow-
up rates may lead to bias in estimates of prevalence unless estimates are 
adjusted to take account of this.  Estimates of relationships between risk 
factors and outcomes are less likely to be biased, since for bias to occur the 
relationship between measured variables would have to be different in the 
responders than in the non-responders, which is unlikely but could occur.  
Rothman has argued that lack of representativeness can be an advantage since 
it is better to ‘control skilfully for confounding variables’ rather than to 
attempt to find the most representative sample and thereby be blinded to any 
bias that this sample may produce
123
.   
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3.2a) Socio-economic status (SES) and asthma and wheeze  
Since the publication of the Black report by the British Government in 
1980
124
, it has been known that poor SES is associated with a higher risk of ill 
health.  Having a manual occupation, no educational qualiﬁcations and living 
in a deprived area all independently predict lower lung function, even after 
controlling for smoking habit
125
.  In contrast eczema
126
, rhinitis
127
 and atopy
128
  
are all more prevalent among subjects from higher social classes.  However, 
asthma is one disease that can be associated with the above three but, itself, 
has not been shown to be consistently associated with higher social class.  
Strachan et al found no association of social class with prevalence of wheeze, 
which was used as a proxy for asthma, among 5-17 year olds in a UK 
cohort
129
, while the European Community Respiratory Health Survey 
(ECRHS) found that asthma prevalence was higher in lower socio-economic 
groups, whether defined by educational level or social class, regardless of 
atopic status
102
.   Court et al also reported that, in a large cross-sectional study 
of 18 434 households, asthma was more common in those of lower social 
class, determined by the occupation of the head of the household
38
.   ALSPAC 
found that both parents and children who lived in relatively deprived housing 
(council housing or rented accommodation) were more likely to wheeze than 
subjects from relatively affluent housing (owner occupier or mortgaged)
130
.  
Tariq et al, in the Isle of Wight study also showed that asthma is more 
prevalent in 4 year old children from lower socio-economic groups
101
.      
 
 
3.2b) SES and severe asthma and wheeze 
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Recent guidelines on the management of severe asthma care have defined 
severe asthma as asthma that requires high doses of medication to control it
131
. 
This is not a definition that has been used in epidemiological studies, which 
tend to use symptoms, rather than treatment, to define severe asthma. A recent 
ISAAC international study of children defines severe symptoms of asthma as 
severe wheeze which is more than four attacks of wheeze in the last 12 
months; or more than 1 night per week of sleep disturbance from wheeze; or 
wheeze affecting speech in the past 12 months. Severe wheeze was, relatively, 
more prevalent in less affluent countries, although wheeze as a whole was 
more prevalent in affluent countries
18
. In the UK-based study considered 
above, although wheeze increases with higher social class severe asthma 
symptoms occurred more frequently in those from a lower socio-economic 
group
129
.  
 
3.2c) Temporal changes in the association of SES with the prevalence of 
asthma   
Some evidence that the role of social class may have changed over time is 
provided by Braback et al who investigated Swedish males born between 1952 
and 1977, identified at age 17 years by the Swedish Military Service 
Conscription Register. This was a repeated cross-sectional study, investigating 
each birth cohort separately at age 17 years. They found that the prevalence of 
asthma at age 17 years increased continuously with year of birth during the 
entire study period, and that subjects of low SES showed the steepest increase 
in prevalence of asthma compared to subjects from high SES.  This increase 
became progressively greater over the years from earlier birth cohorts to later 
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ones
132
.  A similar chronological change of the association between asthma 
and social class was shown by Rona et al in a UK wide survey of 5-11 year 
olds.  In 1977 the survey showed no significant association between 
prevalence of asthma and paternal SES: In the 1993/94 survey children whose 
fathers had a semi or unskilled manual occupation had a higher prevalence of 
asthma (16%) than children whose fathers belonged to other social classes 
(13%)
133
. The German MAS found that, although parental prevalence of 
asthma was higher in high SES groups, children of high SES parents were no 
more likely to have recurrent wheeze (used as proxy for asthma) up to the age 
of 6 than their contemporaries.  This finding suggested that high SES was a 
risk factor for asthma in one generation but not in their children
122
. These 
studies suggest that the increase in asthma prevalence may be associated with 
socio economic differences, but that these differences may change over time.  
This is no surprise as differences in socio-economic status have also changed 
over the decades.  The home environment for lower SES children today may 
resemble the home environment of higher SES children of 40 years ago more 
closely than it does the home environment of lower SES children of 40 years 
ago.  For example not every household had a television in the 1960s but this is 
considered standard now, and a recent study showed that the watching of TV 
for 5 or more hours compared to less than 1 hour in a 24 hour period was 
associated with an increased risk of current wheeze in 6-7 year olds and in 13-
14 year olds
134
.    
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3.2d) Deprivation in Merthyr Tydfil and surrounding area  
In 1980 in England 28% of the population were in social class I or II and the 
rate increased to 30% by 1984
135
.  By contrast, in the cohort under study only 
13.5% of subjects’ families were in  social class I or II in 1983-5 when they 
were 1 year old and 14.4% when subjects were age 7 (1990-92).  At a time 
when unemployment in the UK was reported in the media as reaching ‘an 
historical high’ of 12% in February 1984136,  this cohort had an unemployment 
rate of 18%.   This suggests a high level of deprivation in the cohort under 
study. 
 
3.3 Familial Disposition  
Familial tendency is known to predispose to asthma. However locating the 
‘asthma gene’ has been difficult137.   A detailed review of genetic associations 
is beyond the scope of this work, but is given by Vercelli 
138
 and Kumar
139
.   
 
It has been understood for many decades that atopic disease runs in families. 
Burke et al reviewed  more than 30 worldwide, population-based studies that 
evaluated a family history of asthma in children and found that although a 
positive family history predicts an increased risk of asthma, it identiﬁes a 
minority of children at risk, since a large percentage of asthma sufferers have 
no familial predisposition
140
.   Sarafino et al investigated parent and child 
connections for the atopic illnesses of asthma, eczema, food allergies, and hay 
fever, in a sample of 325 families
141
.  They found that children were more 
likely to have at least one atopic illness if both parents were atopic than if 
neither parent was atopic. In addition the number of atopic illnesses in the 
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children was associated with the number of atopic illnesses in the parents. 
These findings may support the evidence for genetic factors in the 
development of atopic illnesses since they suggest that the atopic disease of 
each parent may contribute to an aggregate risk for their children; however it 
is not possible to rule out environmental factors, since parents and child will 
share their environment.  
  
Heritability can be defined as the proportion of observed variation in a 
particular trait that can be attributed to inherited genetic factors in contrast to 
environmental ones and can be investigated using twin studies. One study of 
twin pairs and self-reported asthma, wheezing, and hay fever suggested 60% 
heritability
142
.  If genes influence a particular trait, then because of the greater 
genetic similarity, monozygotic twins, sharing 100% of genes, should 
resemble each other to a greater extent than dizygotic twins, who share on 
average 50% of their genes
143
.   Los et al reviewed a number of European twin 
studies over a thirty year period from 1971 and found the heritability of 
asthma ranged between 0.36  (monozygotic correlation 0.43; dizygotic 
correlation 0.25) to 0.79 (monozygotic correlation 0.76; dizygotic correlation 
0.45)
143
.  Even among monozygotic twins there is incomplete heritability of 
asthma, which suggests that environmental factors have some influence on the 
development of asthma.   
 
One American high risk birth cohort study (at least one parent had asthma, 
rhinitis or eczema) with follow up until a mean age of 3.5 years, showed the 
odds of having a child with asthma were three times greater in families with 
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one asthmatic parent and six times greater in families with two asthmatic 
parents than in families where only one parent had inhalant sensitivity without 
asthma.  Maternal asthma was found to be strongly linked to asthma in the 
children while paternal asthma was only weakly linked
144
.   A further 
American childhood allergy study reported on a birth cohort recruited between 
1987 and 1989 and followed to age 6-7 years.  The mother was recruited 
during antenatal care before the birth of the subject and was asked about her 
own and the father’s history of childhood asthma, adult asthma and persistent 
asthma (both childhood and adult).   Asthma status in the father, whether it 
was childhood only, adulthood only, or persistent, was associated with current 
asthma in the children (OR ranged between 4.39-7.36)
145
.  By contrast only 
persistent maternal asthma was associated with current asthma in children at 
6-7 years old (OR 2.96).  This suggests a stronger relationship with paternal 
asthma, but since the history of paternal disease was taken from the mother,  it 
is possible that only the more noteworthy and therefore more severe disease 
was reported by the mother
145
.   The Tasmanian Allergy Study (TAS) was a 
longitudinal study that recruited at the age of 7 and continued follow up to 
adulthood (age 29 to 32).  Both maternal and paternal asthma were associated 
with asthma in subjects: maternal asthma - OR 1.90; 95% confidence interval 
(CI) 1.28 - 2 82, paternal asthma- OR 1.61; 95% CI 1.08 - 2.40 
146
.  A large 
German study that investigated children of age 9-11 years found that for 
paternal asthma the OR was 4.4 (95% CI 2.5 - 7.8), while for maternal asthma  
the OR was 1.5 (95% CI 0.7 - 2.7)
147
.  In summary these studies on familial 
attributes show that a family history of asthma is associated with the 
development of asthma.  Despite the differences in methodology between 
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studies, most showed that having a first degree relative with asthma gave the 
index subject an odds ratio for asthma of between about 1.5 and 4, but there 
was variation in whether the maternal or paternal history had greater effect.  
The increase in asthma cases over the past 4 decades cannot be explained by 
genetics alone and there is likely to be a complex interaction between 
environmental and genetic factors
148
.   
 
 
3.4a) Weight, BMI and asthma   
Over 30 years ago Somerville et al first showed that obesity in children is 
associated with respiratory symptoms
149
.   A number of worldwide cross-
sectional studies were reviewed by Ford et al and they found that subjects with 
asthma were disproportionally obese compared to subjects without asthma
150
.  
The National Health and Nutrition Examination Survey (NHANES) is a 
programme of studies designed to assess the health and nutritional status of 
adults and children in the United States. It combines interviews and physical 
examinations and began in the early 1960s.  It has been conducted as a series 
of surveys focusing on different population groups or health topics, including 
NHANES II (1976-80) and NHANES III (1988-1994). In 1999 the survey 
became a continuous programme.  The survey examines a nationally 
representative sample of about 5,000 persons each year. This study found that 
children up to the age of 16, who were above the 85
th
 percentile for weight, 
had a significantly higher risk of asthma than those below the 85
th
 percentile 
for weight
151
. A large cross-sectional ISAAC study of a total of 76,164 
children aged 6–7 years (from 29 centres and 17 countries) and 201,370 
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adolescents aged 13–14 years (from 73 centres and 35 countries) showed there 
was  an association between current wheeze and being overweight or obese 
(based on Cole’s definitions152) in both boys and girls of this age group134.   
 
Adults with high BMI were found to have a positive association with BHR 
(used as proxy for asthma) in an ECRHS multi-centre, multinational study and 
there was a stronger association in males than females
153
.  Shaheen et al, in a 
longitudinal study of 8960 individuals from the 1970 British Cohort Study 
(BCS70), found that the prevalence of asthma increased with increasing BMI 
in adults and that the association  between being overweight or obese and 
asthma was stronger in females
154
.  A total of 731 (406 male) children were 
followed from birth and were reviewed at age 3, 5 and 8 years, as part of the 
longitudinal MAAS study. Higher body mass index (BMI) was associated 
with an increased risk of wheeze at each of 3, 5 and 8 years
155
, although at age 
8 years there was a significant association only in girls
155
.  The Normative 
Aging Study is a longitudinal study which recruited men from the Greater 
Boston area aged between 21–80 years.  It showed that both men with a high 
BMI and also men with a low BMI, had an increased risk of BHR, used as a 
proxy for asthma in this study
156
.   This ‘J shaped’ relationship has also been 
shown in a large Chinese study where being either underweight or overweight 
were associated with asthma in women, and being underweight was associated 
with asthma in men
157
.  In a review and detailed analysis Delgado concludes 
that most of the epidemiological data indicate that obesity can increase the 
prevalence and incidence of asthma, although the effect appears modest
158
.  
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In a cross-sectional European multicentre study of the clinical phenotype of 
chronic severe asthma, obesity was found to be associated with severe 
asthma
159
.   Obesity has been shown to be associated with worse asthma 
outcomes, especially an increased risk of asthma-related hospitalization
160
.    
The Severe Asthma Research Programme (SARP) has shown that one 
phenotype of severe asthma is a group of mostly older obese women with late-
onset non-atopic asthma, moderate reductions in forced expiratory volume in 
one second (FEV1), and frequent oral corticosteroid use
161
 and Dixon et al 
have shown an improvement in asthma severity after surgery for morbid 
obesity
162
.  These studies suggest obesity is associated with an increased risk 
of developing severe asthma. 
 
3.4 Aims and objectives:  
The aim of this chapter is to describe some features of the MAPS cohort in 
order to create a context for interpreting results given in later sections of the 
thesis.  In addition we will investigate the association of childhood allergic 
disease, socio-economic class (SES), family history and BMI with outcomes at 
age 23 years. 
 
Objectives 
To examine how the participation rate at age 23 years varies between 
subgroups. 
To describe the rate of wheeze, rhinitis and eczema at age 23 years and the 
association of childhood wheeze rhinitis and eczema with asthma and wheeze 
at age 23 years 
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To describe the social class of subjects in the MAPS cohort and investigate 
associations with outcome variables at age 23 years 
To investigate the association of family history with asthma, wheeze and atopy 
at age 23 years 
To investigate the association between BMI in both childhood and adulthood, 
and wheeze at age 23 years. 
 
 3.5 Methods 
Full methods are given in chapter 2.  Here are details of methods specific to 
this chapter.  Subjects at age 15 were asked if they had ever had eczema, 
rhinitis or a wheeze.  At age 23 years eczema was defined as answering yes to 
the question ‘Have you ever had an itchy rash that was coming and going for 
at least 6 months?’ and then answering yes to the question ‘Have you had this 
itchy rash at any time in the last 12 months?’  Rhinitis at age 23 was defined 
as answering yes to the question ‘In the last 12 months have you had a 
problem with sneezing, or a runny or blocked nose, when you DID NOT have 
a cold or flu?’  Wheeze was defined as answering yes to the question “Have 
you had wheezing or whistling in the chest in the past 12 months?”  Severe 
wheeze was defined as wheeze that limits speech or disturbs sleep at least 
once a week, i.e. answering yes to either of the questions:  ‘Do you have 
wheeze that limits speech’ or ‘Do you have wheeze that disturbs your sleep at 
least once a week’. 
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Social class was categorised using the Registrar General’s occupations and 
social class categories (see appendix 1).  At age 23 subjects were asked with 
reference to their housing if it was owner occupied, rented or council.   
 
Body mass index (BMI) is defined as the weight (in Kg) divided by the square 
of the height (in metres).  Obesity in adults is usually defined as having a BMI 
of 30 kg/m
2
 or greater, while having a BMI of between 25 and 30 is defined as 
being overweight
163
. In children the definition varies with age.  Cole et al
152
 
have used modelling of data from multi-national studies to derive thresholds 
for being overweight and obese at different ages, structuring the analysis to 
ensure continuity with the definitions for overweight and obese in adults at age 
18.  For example, using Cole’s analysis, obesity at age 7 years was defined as 
a BMI exceeding 20.63 kg/m
2
 in boys and 20.51 kg/m
2
 in girls.  Since the 
proportion of obese children is small in our cohort, we have also used the 
actual recorded BMI as a continuous variable in a binary logistic regression to 
model wheezing status at age 23 years with BMI both at age 23 years and also 
in childhood.   The results are given as odds ratios for a 5 unit difference in 
BMI (i.e. a change of 5kg/m
2
).  The OR for this 5 kg change in BMI is given 
by taking the OR for a 1 unit change and raising it to the power 5; confidence 
limits are obtained in a similar way.  
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3.6 Results 
 
3.6a) Response rate at age 23 years and representativeness of responders 
compared to original cohort 
As in other longitudinal studies, the MAP study has been vulnerable to the loss 
of subjects over time. Approximately 62% of the original birth cohort of 487 
subjects took part at age 23 years.  Of the 438 (229 males) subjects deemed 
contactable at age 23, 304 (69%) participated in the study at age 23.  The 
response rate for males was 65% (n=148) and 75% (n=156) for females.   
Since it is important to investigate how representative the cohort at 23 years is 
with respect to the original population, we can consider this statistically.  
Table 3.1 shows the response rate for groups based on important variables in 
the study at recruitment and at age 1.  Table 3.1 is based on the total 
population of 487 who were randomised in the initial study rather than the 438 
who were deemed contactable at age 23 years, since our aim is to show that 
those lost to follow up were not significantly different from those that 
attended.  There was no association between the original randomisation and 
participation at age 23 years, however, participation rates at age 23 years were 
lower in males than in females, lower in those who wheezed at age 1 year and 
lower in children from unemployed families.    
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Table 3.1 Response rate at age 23 years for important subgroups of the study 
population. 
Subgroup  Variable  Response 
rate 
OR (95%CI) p-value 
Gender Male§ 146/257 
(56.8%) 
1  
 Female 153/230 
(66.5%) 
1.51  (1.05- 
2.18) 
0.028* 
Randomisation 
group 
Control group§ 153/249 
(61.4%) 
1  
 Intervention 
group 
146/238 
(61.3%) 
1.00 (0.70- 
1.45) 
0.98 
Wheeze age 1 No wheeze age 
1§ 
200/303 
(66.0%) 
1  
 Wheeze age 1 89/158 
(56.3%) 
0.66 (0.45-
0.99) 
0.042* 
Parental 
employment 
age 1 
Employed 
parent§ 
249/389 
(64.0%) 
1  
 Unemployed 
parent 
42/88 
(47.7%) 
0.51 (0.32-
0.82) 
0.005* 
* Significant results 
§ reference categories for each analysis 
 
 
Table 3.2 shows the rates of attendance at the research clinic among those who 
participated at age 23 years by key characteristics.  Rates of attendance at the 
clinic were higher among females and among those who had wheeze or 
asthma at age 23 years, suggesting that the population who attended the clinic 
had higher levels of illness.  Table 3.2 shows there was no significant 
difference between those who attended and those who did not attend with 
regard to randomisation group, wheeze at age 1 or unemployment at age 1.  
Although the attendance rate was higher in subjects with symptoms at age 23, 
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this is unlikely to have a major effect on the analysis of the relationship 
between variables.   
 
Table 3.2 Clinic attendance rates at age 23 for important sub groups of the 
study population  
Subgroup  Variable  Attendance at 
research clinic  
OR (95%CI) p-value 
Gender Male§ 50/146 
(34.2%) 
1  
 Female 70/153 
(45.8%) 
1.62  (1.02- 
2.58) 
0.04* 
Randomisation 
group 
Control 
group§ 
62/153 
(40.5%) 
1  
 Intervention 
group 
59/146 
(40.4%) 
1.01 (0.63- 
1.60) 
0.98 
Wheeze age 1 No wheeze§ 82/200 
(41.0%) 
1  
 Wheeze 36/89 (40.4%) 0.98 (0.59-
1.63) 
0.93 
Parental 
employment 
age 1 
Employed 
parent§ 
102/249 
(41.0%) 
1  
 Unemployed 
parent 
16/42 (38.1%) 0.89 (0.45-
1.74) 
0.73 
Wheeze age 23 No wheeze§ 67/201 
(33.3%) 
1  
 Wheeze 53/98 (54.1%) 2.36 (1.44-
3.86) 
0.001* 
Asthma age 23 No Asthma§ 89/244 
(36.5%) 
1  
 Asthma 31/52 (59.6%) 2.57 (1.39-
4.74) 
0.003* 
* Significant results 
§reference categories in the above analysis. 
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3.7) Prevalence of wheeze, rhinitis and eczema in MAPS cohort 
Figure 3.1 shows the prevalence of wheeze, rhinitis and eczema, and their 
combinations, among the 294 subjects on whom we have complete data at age 
23 years. Eczema has the lowest prevalence and rhinitis the highest prevalence 
in this group.  A total of 18 (6.1%) of the population had all three diagnoses.    
 
 
Figure 3.1 Distribution of allergic disease in the cohort at age 23 years  
 
 
 
 
Table 3.3 shows the association of childhood eczema, rhinitis and wheeze and 
adult eczema and rhinitis with wheeze, asthma and atopy age 23 years based 
on 294 subjects with complete data.  There are a number of positive 
associations, ever having a wheeze or rhinitis up to age 15 is associated with 
Wheeze 95 (32.3%) 
Rhinitis 130 (44.2%) Eczema 49 (16.7%) 
5 42 
13 
18 
None of these 
diagnoses 115 
(39.1%) 
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asthma or wheeze at age 23 years.  Childhood eczema shows the least 
evidence of an association with adult wheeze or asthma. Adult eczema and 
rhinitis are both associated with asthma and wheeze at age 23 years.   
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Table 3.3 Association of wheeze age 23years, asthma age 23 years and atopy 
age 23 years with atopic symptoms ever in childhood and at age 23 years. 
 Wheeze age 23  No wheeze age 23 OR (95%CI) p 
Ever Eczema age 15  28/86 (32.6%) 48/179 (26.8%) 1.32 (0.75-2.31) 0.33 
Ever Rhinitis age 15  41/86 (47.7%) 47/179 (26.3%) 2.56 (1.49-4.38) <0.0001* 
Ever wheeze age 15  69/83 (83.1%) 113/174 (64.9%) 2.66 (1.38-5.11) 0.003* 
Eczema age 23  23/96 (24.0%) 26/198 (13.1%) 2.08 (1.12-3.89) 0.02* 
Rhinitis age 23  61/97 (62.9%) 71/201 (35.3%) 3.10 (1.88-5.13) <0.0001* 
 Asthma age 23 No asthma age 23 OR (95%CI) p 
Ever Eczema age 15  18/47 (38.3%) 58/218 (26.6%) 1.71 (0.89-3.31) 0.11 
Ever Rhinitis age 15  25/47 (53.2%) 63/218 (28.9%) 2.80 (1.47-5.32) 0.002* 
Ever wheeze age 15  41/46 (89.1%) 141/211 (66.8%) 4.07 (1.54-10.76) 0.005* 
Eczema age 23  16/52 (30.8%) 33/241 (13.7%) 2.80 (1.40-5.61) 0.004* 
Rhinitis age 23  37/52 (71.2%) 93/243 (38.3%) 3.98 (2.07-7.65) <0.0001*  
 Atopy§ age 23 No atopy age 23 OR (95%CI) p 
Ever Eczema age 15  21/64 (32.8%) 11/46 (23.9%) 1.55 (0.66-3.65) 0.31 
Ever Rhinitis age 15  34/64 (53.1%) 6/46 (13.0%) 7.56 (2.81-20.31) 
<0.0001* 
Ever wheeze age 15  46/63 (73.0%) 31/45 (68.9%) 1.22 (0.53-2.83) 0.64 
Eczema age 23  18/70 (25.7%) 8/48 (16.7%) 1.73 (0.68-4.38) 0.25 
Rhinitis age 23  50/70 (71.4%) 15/49 (30.6%) 5.67 (2.55-12.60) 
<0.0001*  
* Significant result   
§ Atopy age 23 years is defined as a positive skin prick test result at age 23 
years 
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3.8) Association between wheeze and social class  
Social class was recorded at ages 1 and 7 but at age 23 years the subject was 
asked if s/he was living in owner occupied, rented or council accommodation 
and if s/he were employed.  A total of 68.3% were both employed and living 
in owner occupied housing.  There was a highly significant weak correlation 
between social class at age 1 and age 7 years and living in homeowner 
occupied accommodation at age 23 years (spearman correlation 0.260 
p<0.0001).  Table 3.4 shows the percentages of subjects who wheezed at ages 
1, 7, 15 and 23 years by social class at age 1 year.  There was a highly 
significant trend at age 1 showing that children of lower social classes had a 
higher prevalence of wheeze than those of higher social class.  This 
association was not present at subsequent ages.    However if we investigate 
social class as determined at age 7 years there is a significant association 
between wheeze at age 7 and social class but not at older ages as shown in 
table 3.5.
85 
 
Table 3.4 Proportion with wheeze at ages 1, 7, 15 and 23 in each social class 
as established age 1 year.  
Social Class at 
age 1 year 
 Proportion 
who wheeze at 
age 1 year (%) 
 Proportion 
who wheeze 
at age 7 years 
(%) 
 Proportion 
who wheeze at 
age 15 years 
(%) 
Proportion 
who wheeze at 
age 23 years 
(%) 
I 2/12 (16.7%) 4/11 (36.4%) 3/8 (37.5%) 4/6 (66.7%) 
II 10/49 (20.4%) 6/47 (12.8%) 13/45 (28.9%) 12/36 (33.3%) 
III non-manual 12/53 (22.6%) 15/50 (30.0%) 13/43 (30.2%) 8/36 (22.2%) 
III manual  51/160 
(31.9%) 
44/161 
(27.3%) 
39/130 
(30.0%) 
34/109 
(31.2%) 
IV  14/44 (31.8%) 13/43 (30.2%) 12/36 (33.3%) 12/31 (38.7%) 
V  24/54 (44.4%) 20/52 (38.5%) 12/40 (30.0%) 10/31 (32.3%) 
Unemployed 40/79 (50.6%) 21/72 (29.2%) 20/46 (43.5%) 15/42 (35.7%) 
Overall 
proportion 
153/451 (34%) 123/436 
(28.2%) 
112/348 
(32.2%) 
95/291 
(32.6%) 
Chi Squared 
for trend 
p<0.0001* p=0.109 p=0.226 p=0.836 
*  significant result 
 
Table 3.5 shows the proportions of wheeze by social class at age 7 years.  
Wheeze at age 7 years shows a trend in that those with lower social class are 
more likely to wheeze, but there is little evidence of associations at ages 15 or 
23. 
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Table 3.5 Proportion with wheeze at age 7, 15 and 23 in each social class at 
age 7.  
Social Class at 
age 7 
 Proportion 
who wheeze 
at age 7 years 
(%) 
 Proportion 
who wheeze at 
age 15 years 
(%) 
Proportion 
who wheeze at 
age 23 years 
(%) 
I 4/18 (22.2%) 6/16 (37.5%) 5/14 (35.7%) 
II 22/67 (32.8%) 22/60 (36.7%) 17/47 (36.2%) 
III non-manual 10/44 (22.7%) 11/37 (29.7%) 9/31 (29.0%) 
III manual  26/133 
(19.5%) 
30/110 
(27.3%) 
26/93 (28%) 
IV  17/59 (28.8%) 17/49 (34.7%) 19/45 (42.2%) 
V  10/32 (31.2%) 7/26 (26.9%) 4/22 (18.2%) 
Unemployed 38/92 (41.3%) 21/57 (36.8%) 18/46 (39.1%) 
Overall 
proportion 
127/445 
(28.5%) 
114/355 
(32.1%) 
98/298 
(32.9%) 
Chi Squared 
for trend 
p=0.029* p=0.97 p=0.82 
 
 
As there was no direct measurement of social class at age 23, we can only use 
housing tenure and employment status as indicators of socio-economic class. 
Table 3.6 shows the association between wheeze and accommodation tenure at 
23 years while table 3.7 shows the same outcomes and their association with 
employment status at age 23 years.  There is no significant association with 
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either living in owner occupied accommodation or being employed and 
wheeze, asthma or atopy at age 23.  
 
Table 3.6 Association of housing tenure age 23 years with wheeze, asthma and 
atopy at age 23 years. 
Age Living in rented 
or council 
housing age 23 
Living in owner 
occupied home 
age 23 
OR (95% CI) p 
Wheeze 23  22/72 (30.6%) 70/207 (33.8%) 0. 86 (0.48-1.54) p=0.61 
Asthma 23  10/71 (14.1%) 41/207 (19.8%) 0.66 (0.31-1.41) p=0.29 
Atopy age 23 16/24(66.7%) 54/95 (56.8%) 1.51 (0.53-3.84) p=0.38 
Reference category is living in owner occupied accommodation 
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Table 3.7 Association of employment status age 23 years with wheeze, asthma 
and atopy at age 23 years. 
Age  Unemployed 
age 23 
Employed age 
23 
OR (95% CI) p 
Wheeze 23  13/39 (33.3%) 83/256 (32.4%) 1.04 (0.51-2.13) p=0.91 
Asthma 23  6/39 (15.4%) 46/255 (18.0%) 0.83 (0.33-2.09) p=0. 69 
Atopy age 23 6/11 (54.5%) 64/108(59.3%) 0.83 (0.24-2.87) p=0.76 
Reference category is employed status in above analysis 
 
 
3.9a) Association of wheeze, asthma and atopy with parental allergy and 
asthma 
Parental allergy was based on the mothers’ responses to questions in the 
antenatal questionnaire. Pregnant women were asked if there was a history of 
asthma, rhinitis or eczema in themselves or the unborn child’s father.  
 
Table 3.8 shows the frequency of a parental history of asthma and allergy.  
Fewer than 20% of subjects had parents with no history of asthma, rhinitis or 
eczema.  This was consistent with the admission criteria to the study since 
subjects were only recruited if a first degree relative had one of these 
diagnoses, and some of those would be siblings rather than parents.  Fewer 
than 40% of subjects had one or more parent with asthma.
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Table 3.8 Frequency of parental history of asthma alone and asthma, rhinitis or 
eczema. 
Attribute Present in 
neither parent 
Present in 
father only 
Present in 
mother only 
Present in 
both parents 
Asthma  298/486 
(61.3%) 
94/486 
(19.3%) 
83/486 
(17.1%) 
11/486 
(2.3%) 
Asthma, 
rhinitis or 
eczema 
95/486 
(19.5%) 
142/486 
(29.2%) 
191/486 
(39.3%) 
58/486 
(11.9%) 
 
 
 
Table 3.9 shows the association between parental history of allergy and 
wheeze, asthma and atopy at age 23.  Where both parents, and father only had 
allergy the subject was significantly more likely to wheeze, have asthma or 
atopy at age 23 years.  The associations with maternal allergy alone were not 
significant. 
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Table 3.9 Association of parental history of allergy† with wheeze, asthma and 
positive skin prick test at age 23 years. 
Family 
history of 
allergy 
Wheeze age 
23 years 
No wheeze 
age 23 years 
OR 95% CI 
Neither 10 45 1  
Mother only§ 38 80 2.14 0.97- 4.69 
Father only§§ 33 53 2.80 1.24 – 6.31* 
Both†† 17 23 3.33 1.31 – 8.42* 
 Asthma age 
23 years 
No asthma 
age 23 years 
OR 95% CI 
Neither 5 50 1  
Mother only§ 16 100 1.60  0.55-4.62 
Father only§§ 19 66 2.88  1.01-8.24* 
Both†† 12 28 4.29 1.37 – 13.42* 
 Atopy # age 
23 years 
No atopy age 
23 years 
OR 95% CI 
Neither 7 14 1  
Mother only§ 26 20 2.60 0.88- 7.64 
Father only§§ 29 13 4.46 1.46 – 13.65* 
Both†† 8 2 8.00 1.33 – 48.18* 
*Significant result  †Parental history identified before birth of subject 
§Mother only with allergy, exclusion of subjects with both parents who have 
allergy 
§§ Father only with allergy, exclusion of subjects with both parents who have 
allergy 
††Both parents have allergy, exclusion of those who have only one parent who 
have allergy 
#  Atopy defined as positive skin prick test to one allergen or more at age 23 
years 
 
 
  
91 
 
3.9b Association of wheeze, asthma and atopy with parental asthma  
 
Table 3.9 showed the association between the prevalence of wheeze, asthma 
and atopy at age 23 years and any parental history of allergic disease.  Table 
3.10 shows comparable results when the parental history is restricted to 
parental asthma.  The number of parents with asthma is fewer and therefore 
the power of these comparisons is lower and confidence intervals for effect 
sizes are wider.  There are significant associations for father only and both 
parents having asthma and wheeze and asthma age 23 years.  Maternal asthma 
is not associated with any significant outcomes.  There are no significant 
results between parental asthma and atopy age 23 years. 
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Table 3.10 Association of parental history of asthma† with wheeze, asthma 
and positive skin prick test at age 23 years 
Family 
history of 
asthma 
Wheeze age 
23 years 
No wheeze 
age 23 years 
OR 95% CI 
Neither 10 45 1  
Mother only§ 12 28 1.93 0.74- 5.05 
Father only§§ 17 27 2.83 1.13 – 7.08* 
Both†† 5 2 11.25 1.90 – 66.53* 
 Asthma age 
23 years 
No asthma 
age 23 years 
OR 95% CI 
Neither 5 50 1  
Mother only§ 4 36 1.11  0.28-4.43 
Father only§§ 12 32 3.75  1.21-11.65* 
Both†† 4 3 13.33 2.30 – 77.24* 
 Atopy# age 
23 years 
No atopy age 
23 years 
OR 95% CI 
Neither 7 14 1  
Mother only§ 7 9 1.56 0.41- 5.95 
Father only§§ 13 9 2.89 0.83 – 10.02 
Both†† 1 0 NA NA 
*Significant result    †Parental history identified before birth of subject 
§ Mother only has asthma, exclusion of subjects with both parents who have 
asthma 
§§ Father only has asthma, exclusion of subjects with both parents who have 
asthma 
§§§Both parents have asthma, exclusion of those who have only one parent 
who has asthma  
#  Atopy defined as positive skin prick test to one allergen or more at age 23 
years 
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3.10a) Body Mass Index (BMI) and wheeze age 23 years 
Using Cole’s cut off points for defining obesity from BMI, (20.63 kg/m2 in 
boys and 20.51 kg/m
2
 in girls at age 7 years)
152
, 10 out of 218 (4.6%) of male 
children and 9 out of 199 (4.5%) of female children aged 7 in our cohort were 
obese.   At age 23, 18.1% were obese, 15.0% of males and 21.4% of females.   
 
Table 3.11 presents the mean BMI at different ages in childhood, for those 
who wheeze and those who do not at age 23 years.  In addition it gives the OR 
and 95% confidence interval, with p value, for a 5 unit difference in BMI 
(5Kg/m
2
),  calculated using binary logistic regression with BMI as a 
continuous variable  as described in the methods.  The results in table 3.11 
show in female subjects that wheeze at age 23 is significantly associated with 
a BMI at ages 1 year, 7 years and 23 years but that is not so for male subjects. 
The effect size, the OR for a difference of 5kg/m
2
 decreases with age but this 
is largely because the difference of 5kg/m
2
 at age 1 is relatively much larger 
than at older ages.  This finding suggests that BMI in childhood may be 
associated with wheeze in adulthood in female subjects.   
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Table 3.11 Summary statistics of BMI by wheezing status at age 23 years, and 
the OR, and 95% confidence interval, for a difference of 5kg/m
2
. 
Male subjects only 
Age BMI 
measured 
Mean (SD, n) 
BMI in those 
who wheeze at 
23  
Mean (SD, n) 
BMI in those 
who do not 
wheeze at 23  
OR for 
difference of 
5kg/m
2 
(95% CI) p  
1 year 17.94 (1.33, 
47) 
18.51 (3.03, 88) 0.50 (0.17 to 1.54) 
0.22 
7 years 16.29 (1.29, 
45) 
16.32 (2.25, 93) 0.95 (0. 39 to 2.39) 
0.93 
23 years 26.05 (4.44, 
47) 
26.02 (4.67, 86) 1.00 (0.70 to 1.47) 
0.97 
Female subjects only 
Age BMI 
measured 
Mean (SD, n) 
BMI in those 
who wheeze at 
23  
Mean (SD, n) 
BMI in those 
who do not 
wheeze at 23  
OR for 
difference of 
5kg/m
2 
(95% CI) p  
1 year 17.88 (1.41, 
43) 
17.29 (1.29, 95) 5.19 (1.28 to 21.67) 
0.02* 
7 years 17.01 (2.85, 
49) 
16.04 (2.08, 
100) 
2.29 (1.10 to 4.83) 
0.02* 
23 years 27.49 (6.73, 
40) 
25.08 (5.25, 86) 1.40 (1.00 to 1.93) 
0.03* 
*significant results 
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3.10b) Severe wheeze and BMI 
As cited earlier, there is evidence that severe asthma is associated with 
obesity, especially in females.  For this reason we have investigated the effects 
of BMI on severe wheeze, as a proxy for severe asthma, in males and females.  
Table 3.12 demonstrates that severe wheeze is associated with a high BMI at 
age 23 but only in females.  The mean BMI in men with severe symptoms is 
lower than the BMI of those without symptoms, but the difference is not 
statistically significant.  High BMI is almost certainly associated with severe 
wheeze in females but not in males. 
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Table 3.12 Summary statistics of BMI by severe wheeze status at age 23, and 
the OR, and 95% confidence interval, for a difference of 5kg/m
2
. 
 Mean (SD, n) 
BMI in those 
who have severe 
wheeze at 23  
Mean (SD, n) 
BMI in those 
who do not have 
severe wheeze at 
23  
OR for 
difference 
of 5kg/m
2 
(95% CI) p  
Total 
group 
27.87 (6.63, 29) 25.70 (4.98, 230) 1.40 (1.00 - 2.01) 
0.038* 
males 24.13 (3.45,11) 26.19 (4.63,122) 0.52 (0.22 - 1.28) 
0.15 
Females 30.15 (7.13, 18) 25.13 (5.31, 108) 1.93 (1.28 - 2.82) 
0.002* 
 
 
 
 
3.11 Discussion 
3.11a) Response rate at age 23 years 
             
In this chapter we have investigated the response rate for subjects at age 23 
years and found that subjects who had wheeze at age 1 year, were male or 
were from unemployed families at age 1 year were significantly less likely to 
be followed up than those not in these groups.  The higher loss to follow-up 
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from male subjects is consistent with other studies
164
, but this effect has not 
been shown in the MAPS cohort before.   
 
There were significant differences between those who attended the laboratory 
for physiological measurements and those who did not.  This was probably 
due to self-selection of those who had more symptoms. Sample selection in 
cohort studies may alter the confounding patterns originally present in the 
general population, but this does not necessarily introduce selection bias in the 
exposure-outcome estimates. While there is some evidence that the group 
under investigation is not completely representative of the original population, 
this is unlikely to have a major impact on the estimate of the associations 
between risk factors and outcomes. 
 
3.11b) Rate of atopic disease and association with outcomes  
In the MAPS cohort we found high rates of rhinitis (44.4%) and low rates of 
eczema (16.7%) at age 23.  Childhood rhinitis was associated with wheeze, 
asthma and atopy at age 23 years and childhood wheeze was associated with 
adult wheeze and adult asthma.  Childhood eczema was not associated with 
any of these attributes at 23 years of age.  In the MAPS cohort there was an 
association of childhood rhinitis and wheeze up to age 15 years with wheeze 
and asthma age 23 years and childhood rhinitis with atopy age 23 years.  Adult 
rhinitis and eczema were associated with wheeze and asthma at age 23 years 
and adult rhinitis with atopy at age 23 years. The TAS (now named the 
Tasmanian health study) found there was an association of childhood rhinitis 
and eczema with adult atopic asthma, defined as asthma and sensitisation to 
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four perennial allergens, and that childhood eczema and rhinitis were only 
associated with atopic asthma but not with non-atopic asthma
165
.  Although 
another GP based study found that eczema followed by asthma followed by 
rhinitis is the usual allergic march trajectory
166
, we found no association of 
childhood eczema with wheeze, asthma or atopy, in the MAPS cohort, 
suggesting this was not a common trajectory with our subjects.   
   
3.11c) Socio-economic status and outcomes   
We have shown that wheeze at age 1 year was more likely in those from a 
lower social class at age 1 year.  There was also a significant association 
between wheeze age 7 years and social class at age 7 years, although the 
association is not as strong as that at age 1 year.   At both age 15 and age 23 
years wheeze was not associated with social class at age 1 or age 7.  Therefore 
the association of wheeze and social class does not appear to persist after the 
age of 1.  There are a number of possible explanations for this.  
  
We have used housing tenure to indicate social class and there is a precedent 
for this since Davies et al used data from two well-established sample surveys, 
the Family Expenditure Survey (FES) 1983 and 1990 and the General 
Household Survey (GHS) 1984 to estimate associations between housing 
tenure and income.  They showed that living in rented accommodation was 
significantly associated with low income and living in an owner-occupied 
dwelling was an important indicator of relative affluence.  The effect was 
greater for data taken in 1990 compare to 1983 in the FES
167
.  Therefore we 
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are left with the question of why we did not show any association with wheeze 
at age 23 years but did with wheeze at age 1 and social class. 
One explanation is that there may be an association between social class and 
wheeze and asthma age 23 years but the lack of a good assessment of social 
class at age 23 years has reduced the effect size of this association.  Using a 
poor measure, whether that from an earlier age or a proxy such as housing 
tenure, is likely to weaken associations.  Although Davies et al have shown 
that housing tenure is usually an effective measure of relative deprivation, the 
housing stock for our cohort in Merthyr Tydfil may not require such affluence 
to own.  Almost 75% of the population in our cohort were owner occupiers 
while only 60% in the Davies study were.  Over 40% of unemployed subjects 
in the MAPS cohort were owner occupiers of housing.  These facts suggest 
that housing tenure may not have been such a good indicator of social class in 
our subjects at age 23 years, and this may be why we found no association 
between social class and wheeze at this age. 
Yet another possible explanation is that there really is no association between 
wheeze age 23 years and social class.  So there is a pattern of associations 
which weakens with age.  This is not consistent with other studies such as that 
by Braback et al of Swedish recruits.  They found that low socio-economic 
status (SES) was associated with an increased risk of asthma without allergic 
rhinitis (1.14, 95% confidence interval (CI) 1.11–1.17) but a slightly reduced 
risk of asthma with allergic rhinitis (0.96, 95% CI 0.93–1.00) 132.  This was a 
large population study with social class contemporaneously assessed, which 
may explain the differences between their results and those found in MAPS.  
However, the German MAS study found that the association of social class 
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and wheeze changed over generations, with parents in high SES groups more 
likely to have recurrent wheeze than those in lower SES groups, while in their 
children’s generation there was no such association. Although the MAPS is 
not completely comparable, as it contains only one generation of subjects, it is 
possible that the environmental factors that are associated with lower social 
class subjects and wheeze when they were age 1 year, have changed in some 
way over the intervening period so that the social class differentiation is lost 
over time.    
 
A further reason why wheeze at age 1 was associated with social class and 
later wheeze was not is that early life wheeze may be aetiologically different 
to the wheeze in later childhood and adulthood.  Early wheeze is often 
considered to be as a result of respiratory infections, which could be more 
common in lower social class subjects where the environment may be more 
crowded.  In addition not all subjects who wheeze at age 23 years are suffering 
from the same wheezing disorder and some may have COPD while others 
have asthma. 
 
Lastly the number of subjects in this study is small at age 23 years and as there 
are 5 social classes we may not have had the power in our study to show the 
relationship between social class and outcomes at age 23 years even though a 
relationship does exist.  Hence even though we have not found an association 
this doesn’t mean there isn’t one.   
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3.11d) Familial disposition  
Parental allergy, especially allergy in the father of subjects in MAPS, was 
associated with wheeze and asthma at age 23 years.  Our results showed no 
significant association with maternal asthma or maternal allergy.  Although 
this was similar to the study by Alford et al, which showed that paternal 
allergy and asthma was more strongly associated with asthma when aged 6-7 
years
145
, there have been no studies which give similar results to MAPS for 
subjects in early adulthood.  The Tasmanian population-based longitudinal 
study showed that both maternal and paternal asthma were associated with 
asthma in the adult offspring but maternal asthma gave a higher OR
146
.  It is 
not clear why our results were so different but one possible explanation is that 
the history was most often taken from the mother at booking in clinic.  This 
may have introduced bias as the mother would have more information on her 
previous history than her spouse’s history and it is possible that only the more 
severe asthma and allergy symptoms in her partner were noted by the mother. 
There is some evidence that mothers may have under reported father’s allergic 
disease since mothers were more frequently affected by allergic symptoms 
(51% of mothers) than their spouses (41% of fathers).   Although this 
difference is small, there is no reason to suspect that females would be more 
likely to suffer from atopic disease than males, especially since  atopic disease 
defined by skin prick test is more common in adult males than females
37
. In 
summary our findings are similar to other published work on parental allergy 
and asthma although there was a tendency for paternal allergy and asthma to 
be particularly important in the inheritance patterns of our subjects.         
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3.11e) BMI in childhood and adulthood and outcomes in adulthood  
Our results show a significant association between BMI in females at ages 1, 7 
and 23 years and wheeze at age 23 years.  A high BMI in childhood is 
associated with the occurrence of disease symptoms in adulthood, which is 
evidence against the view that obesity occurs because subjects are unable to 
exercise (reverse causality), since subjects had higher BMI than their 
counterparts up to 22 years before the outcome measure.   Chen et al found 
that Canadian female subjects aged at least 12 years with a BMI at least 28 
kg/m
2
 had a significantly raised risk of asthma compared to those with a  
lower BMI; there was no similar increased risk in males
168
.    However they 
did not investigate associations between BMI in childhood and wheeze in 
adults.  One study by Castro-Rodriguez et al in USA, investigated obesity in 
childhood and found females who became overweight or obese between 6 and 
11 years of age were at a significantly increased risk of developing new 
asthma symptoms and increased BHR during the early adolescent period
169
.  
An RCT of weight reduction in obese adult subjects with asthma showed 
improved lung function, symptoms, morbidity, and health status as weight was 
reduced
13
. Our study was not powered to investigate obesity.  Are there 
explanations of this association between BMI in childhood and symptoms in 
early adulthood?  Firstly there may be common risk factors for both asthma 
and increase in weight. There is evidence that immune responses and 
metabolic regulation are highly integrated and the proper function of one is 
dependent on the other
170
.  Increase in weight would affect the metabolic 
regulation of an individual and thereby could have an effect on their immune 
response.  Some have suggested an association between  obesity and atopy
171
, 
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but there was no evidence for that in this cohort. However one study from 
Adelaide showed an increased risk of asthma in females without atopy
172
.  
Secondly there may be common dietary risk factors for both obesity and 
asthma.  For example, fast food has low levels of antioxidants and vitamins, 
while hamburger consumption is associated with childhood asthma and take-
away consumption is associated with bronchial hyper reactivity
56
.  Both 
excess take-away food and hamburger consumption are associated with an 
increased risk of obesity.  A sedentary life style may also lead to greater time 
spent at home and therefore greater exposure to aeroallergens that are present 
in modern homes and this may induce an association between obesity and 
asthma.  However none of these explanations account for the differences 
between males and females.  Adult females have relatively smaller airways for 
their lung size than do adult males (dysynapsis ratio)
173
 and so adiposity and 
restriction of the chest wall due to adiposity may make obstruction of airways 
more likely in females.   
 
A further explanation of why women with a higher BMI have an association 
with wheeze at age 23 years while men do not is provided by the fact that 
Wheeldon et al have shown that in females during the luteal phase of the 
menstrual cycle, there is an increase in β2-adrenoceptor density on 
lymphocytes which is significantly higher than in male subjects
174
 and 
hormonal changes are known to occur in over weight and obese women
175
.  
The β2 receptors are important targets for many drugs used in the treatment of 
asthma and it may be that hormone levels in females with a higher BMI 
interfere with normal cyclical control of β2 receptors.  
104 
 
 
In summary chapter three has presented that this cohort is representative of the 
original population.  We have also found that there is no significant 
association between social class and outcomes at age 23 years, although we do 
not have a good measure of social class at age 23.  We found that family 
history of allergic disease is linked to wheeze and asthma in young adults and 
that BMI, in childhood as well as adulthood, is associated with wheeze and 
severe wheeze but only in female subjects.    These findings support the view 
that early life events make an important contribution to risk of adult life 
outcomes. 
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Chapter 4 
 
Atopy and Asthma 
4.0 The Association of Atopy and Asthma 
Atopy is the ability to mount an IgE mediated specific response against an 
allergen.  It is measured by sensitisation on either positive skin prick testing or 
a raised IgE level in serum to a specific allergen.  There is strong evidence of 
the association of atopy with asthma in both cross-sectional
41, 176
 and 
longitudinal
47
 studies.   Allergen exposure is known to lead to inflammation in 
atopic asthma
177,
 
178
 and cause exacerbations of asthma
179
, but whether 
allergen exposure actually causes asthma still remains controversial with some 
evidence for
180
 and other evidence against
83
.     
 
The longitudinal Tucson epidemiological study of airway obstructive diseases 
(TESAOD) study found that sensitisation before the age of 8 years was 
associated with symptoms of wheeze and shortness of breath in later 
childhood and children who were sensitised after 8 years of age were no more 
likely to have wheeze and shortness of breath than children who were never 
found to be sensitised. Based on these results they concluded that early 
allergic sensitisation was a signiﬁcant risk factor for later development of 
symptoms of wheeze, and late sensitisation was not
181
. Arshad et al studied 4 
year old children in a birth cohort.  Of those with positive skin prick test 
reactions to 4 or more allergens nearly 80% had asthma, eczema, and/or 
rhinitis compared with 20% of those who had no positive skin prick test 
reactions
34
.   The German MAS longitudinal study found that atopy had been 
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present from an earlier age in subjects with asthma at age 7 years than in those 
without asthma at this age
182
.  They also found that persistent sensitivity to 
food allergens by the age of 2 years
183
 and aeroallergens by age 7
182
 was 
associated with asthma later in life, and that 90% of children who had wheeze 
but no atopy lost their wheeze and had normal lung function by school age 
while having atopy by the age of 3 years was associated with loss of lung 
function at school age
49
.   Early sensitisation to a broad panel of allergens was 
shown to be more strongly associated with asthma at age 10 (Isle of Wight 
cohort) or 11 (Manchester Asthma and Allergy Study-MAAS) than 
conventional atopy (sensitisation to one or more allergen)
184
.  The MAAS 
study has shown that multiple early sensitisation, defined by cluster analysis in 
subjects who were tested at age 1, 3, 5 and 8, was associated more strongly 
with asthma at age 8 than conventional atopy (positive sensitisation to at least 
one allergen)
89
.  These studies suggest that sensitisation to allergens early in 
life is often associated with concurrent asthma and also with persisting asthma 
symptoms later in life.  The two phenotypes of early childhood wheeze most 
likely to develop into asthma at age 16 years, in the TCRS cohort, were the 
persistent and late onset wheeze phenotypes.  Both these phenotypes were 
associated with sensitisation to common allergens
185
. 
 
4.1 Prevalence of sensitisation over time 
Sensitisation is the ability of the immune system to mount a response to a 
specific allergen. The definition of atopy is usually given as the presence of 
sensitisation to at least one perennial allergen.  Sensitisation to at least one 
allergen
186
, and to 5 or more allergens (polysensitisation)
187
, has been shown 
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to be more common in males.   The NHANES II cross-sectional study reported 
that sensitisation peaks in teenagers and young adults
188
.  NHANES II also 
reported that there was an association between skin prick reactivity and socio-
economic status with those from a higher social class being more likely to be 
sensitised
189
.   Sensitisation to at least one of the 6 allergens tested in both 
NHANES II (1976-80) and NHANES III (1988-1994) revealed a large 
increase in sensitivity between the two studies with 22% of subjects positive in 
the earlier study, and 42% positive in NHANES III
190
.  This echoes the 
findings in other studies, as reviewed by Eder, that the prevalence of atopy is 
increasing
6
.   
 
TESAOD investigated atopy defined by an allergen skin prick test to 5 
allergens, on a population of 1333 subjects aged between 3 years and over 75 
years.  On the initial review 39.1% of subjects were positive to at least one 
allergen.  Approximately 8.5 years later, at follow up, 50.7% were positive.  
They found that atopy was more prevalent at younger ages, peaking at age 15-
34 and that the greatest increase in prevalence of atopy occurred among those 
who were children and teenagers (less than 5 to 14 year of age at base line), 
22.2% and 19.5% respectively, with only minimal increases after the age of 65 
years, 6.0%
191
. A British study divided subjects from a population age 18 to 71 
into six 9 year successive birth cohorts and each subject was tested twice once 
in 1991 and once in 2000.  They found that the prevalence of sensitisation was 
higher in younger subjects in both studies in the initial study 46% of the 18-26 
years age group had a positive skin prick test result while only 21% of the 63-
71 age group had a positive skin prick test.  There was no significant change in 
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prevalence of sensitisation between the two groups over the 9 year period 
(46% and 23%) respectively
192
.   
 
The prevalence of atopy in childhood increases with age, as shown by the 
Tucson Children’s Respiratory Survey (TCRS) based on an unselected 
population of children from a Health Management Organisation (HMO) in 
Tucson, Arizona, who were skin prick tested to aeroallergens.  At age 6 years, 
38.6% of children were positive while at age 11 years 58.1% were positive
193
. 
The longitudinal birth cohort study from Stockholm (BAMSE) showed that 
from age 4 to 8 years, the proportion of children sensitised to any of the 
aeroallergens tested, increased from 15% to 25%
194
.  Although the ages are 
comparable in the TCRS and BAMSE studies, it is clear that children from 
Tucson have a higher rate of atopy than those from Stockholm.  This is 
probably due to differing environmental conditions in different countries.  
Studies have shown that the prevalence of sensitisation varies between 
countries
195-197
, and in different geographical areas within a country
198
. 
 
Aslund et al published in 2008 the results of 2 skin prick test examinations, 3 
years apart, on subjects from Copenhagen aged 14-44 years, who answered a 
postal questionnaire reporting they had symptoms suggestive of asthma or 
allergy.  On repeat testing, they found that 22% had developed de novo 
sensitisation to 1 or more allergens that they were not sensitive to on the 
original test.  A total of 39% had either a gain or a loss of sensitivity and 
therefore there was a high prevalence of change in sensitisation in this 3 year 
period
199
.  In 2004, Bodgter et al investigated a population of 18–69 year olds 
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in Copenhagen and their 8-year remission rates for sensitisation to pollen 
allergens and dust mite/pet allergens based on specific IgE were 6% and 11%, 
respectively
200
. This suggests that once aeroallergen sensitisation occurs it 
rarely remits.  The German MAS study investigated serum IgE levels to 
aeroallergens at 2, 5, 7 and 10 years in 273 children and found the prevalence 
of sensitisation to each allergen increased steadily throughout childhood, and a 
hierarchy of sensitisation prevalence (grass > birch> house dust mite (HDM)> 
cat> dog) was maintained from 5 years of age onwards. A mono-sensitisation 
state was relatively short (measurable half-life = 3 years) as additional 
sensitisations were acquired frequently, and relatively soon after the ﬁrst one. 
Remission of weak sensitisation was also quite frequent, especially before 5 
years of age. By contrast, stronger IgE responses were more likely to be 
persistent. Early sensitisation was associated with a higher tendency for poly-
sensitisation at 10 years of age
201
.    
 
4.2 Allergen exposure and sensitisation 
The German MAS longitudinal study showed that high levels of allergen 
exposure (defined as Der p 1 and Der f 1 level present in carpet dust, collected 
at 6 months and again at 18 months by vacuuming undertaken by the subject’s 
family), were associated with sensitisation in the first three years of life
202
.  
Sporik et al showed a non-significant association between house dust mite 
exposure in infants (those with the highest quartile of der p1 in their 
mattresses and carpets) and sensitisation at age 10-11
180
. Cullinan et al found 
no significant linear association between allergen exposure and sensitisation at 
age 5 but their results suggested that at low levels of allergen exposure there 
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was a linear relationship between exposure and sensitisation which was 
attenuated at higher exposure levels
36
.  However, control of the environment, 
by reducing antigenic load during infant years, did not improve sensitisation 
rates in the longitudinal MAAS study
203
.   The MAPS also found no evidence 
of an association between the rate of sensitisation, defined by skin prick tests 
at age 1 year or age 7 years,  and the level of  house dust allergen
107
.  This 
evidence suggests that the level of exposure may not be associated with the 
prevalence of sensitisation. 
 
4.3 Studies of total serum IgE and asthma 
A decade after IgE was first discovered,  Brown et al showed that heightened 
levels of IgE were associated with allergic respiratory diseases and rhinitis, 
and that skin prick test reactivity correlated with both total and specific IgE
204
.  
However, it has been difficult to establish normal values for serum total IgE
205
 
and subjects who have what is considered to be the non-atopic range for total 
serum IgE (i.e. below 30iu/ml) may still have a raised positive specific IgE to 
house dust mite allergen
38
.  Burney et al as part of an international European 
Centre Respiratory Health Study (ECRHS) found that there are substantial 
variations in the prevalence of positive skin prick test and the level of serum 
IgE worldwide, and that the variations were independent of each other and 
likely to be largely environmental in origin
195
. Sears et al reported, in 1991, 
that asthma risk was related to total IgE in 11 year olds.  They found that no 
child with IgE levels below 32iu/ml had asthma whereas 36% of those with 
total IgE levels above 100iu/ml did
206
.  Burrows et al investigated the 
association of self-reported asthma with serum total IgE levels and skin-test 
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reactivity to common allergens in 2657 subjects in a general-population study 
in Tucson Arizona. They found that regardless of the atopic status of the 
subject, the odds ratio for asthma increased linearly with the log serum total 
IgE level after controlling for possible confounders and the degree of 
reactivity to skin tests (p< 0.0001)
41
.  An analysis of the Spanish data from the 
ECRHS confirmed that asthma was associated with serum total IgE 
independently of specific IgE levels.  Serum total IgE above 100iu/l was 
especially likely to be associated with current asthma in this study
207
.  In 
further studies serum total IgE has been linked to greater BHR
208
.    
 
4.4 Exclusion of allergens as prevention of allergic disease 
Sporik et al showed that children who had been exposed to high levels of 
house dust mite in the first year of life were more likely to suffer with asthma 
at the age of 11
180
.  Subsequent research
209, 210
 has attempted to exclude 
allergens, such as house dust mite, that have been thought to pose a risk of 
atopy and asthma but has found no benefit despite evidence that significant 
allergen exclusion was achieved. There is no evidence that exclusion of one 
antigenic substance early in life reduces the risk of asthma
203, 211
, although the 
exclusion of multiple allergens from birth to 12 months of age in the Isle of 
Wight study has been associated with a reduction in the risk of developing 
asthma at age 18 years
212
.   
 
In conclusion, although controversy remains regarding the causal pathway 
linking atopy and asthma, the importance of immunological markers of atopy 
in the asthma syndrome is clear.  For this reason it is important for us to 
112 
 
investigate the atopic status of our cohort, how different measures of atopy 
compare in this cohort, and with what symptoms these markers of atopy are 
associated. 
 
4.5 Aims and objectives:  
The aim is to investigate changes in atopy, defined through both skin prick 
tests and IgE, from birth to age 23 years and to investigate associations 
between atopy and outcomes at age 23. 
 
Objectives 
 To investigate the changing pattern with age of atopy as assessed by a 
positive skin prick test and by total IgE 
 To compare definitions of atopy based on total IgE and on skin prick 
tests to assess if a cutpoint can be determined for total IgE, above which atopy 
can be defined in this cohort . 
 To investigate the association of atopy, using both of these definitions, 
with outcomes at age 23 years 
 To investigate the prevalence of atopy among subjects who wheeze in 
the MAP study cohort 
 To investigate the association of total IgE with outcomes at age 23 
years after adjustment for atopy (defined as at least one positive skin prick 
test), as a way of signifying a relationship between total IgE and asthma that is 
beyond atopic status. 
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4.6a) Methods  
Details of methods for skin prick testing are given in chapter 2.  Skin prick 
testing was undertaken at age 6 months to 12 allergens (cat, egg, grass pollen, 
tree pollen, milk, soya, house dust mite, feather, fish, flour, Aspergillus sp, dry 
rot) and at 1 year to 14 allergens: the above 12 and also house dust and weed.    
At age 7 years cat, egg, grass, milk, house dust mite, mould 1 (mixture 
containing [fungi imperfecti] Cladosporium sp and Alterneria sp) and mould 2 
(Alterneria sp) were tested.  At age 23 years subjects were tested for the 
following allergens: house dust mite (HDM), cat, dog, grass, tree, moulds, 
milk, peanut, eggs. At each age, atopy was defined as having a positive 
response to at least one allergen. 
 
Total IgE was measured in maternal blood taken during pregnancy.  Total IgE 
was also measured in cord blood, and samples were taken for total IgE at age 3 
months, 1 year, 7 years and 23 years.  The number of samples taken at age 1 
was small (only 13.1% of the cohort) and therefore total IgE results at age 1 
have been disregarded. 
 
4.6b) Statistical methods 
For basic statistical methods please refer to chapter 2.  Total IgE is usually 
normally distributed after logarithmic transformation
213
 and all analyses have 
used the log of IgE. Linear regression analysis was used to investigate 
relationships between log total IgE at different ages adjusting for 
randomisation status and for gender, a known confounder. The results were 
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summarised using the values of R
2
; this measures the square of the 
multivariate correlation coefficient.  This test gives an indication of how much 
variation in the outcome variable is due to the explanatory variables.  
 
 
4.6c Defining atopy using total IgE 
 
 
To define atopy using total IgE we need to define a cutpoint such that any 
value of total IgE at least equal to this value indicates atopy. This is achieved 
by relating the total IgE levels to the results of skin prick testing, taking those 
as the gold standard. There are several criteria for choosing the ‘optimal’ 
cutpoint.  One approach to establishing a cutpoint for total IgE is to take a 
fixed threshold based on previous work.  This was the approach taken by 
Sunyer et al in the ECRHS multicentre study in 1996 when they used total IgE 
above 100iu/l based on previous studies to define a cutpoint for IgE.  They 
found that subjects with an IgE above 100 were more likely to have current 
asthma even if they were negative for specific IgE
207
.  However this approach 
may not be correct for every population since total IgE is likely to be specific 
to each population.  For the MAPS cohort we will use other methods to define 
our cutpoint.  One is based on sensitivity and specificity of IgE for a positive 
skin prick. The sensitivity of a diagnostic test is the proportion of subjects, 
who are truly positive, who are correctly identified by the test. The specificity 
is the proportion of subjects who are truly negative that are correctly identified 
as negative by the test.  The Receiver Operator Characteristic (ROC) curve is a 
graphical representation of how well a diagnostic test measures against a 
‘Gold Standard’, such as a clinical diagnosis of a disease.  It plots sensitivity 
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against 1 minus specificity and the area under the curve (AUC) is a measure of 
the diagnostic ability of the test.  An AUC of 1 differentiates perfectly 
between diseased persons (sensitivity = 1) and healthy persons (specificity = 
1)
214
.  An AUC of 0.5 means that, overall; there is a 50-50 chance that the 
biomarker will correctly identify diseased or healthy persons as such.  The 
ideal test would have an area under ROC curve of 1, whereas a random guess 
would have an area under ROC of 0.5
215
.  
 
It is desirable to choose a cutpoint that has high values for both sensitivity and 
specificity but varying a threshold usually leads to an increase in one at the 
expense of a decrease in the other. One widely-used criterion is to choose the 
cutpoint which maximises the sum of the sensitivity and specificity.  A second 
criterion is based on choosing a cutpoint which gives a similar prevalence of 
atopy based on the total IgE to that using skin prick tests. 
 
4.7 Results 
4.7a Skin Prick Test results 
Figure 4.1 shows the prevalence of skin prick positivity to six different 
allergens at ages 6 months, 1, 7 and 23 years. These are based on the subjects 
who had skin prick tests at all of these ages.  The results show an increase in 
atopy with age, with a rate of 9% at 6 months of age, 18% at age 1 year, 25% 
at age 7 years and 59% at age 23 years.   Food allergen sensitivity peaked in 
early childhood and then returned to a low level by age 7 years.  The 
prevalence of HDM sensitivity increased from 0.8% at 6 months to 42.4% at 
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23 years, while the prevalence of egg sensitivity was 11.9% at 6 months, 
reached a peak of 12.7% at age 1 year and fell to 1.7% at age 23 years.  
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Figure 4.1: Positive skin prick test to 6 different allergens over time in those 
tested on all four occasions. 
 
 
Changes in positive and negative skin prick tests, over time, for the 118 
subjects who had a skin prick test on every occasion, are tracked in Table 4.1 
and show that all those who were positive in their first 6 months of life were 
also positive at age 23 although some had a period of negative skin prick test 
in their childhood.  Of 30 subjects who had a positive skin prick test at age 1 
year, 12 were positive at age 6 months and 18 were negative at 6 months. On 
the whole, the subjects were more likely to become positive later in life if they 
had been positive earlier in life.  Over the course of the study just under a third 
of subjects who were tested on every occasion were never atopic, while 
another third were only atopic on one out of the four occasions. 
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Table 4.1 The time course for the positive skin prick test of the 118 subjects 
who were tested at all four ages. 
Age 6 months 1 year 7 years 23 years 
positi
ve 
negati
ve 
positi
ve 
negativ
e 
positi
ve 
negativ
e 
positiv
e 
negati
ve 
6
m
o
n
th
s po
si
 16  12 4 12 4 16 0 
n
eg
  102 18 84 23 79 54 48 
1
 y
ea
r 
 
p
o
si
   30  14 16 21 9 
n
eg
    88 21 67 49 39 
7
  
y
ea
rs
  
p
o
si
     35  34 1 
n
eg
      83 36 47 
2
3
  
y
ea
rs
  
p
o
si
       70  
n
eg
        48 
Posi= positive skin prick test   
neg=negative skin prick test  
       =positive at earlier age and remains positive               =positive early and negative later 
       =negative early and then positive                  =negative up to this time point 
 
Table 4.2 shows the relationships between atopy at different ages, emphasising 
this tracking of atopy throughout the study period.  A positive skin prick test 
early in life means that a positive skin prick test later in life is more likely.  
There is a significant association between an early positive skin prick test and 
positive skin prick tests later in life.  Few subjects had skin prick test 
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undertaken at age 23 years and therefore the confidence intervals are wide, 
though the effect sizes are quite striking.  
 
 
Table 4.2 Association between skin prick testing at different ages for all 
subjects who underwent skin prick testing at each age 
Earlier age Later age OR (95% CI) P value 
6 months  1 year 11.19 (5.69-21.99) <0.0001 
 7 years 6.46 (3.27-12.77) <0.0001 
 23 years NA† NA† 
1 year 7 years 3.54 (2.10-5.97) <0.0001 
 23 years 1.73 (0.71-4.23) 0.16 
7 years 23 years 48.38 (6.32-370.66) <0.0001 
† OR cannot be calculated as all subjects who were atopic at age 6 months 
were also atopic at age 23 years 
4.7b) Serum total IgE results 
We will now present changes in total IgE over the years in this cohort.  The 
distribution of IgE is well known to be highly skewed and therefore we have 
taken log values to undertake analysis and report the geometric mean.   Table 
4.3 summarises the distribution of IgE at different ages using the geometric 
mean, median, maximum and minimum.  The maximum levels are found at 
age 7 years and 23 years.  
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Table 4.3 The value of IgE in maternal blood, cord blood and subjects at age 3 
months, 7 years and 23 years. 
 Number 
tested 
Minimum Maximum Median 
 
Geometric 
Mean  
Maternal IgE 433 0.2 10240.0 42.0 42.0 
Cord Blood 
IgE 
386 0.1 447.0 0.3 0.3 
3 months IgE 450 0.1 151.00 1.5 1.5 
7 year IgE 338 0.1 4137.00 44.0 47.6 
23 years 99 0.3 2287.00 44.5 47.4 
 
Table 4.2 showed that there were strong associations between atopy (defined 
as positive skin prick test) at different ages.  Although atopy has not yet been 
defined using IgE, Table 4.4 shows associations between IgE at different ages.  
Linear regression analysis has been used to analyse total IgE at different ages 
and the results are summarised using the values of R
2
; this measures the 
square of a multivariate correlation coefficient but here it has been adjusted to 
show the percentage of variation explained only by the earlier IgE value.   As 
with atopy defined using positive skin prick tests (table 4.2), there are 
substantial associations between IgE levels at different ages.  There is also an 
increase in median IgE up to age 7 years (table 4.3) but the behaviour from 
age 7 to age 23 years is very different to skin prick test results which continue 
to rise especially for aeroallergens as shown in figure 4.1.  
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Table 4.4 The relationships between log serum IgE at different ages 
Earlier age Later age R
2
 P value 
Newborn 
(cord) 
3 months 0.057 <0.0001 
 7 years 0.019 0.076 
 23 years 0.004 0.589 
3 months 7 years 0.101 <0.0001 
 23 years 0.095 0.002 
7 years 23 years 0.284 <0.0001 
†adjusted for gender and randomisation group and the R2 values are derived 
from the variation that are not explained by these two variables. 
 
4.8 Definition of atopy as determined by total IgE- Establishing a cutpoint of 
serum total IgE to define atopy in the MAP study cohort  
Although we know that high values of total IgE are associated with atopy and 
asthma, it is difficult to demarcate the upper limit of normal in a population.  
However not all populations are the same and it may be that the population of 
the MAP study may have a natural cutpoint.  With this in mind we will 
attempt to establish a cutpoint of total IgE that may define atopy in this cohort. 
 
One approach to establishing a cutpoint for total IgE is to take a fixed 
threshold based on previous work.  Another approach is to use the skin prick 
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test results, as a ‘Gold standard’ and to choose the threshold for IgE in relation 
to this standard. Having a positive skin prick test is a binary outcome which 
we can use to define atopy. We need to find a threshold above which atopy is 
indicated, i.e. one that can define an increased risk of atopic disease. However, 
we must first prove there is an association between positive skin prick test and 
log total IgE. 
 
 
Figure 4.2 shows there is a relationship between total IgE at age 23 years and 
skin prick testing at age 23.  Using the student t test the mean log total IgE at 
age 23 in those who are skin prick test positive is significantly higher than 
those who are skin prick test negative p<0.0001.  Similar is true of log IgE at 
age 7 years and skin prick test result at age 7 years (p<0.0001) and for log IgE 
at 3 months and skin prick test result at 6 months (p<0.0001). This shows 
there is a relationship between total IgE and skin prick test results in our 
cohort but does not necessarily mean that we can define atopy reliably using 
total IgE.  
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Figure 4.2 Distributions of log IgE at age 23 years for subjects who are skin 
prick positive and negative at age 23 years 
 
 
 
 
Using our own data to establish a cutpoint there are two possible methods: one 
is to find the threshold for total IgE which maximises the sum of the 
sensitivity and specificity against a gold standard such as a positive skin prick 
test, while another is to choose a cutpoint which gives approximately the same 
prevalence as the gold standard (point prevalence).  
 
Figure 4.3 shows the ROC curve for the analysis at age 23, plotting sensitivity 
against 1-specificity over all possible cutpoints with atopy defined by skin 
prick testing as the ‘Gold Standard’.   The ROC curves for the other ages are 
not shown. The area under the ROC curve (AUC) is 82% here. At 3 months, 
relating total IgE to positive skin prick test at age 6 months, the AUC was 0.59 
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which is only just above 50%.  At age 7 the AUC was 0.79, this suggests that 
at age 3 months the total IgE can only just discriminate between atopic and 
non-atopic subjects as defined by skin prick test at age 6 months, while at ages 
7 and 23 the total IgE is a much better discriminator. This may be at least 
partly because there was no time lag between the two tests being undertaken, 
as there was when the subject was an infant. 
 
A perfect test would have sensitivity and specificity both equal to 1.  If a cut-
off value existed to produce such a test then the sensitivity would be 1 for any 
non-zero values of 1- specificity.  The ROC curve would start at the origin 
(0,0), go vertically up the y-axis to (0,1) and then horizontally across to (1,1). 
A good test would be somewhere close to this ideal
215
.  The ROC curve in 
figure 4.3 approximates this idealised curve but is not perfect. 
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Figure 4.3 ROC of log IgE age 23 years compared to positive skin prick test 
age 23 years 
 
 
 
Table 4.5 shows cutpoints for total IgE at ages 3 months, 7 years and 23 years, 
based on maximizing the sum of the sensitivity and specificity, as well as the 
sensitivity and specificity and the prevalence for that cutpoint, that is the 
percentage of subjects whose IgE value exceeds the cutpoint.  At age 3 
months, the cutpoint is only 1.45 iu/ml and the prevalence of atopy, based on 
this cut point, is 52% compared to 9.4% using skin prick testing.   This 
suggests this is a poor cutpoint for defining atopy at age 3 months.  At age 7 
years the cutpoint is higher at 45.5 iu/ml, with a consequent prevalence of 
atopy of 48%, compared to 25.3% using a skin prick test. Again the cutpoint 
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could be considered too low as too many subjects have total IgE above the 
cutpoint. At age 23 the cutpoint of IgE is a little higher than at age 7 and the 
prevalence of atopy is 48% based on this, compared to 58% using skin prick 
tests. 
 
Table 4.5 IgE cut off, equivalent to a positive skin prick test, calculated using 
sensitivity and specificity. 
Age of 
Serum 
IgE 
level 
Total IgE cut 
off based on 
maximised 
sum of 
Sensitivity 
and 
Specificity 
(iu/ml) 
Age of 
SPT 
undertak
en 
% SPT 
positive 
(positive/t
otal tested) 
S
en
sitiv
ity
 
S
p
ecificity
 
% of 
subjects 
with 
total IgE 
above 
cutpoint 
value 
PPV 
3 
months  
1.45 6 months  9.4%  0.79 0.51 52% 0.14 
7 years  45.5 7 years 25.3%  0.77 0.61 48% 0.4 
23 
years  
49.2 23 years 58.8%  0.70 0.83 48% 0.85 
PPV positive predictive value of this cut off point for IgE compared to 
positive skin prick testing 
SPT skin prick test 
 
These results are rather poor and so using the criterion of ensuring similar 
prevalences may be more useful. Therefore cutpoints are chosen to 
approximate the same proportions of positive results we would obtain with our 
‘gold standard’, i.e. the proportion above the cutpoint at age 3 months would 
be 9.4% and  25.3% at age 7 years and 58.8% at age 23 years.  The resulting 
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cutpoints, and the corresponding values of sensitivity and specificity, are 
shown in Table 4.6.  
 
Table 4.6 IgE cut off equivalent to positive skin prick test calculated using 
point prevalence 
Age of 
Serum 
IgE 
level 
IgE cut off 
based on 
point 
prevalence 
(iu/ml) 
Age  SPT 
undertaken. 
% SPT 
positive 
(positive/total 
tested) 
S
en
sitiv
ity
 
S
p
ecificity
 
% of 
subjects 
with 
total 
IgE 
above 
cut off 
value 
PPV 
3 
months  
7.7  6 months  9.4%  0.33 0.93 9.6% 0.34 
7 years  131.0  7 years 25.3%  0.56 0.85 25.1% 0.55 
23 
years  
35.0  23 years 58.8%  0.80 0.73 58.6% 0.80 
PPV positive predictive value of this cut off point for IgE compared to 
positive skin prick testing 
SPT skin prick test 
Using point prevalence to find the cutpoint, there is an improvement in the 
positive predictive value at ages 3 months and 7 years, but no change at age 23 
years although the positive predictive value was already relatively high at age 
23 years.  The important issue is whether or not this cutpoint for total IgE can 
define the clinical syndrome of atopy and we will therefore investigate if there 
is an association between atopy, defined using these cutpoints, and  asthma 
and wheeze at age 23 years.   
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4.9 Association between markers of allergy and wheeze and asthma at age 23 
years 
In this section we will investigate associations between atopy, defined using 
total IgE levels, and outcomes at 23 years and compare these to associations 
between atopy defined as one or more positive skin prick tests and outcomes 
at age 23 years.  These results, including odds ratios and corresponding 
confidence intervals, are given in table 4.7. Neither version of atopy at age 3 
months or 6 months is associated with outcomes at age 23 years.  However, a 
positive skin prick test at both 1 year and also at 7 years does have a 
significant association with both wheeze and asthma at age 23 years.   A high 
total IgE using point prevalence to determine the cutpoint at age 7 years is 
associated with asthma, but not wheeze, at age 23 years.  At age 23 years the 
odds ratios are high but the small sample sizes mean the results are mostly not 
significant, as can be seen from the wide confidence intervals.  Atopy, based 
on IgE and a cutpoint ascertained by using the ROC, i.e. maximising the sum 
of sensitivity and specificity, gives larger effect sizes, as shown in table 4.7, at 
age 23 years than when using a cutpoint based on matching the prevalence.   
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Table 4.7 Associations between three different definitions of atopy* and 
wheeze and asthma at age 23 years. 
Age of 
total IgE 
or 
positive 
skin 
prick test 
Wheeze age 23 Asthma age 23 
IgE using 
sensitivity 
vs 1-
specificity 
IgE using 
point 
prevalence 
Skin prick 
test 
IgE using 
sensitivity 
vs 1-
specificity 
IgE using 
point 
prevalence 
Skin 
prick test 
3 
months 
1.03 ( 
0.63-1.70) 
0.50 
1.17 (0.5-
2.77) 0.44 
 1.16 (0.62-
2.16) 0.38 
1.27 (0.45-
3.60) 0.41 
 
6 
months 
  1.52 (0.73-
3.16) 0.18 
  1.87 
(0.81-
4.29) 0.11 
1 year   2.35 (1.30-
4.24) 
0.004* 
  1.96 
(0.98-
3.90) 
0.04* 
7 years 1.09 
(0.63-
1.89) 0.44 
1.32 (0.71-
2.46) 0.24 
1.92 (1.11-
3.32) 
0.019* 
2.00 (0.97-
4.12) 0.07 
2.78 (1.33-
5.82) 
0.006* 
4.26 
(2.23-
8.11) < 
0.0001* 
23 
years 
2.15 
(0.95-
4.85) 0.07 
1.41 (0.62-
3.20) 0.27 
2.88 (1.33-
6.25) 
0.005* 
3.01 (1.10-
8.23) 0.02* 
2.22 (0.79-
6.29) 0.10 
2.30 
(0.93-
5.71) 
0.052 
Unadjusted results 
*Atopy defined using three different definitions, 1 IgE with cutpoint using 
ROC, 2 IgE with cutpoint using point prevalence of skin prick test and 3 
positive skin prick tests 
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4.10 Relationship between measures of allergy and asthma and wheeze at age 
23 years 
This cohort has a high prevalence of wheeze (32.8%) and asthma (17.6%) at 
age 23 years.  The rate of positive skin prick test in each was 73.1% and 
73.3% respectively.   To determine the relationship with IgE we can model the 
relationship between wheeze and asthma and Log IgE by using binary logistic 
regression.  Before undertaking binary regression to model the relationship 
between log IgE and asthma at age 23 years we must check for a linear 
relationship between logit (p (asthma)) and log IgE.  We need to undertake a 
similar procedure for wheeze.  To do this we have used the Hosmer 
Lemeshow test which is available on SPSS.  This test did not give a significant 
result for either asthma or wheeze, suggesting we do not have to reject the 
model.   Log IgE at age 23 is significantly associated with asthma age 23 years 
OR 2.82 (95% CI 1.22-6.52) p=0.015.  When this is adjusted for skin prick 
test result, the analysis is no longer statistically significant but the OR remains 
high OR 2.25 (95% CI 0.88-5.79) p=0.09.  The OR for log IgE and wheeze is 
1.72 (0.93-3.19) p=0.086 and when adjusted for positive skin prick test the OR 
is 1.27 (0.6-2.67) p=0.52.  The results of the association with log IgE suggest 
that the relationship of IgE with asthma is different to the relationship with 
wheeze.   
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4.11 Prevalence of atopy (defined by positive skin prick test) amongst subjects 
who wheeze 
Childhood atopy in this cohort appears to have a significant but low effect on 
wheeze.  Table 4.8 illustrates that among those who wheeze, from age 6 
months to age 23 years, atopy increases from 13.3% at age 6 months to 72.5% 
at age 23 years.  Of 28.8% who wheeze at age 7 years, only 50% are atopic.   
A total of 21.1% of those subjects who had never had a positive skin prick test 
result had a wheeze at age 23 years.  Atopy becomes more common the older 
the subjects become, and was relatively uncommon in childhood.  This cohort 
appears to suffer, commonly, from non-atopic wheeze in childhood and atopic 
wheeze and asthma in adulthood.   
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Table 4.8 Prevalence of atopy in those who wheeze at ages 1, 7 and 23, in 118 
subjects available for skin prick testing at 1, 7 and 23 years. 
Age Number who 
wheeze 
Number who are 
atopic  
Atopic subjects 
with wheeze /total 
no. with wheeze  
6 months† 30 (25.4%) 16 (13.6%) 4/30 (13.3%) 
1 year†† 36 (30.5%) 30 (25.4%) 11/36 (30.6%) 
7 year 34 (28.8%) 35 (29.7%) 17/34 (50.0%) 
15 year 37 (33.9%) NA 18/31 (58.1%)††† 
23 years 51 (43.2%) 70 (59.3%) 37/51 (72.5%) 
† Subjects asked on 2 occasions if wheeze in past 3 months at age 3 months 
and age 6 months 
†† Subjects asked on 3 occasions if wheeze in past 3 months at age 3 months 
and 6 months and if wheeze in past 6 months at age 1 year.  Wheeze at 6 
months is subset of wheeze at 1 year. 
††† Atopy at age 7 used for this calculation since skin prick test not 
undertaken at age 15 years. 
 
 
Of the 118 subjects who were tested for atopy on all four occasions, 29 
(24.6%) had asthma at age 23.    These subjects with asthma had a rate of 
atopy of 72% which was about the same as those who had a wheeze at age 23 
years.   
 
Figure 4.4 shows the rate of wheeze by age in subjects who were atopic at age 
7 years and those who were not atopic at age 7 years. Table 4.9 gives OR for 
the association between atopy at age 7 and wheeze at the stated age.   
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Figure 4.4 Wheeze prevalence in those who are and are not atopic at age 7 
years 
 
Table 4.9 Year of wheeze and association with atopy at age 7 years. 
Age of wheeze OR (95% CI) p= 
1 year 1.41 (0.90-2.23) p=0.14 
2 years 0.76 (0.48-1.21) p=0.25 
3 years 1.59 (1.01-2.49) p=0.045* 
4 years 2.21 (1.41-3.46) p=0.001* 
5 years 2.60 (1.65-4.09) p<0.0001* 
6 years 2.63 (1.67-4.16) p<0.0001* 
7 years 3.65 (2.31-5.78) p<0.0001* 
15 years 3.47 (2.08-5.77) p<0.0001* 
23 years 1.92 (1.11-3.32) p=0.019* 
*  Significant results 
 
Even though absolute numbers of atopy are low, in this cohort, figure 4.4 
shows us that childhood atopy (at age 7 for this cohort) is associated with an 
increased risk of wheeze up to adulthood.   
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4.12 Discussion 
We found that the sensitivity to aeroallergens increased from age 6 months to 
age 23 years.  These findings have been shown in a number of other studies.  
The longitudinal study from the Isle of Wight reported an increase in allergic 
sensitisation to at least one allergen from 19.7% at age 4 years, to 26.9%  at 
age 10 years and 41.3% at age 18 years
216
. The TCRS found an increase in 
prevalence of sensitisation from age 6 years (38.6%) to age 11 years (58.1%).  
The Swedish (BAMSE) longitudinal study also found an increase in atopy up 
to age 8 years, especially sensitisation to aeroallergens which increased from 
15% to 25% between ages 4 and 8 years
194
.  
 
There was a rise in sensitivity to aeroallergens over time, while that to food 
allergens decreased to near zero by early childhood.  The reason for the 
transitory nature of food allergen sensitisation, and the more permanent nature 
of aeroallergen sensitisation, is not clear but may be related to the large 
amount of food allergen that children are exposed to early in life compared to 
the small amounts of aeroallergen.  It has been hypothesised by Holt that the 
infant is exposed to many food allergens and therefore we must have a highly 
effective mechanism for selective down-regulation of the immune response to 
ubiquitous environmental allergens found in the gastrointestinal tract. Holt 
suggests that this mechanism forms the basis for long-term 'protection' of the 
majority of individuals against allergic sensitisation to many food and inhalant 
allergens, and that the occasional failure of this process is responsible for food 
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allergies and leads to lgE production against these allergens
217
.  In short 
advanced mechanisms of tolerance induction probably occur when allergen 
levels are high.  It is likely that such tolerance induction can only occur early 
in life.  One example of tolerance induction in individuals exposed to large 
amounts of allergen  was shown by Nilsson et al, who found that children born 
during the tree pollen season were less likely to develop allergic 
rhinoconjunctivitis or IgE antibodies to pollen, than children born during the 
rest of the year
218
.  
 
We have reviewed the relationship between two immunological 
measurements, and found that there is a significant relationship between 
positive skin prick test at age 23 years, 7 years and 6 months and log IgE 
concurrently at 23 and 7 years and log IgE at 3 months respectively.  This 
close relationship between total IgE and positive specific sensitivity has been 
shown before.  Oryszczyn et al found a strong association between total IgE 
and skin prick test result, on two occasions 5 years apart
219
.  They also found a 
higher total IgE level at the initial assessment in those subjects who converted 
to a positive skin prick test compared to those who were consistently negative 
and a lower total IgE level at initial assessment in those who reverted 
compared to those who remained positive.   
 
The German MAS study undertook a longitudinal study of total IgE beginning 
at the age of 5 years and found that total serum IgE levels in children evolved 
in parallel with overall specific IgE levels. They found that variations in total 
IgE levels at school age were closely reﬂected by variations in overall specific 
137 
 
IgE levels, in their cohort
220
.  However they also found there were a number of 
different longitudinal patterns of total IgE: declining, ﬂat or increasing with 
diﬀerent proﬁles.  These studies suggest that although there is a relationship 
between total IgE and specific sensitivity, they are probably measuring 
different aspects of allergic disease and therefore they are not equivalent. 
To define atopy using the total IgE values, we determined a cutpoint at each 
age; values above this indicate atopy. We have chosen cutpoints by using the 
criterion of maximising the sum of the sensitivity and specificity as well as 
seeking to have a similar prevalence to that using a skin prick test.  The results 
show that at age 3 months the total IgE can only just discriminate between 
atopic and non-atopic subjects as defined by a skin prick test at age 6 months, 
but at ages 7 and 23 years it can discriminate reasonably well.  It is not clear 
why the strength of the association between skin prick tests and IgE changes 
with age in this way.  
 
We found that the rate of wheeze at each age was high but despite the fact the 
subjects were at high risk of atopy, only 50% of those who wheezed at age 7 
years were atopic.  The Isle of Wight longitudinal study also found that 50% 
of 10 year olds who had wheeze were atopic and 50% non-atopic, however 
their study was a population study with only 10% of subjects having 
wheeze
221
.   A Spanish cross-sectional population study of 9-12 year olds 
found that the prevalence of current wheeze was 13.1% and 62.4% of children 
with current wheezing were atopic
222
.   In our cohort there was a much higher 
rate of wheeze, at almost 30% at age 7 years but a low prevalence of atopy 
(50%) among those who had a wheeze.  However atopy was more prevalent at 
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age 23 years (59.3%) and therefore prevalence of atopy in subjects who had 
wheeze was also more common (73%).  The increased prevalence of atopy as 
subjects increase in age, cannot be due to self-selection of subjects at age 23 
since table 4.8 only considers subjects who attended on all four occasions for 
skin prick testing.  It may be that those subjects who attended on all four 
occasions were more likely to be from higher social class since we know that 
loss to follow-up was greater in lower social class.  It is known that subjects 
from higher social class are more likely to develop sensitisation, as shown in 
the NHANES II study where white subjects with education more than 13 years 
had prevalence of positive skin prick test of 25.0% (SD 1.11) while those with 
education of 0-8 years had prevalence of positive skin prick test of 12.2% (SD 
1.22)
223
.  Alternatively it may be that this increase in the atopic nature of 
subjects longitudinally measured and especially those who wheeze has not 
been shown previously and is something specific to our population.  For some 
reason our subjects are not too atopic in childhood but it appears that those 
who wheeze are more likely to be atopic as they get older.   
 
However, a positive skin prick test or raised specific IgE, even in an asthmatic, 
may only indicate that a subject is sensitised against an allergen, and does not 
constitute proof that the symptoms of asthma are caused by an allergic 
response to that particular allergen
224
. Burrows et al investigated parental and 
child IgE levels and found that in subjects with childhood asthma, there was a 
significantly higher level of IgE than would be expected on the basis of 
parental IgE levels.  They speculated that the inflammatory changes in the 
airways of asthmatic children may release mediators that directly or indirectly 
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tend to elevate serum IgE levels above those expected on the basis of their 
parents' IgE values
225
. This could explain a previous finding from Burrows et 
al that there was a very close relationship of asthma prevalence to age and sex-
standardized IgE levels regardless of skin-test reactivity
41
.   
 
Our subjects displayed an association of total IgE with wheeze and asthma.  
However this association was not statistically significant once adjusted for 
positive skin prick test at age 23 years. This was different to the findings of 
Sunyer et al who showed that asthma was associated with increased levels of 
total IgE, even in subjects negative for specific IgE to common allergens
207
.  
This study suggested, like others before 
41
, that the association of total IgE 
with asthma was present even in non-atopic asthma sufferers.  This is 
supported by the findings of other studies that have shown that mechanisms of 
inflammation in severe asthma are the same regardless of the atopic or non-
atopic nature of the disease
226
.  However the recent use of anti IgE therapy in 
the treatment of severe asthma
227
 has nonetheless established the causal link 
between IgE and at least the symptoms of atopic asthma, although inception of 
asthma cannot be confirmed. 
 
Thus we are faced with a conundrum: asthma is associated with atopy, atopy is 
more common in higher social class but asthma is commoner in lower social 
class.  Despite the significant association with atopy there are likely to be 
other, important aetiological factors in the development of asthma and these 
factors may also impact on atopy.  We can venture that atopy may be an 
aetiological factor for asthma in some subjects but in other subjects it may be a 
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sequela of asthma.  As Custovic expressed in a recent review, ‘ It is 
increasingly clear that childhood asthma and atopy are not single phenotypes, 
and it is likely that allergen exposure has different effects on distinct 
subgroups under the umbrella terms of ‘sensitization’ and ‘asthma’228.  This 
view is supported by the worldwide epidemiological studies that have shown 
that the effect of atopy on the prevalence of asthma varies widely between 
worldwide centres both in adult disease
229
 and paediatric disease
230
.   
 
In summary we have characterised atopy over the years of follow up in our 
cohort.  We have defined atopy on the basis of skin prick test positivity and 
sought to define atopy by total IgE.  Although IgE probably has a relationship 
with asthma which is not dependent on specific sensitivity we have been 
unable to show this due to the small population tested at age 23 years.  These 
measures of allergy are an important part of the disease process that is asthma 
but it is not clear if allergy causes asthma, is a bystander in the asthma 
process, is caused by asthma or maybe a combination of all these. 
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Chapter 5 
 
The association of infant diet and asthma in adults 
5.0 Introduction-Dietary factors in the development of asthma 
One environmental factor that the neonate encounters within the first weeks of 
life is diet.  Early tolerance to food is the usual outcome in the development of 
the human infant.  Sensitisation to food allergens is often only a transient state, 
but the inability to tolerate food allergens in early life is thought to be 
important in the aetiology of atopic disease such as eczema231 and therefore 
early tolerance induction may be a factor in reducing the risk of developing  
asthma later in life. Holt et al have reviewed the evidence regarding primary 
sensitisation to aeroallergens in infancy and have argued that the combination 
of exposure to environmental "risk factors", along with the immaturity of the 
mucosal component of the infant's immune system, may provide a basis for 
the increased risk of allergic sensitisation in early childhood
35
. 
Cows’ milk protein has been reported to be a potent allergen in children and 
cows’ milk sensitivity occurs in 2-3% of infants in developed countries232. 
Early use of cows’ milk based formula compared to banked breast milk in the 
preterm neonate has been reported to be associated with an increased risk of 
atopic disease in infants of atopic parents
233
.   
Høst et al reported that solely breast-fed children were exposed to small 
amounts of cows’ milk protein in breast milk, but if solely breast-fed they 
were unlikely to develop cows’ milk allergy234.   Despite the fact that cows’ 
milk protein has been considered allergenic, most alternatives to breast milk 
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are often based on cows’ milk, and recent studies suggest that partially or 
extensively hydrolysed cow’s milk formulae  may protect against the 
development of allergy in high risk children
235
.  
 
5.1 Breast feeding and asthma prevalence 
Breastfeeding is thought to protect against allergic disease, either by removing 
allergenic foods or through immunological factors from the mother that 
suppress the exaggerated immune responses that may lead to asthma.  There 
have been a number of studies investigating the effect of breast feeding on 
wheeze and asthma at varying ages up to adulthood.  However these have not 
given a clear perspective on breast feeding and protection against atopic 
disease.  Each study has different definitions of outcomes and of breast 
feeding and this may be the main reason for no clear consensus on whether 
breast feeding protects or not.  Many have not gathered prospective breast 
feeding history and those that have taken a prospective history have not 
recorded data weekly.  All these studies can therefore introduce recall bias.   
Kramer et al in 1988 attempted to make sense of the conflicting results with 
regard to breast feeding and atopy.  He developed 12 points to standardise the 
study of breast feeding with regard to atopic disease
236
.  One of these 
standards is ‘non-reliance on prolonged maternal recall’ of breast feeding.  He 
stated that because of recent publicity concerning infant feeding and atopic 
disease, some women who have babies with first degree relatives with atopy 
may preferentially choose to breast feed in an attempt to "protect" their child. 
This tends to bias the results against a protective effect of breast feeding, 
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because the breast-fed infant would be at a greater genetic risk for developing 
atopic disease
236
.    Here we will review the studies in detail, dividing them 
into cross-sectional and longitudinal studies.  The longitudinal studies are 
further divided into those that do not give a prospective breast feeding history, 
those that do give some prospective history, but not on a weekly or monthly 
basis, and those that give a weekly or monthly prospective history. 
 
5.2 Cross-sectional studies on breast feeding and asthma prevalence 
Cross-sectional studies depend on recall for a history of breast feeding and 
although this is not as accurate as a prospective history of breast feeding, it is a 
way of gathering a large amount of data on a large population.   
The ISAAC study on breast feeding was an international cross-sectional study 
that asked parents to give a breast feeding history when the child was 8-12 
years. The researchers investigated the association between breast feeding and 
wheeze. They divided countries into non affluent (Gross National Income per 
capita (GNI) less than US$9200) and affluent (GNI greater than US$9200).  
There was a reduced risk of wheeze with breast feeding in both affluent 
(adjusted OR 0.87 95% CI 0.78-0.97) and non- affluent countries (adjusted 
OR 0.80   95% CI 0.68-0.94).  There was, however, a stronger protective 
effect of breast feeding against non-atopic wheeze in non-affluent countries 
(adjusted OR 0.69 95% CI 0.53–0.90)20.  Breast feeding was associated with a 
reduced prevalence of wheeze, especially in non-atopic subjects from non-
affluent countries. 
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5.3 Longitudinal studies with retrospective history of breast feeding 
5.3a) The Tucson Children’s Respiratory Study (TCRS) 
The Tucson birth cohort of 1246 infants was recruited from a Hospital 
Maintenance Organisation (HMO), a managed care organisation that provides 
general health care coverage in the United States and the TCRS would 
therefore be considered a population based study. However it must be 
remembered that all subjects had to have medical insurance to be part of the 
HMO
81
.  The primary outcome at age 2 years was wheeze; beyond this age the 
outcome was asthma,  defined as physician diagnosed asthma in the child and 
wheeze or asthma symptoms reported on two or more questionnaires from age 
6 to 13 years.  Breast feeding history was taken at each health surveillance 
interview; this appears to be yearly, but full details are not given.  In addition a 
full breast feeding history was taken when the subject was age two years.  
There was a 90% concordance between the different methods of extracting a 
history on breast feeding.  The authors reported that breast feeding for more 
than 4 months was associated with significantly lower rates of recurrent 
wheeze up to 2 years of age (OR 0.45, 95% CI 0.2 to 0.9).  Breast feeding was 
not associated with a lower rate of wheeze or asthma after the age of 2.  In 
fact, there was no association between duration of exclusive breast feeding and 
asthma by age 13 years in the total group.   They did, however, find that where 
there was a maternal history of asthma there was an increased risk of asthma if 
the mother breast fed (OR 8.7 95% CI 3.4-22.2)
81
.   With this finding the team 
hypothesised that there might be a maternal asthma factor that is passed 
through breast milk from mother to baby.   However, women who had asthma 
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were significantly more likely to breast feed exclusively than women who did 
not have asthma
81
 (i.e. reverse causality is a possible explanation of the 
finding).  Asthmatic mothers may be more likely to remember if they had 
breast fed asthmatic children than mothers of children who are not asthmatic, 
which is why a prospective history is of such importance. 
 
5.3b) The Dunedin birth cohort 
Sears et al studied an unselected birth cohort of 1037 subjects from Dunedin in 
New Zealand.  They were born between 1972 and 1973, recruited at the age of 
3 years, and followed up to the age of 26 years
75
. The investigators found that 
the risk of current asthma (defined as a positive response to the question “Do 
you (does your child) have asthma?” together with symptoms reported within 
the previous 12 months) was significantly higher at age 9 years [OR 2·54 
(1·45–4·44) 0·0008] and 26 years [1·74 (1·26–2·40) 0·0008] in those that 
were breast fed.   The breast feeding history was taken when the subjects were 
three years old, and the investigators reviewed notes from a community based 
nurse programme, which kept weekly records on breast feeding and formula 
feeding, to check for consistency.   
The normal postnatal practice in Dunedin, at the time, was to give a formula 
feed for the first few nights of the new-born’s life.  Most women stayed in 
hospital for 3 to 4 nights and although the authors state that bottle feeding was 
therefore minimal, others have suggested that one 4 ounce feed of formula 
milk exposes the baby to as much cows’ milk protein as would be present in 
breast milk after 17 years of breast feeding
237
.  However there is evidence that 
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a one off dose of cows’ milk during the neonatal period does not increase 
asthma symptoms up to the age of 5 years compared to placebo
238
.  In 
summary this study found asthma risk was significantly positively associated 
with breast feeding but although the breast feeding history was viewed from 
prospective notes,  breast feeding mothers were encouraged to feed their new 
born babies cows’ milk based formula for the first post-natal days.  For this 
reason this study was flawed and may not conclusively show that breast 
feeding increases the risk of asthma. 
 
5.3c) The Tasmanian asthma study (TAS)   
The Tasmanian cohort consisted of 8,000 subjects born in 1961 who were 
recruited when they were 7 years old. Current asthma was defined as self-
reported ever asthma followed by answering ‘‘in the last 12 months’’ to the 
question, ‘‘How long since the last attack?’’.  Breast-feeding was defined by 
the question, ‘‘How was he/she fed in the first three months of life?’’. The 
parent could answer (1) breast-fed only, (2) bottle-fed only, or (3) breast-fed 
and bottle-fed. Exclusively breast-fed was defined as the breast-fed only 
group. Exclusively breast-fed babies with a maternal history of atopy were less 
likely to develop asthma before the age of 7 years, (odds ratio[OR] 0.8; 95% 
CI, 0.6-1.0).  After age 7 years, the risk reversed, and exclusively breast-fed 
children had an increased risk of current asthma at age 14 (OR 1.46; 95% CI 
1.02-2.07), age 32(OR 1.84; 95% CI 1.06-3.3), and age 44  (OR 1.57; 95% CI 
1.15-2.14) years 
239
.    
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5.3d) The Isle of Wight study  
Tariq et al investigated 1218 children born in the Isle of Wight
101
.  The breast 
feeding history was taken from parents at age 1 year and 2 years, but not 
prospectively.  A diagnosis of asthma was defined as three or more separate 
episodes of wheeze, each lasting 3 days or more.  There was a statistically 
significant association between breast feeding and asthma at the age of 4 
years.  . The OR, comparing infants whose mothers refrained from using 
feeding formula before the age of 3 months to those who did refrain, was 0.56 
(95% CI 0.38-0.83) p<0.01.   
 
 
 
5.3e) The Stockholm (BAMSE) birth cohort   
Kull et al recruited over 75% of all the births in Stockholm from 1994-1996.  
Asthma age 4 years was defined as 4 or more episodes of wheezing during the 
past year or just one episode of wheezing in subjects who had a prescription 
for inhaled corticosteroids. Breast feeding data was collected retrospectively at 
age 1 year.  Exclusive breast feeding was defined as consuming breast milk 
and no other nutrient.  They found that  infants who had 4 months or more of 
exclusive breast feeding had a reduced risk of asthma at age 4 compared to 
those who had less than 4 months exclusive breast feeding (adjusted Odds 
Ratio was 0.73, 95% CI 0.53-0.97)
240
.   
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5.4 Longitudinal studies with some prospective breast feeding history but not 
weekly or monthly 
5.4a) The Prevention and Incidence of Asthma and Mite Allergy (PIAMA)   
The PIAMA (Prevention and Incidence of Asthma and Mite Allergy) birth 
cohort study of Dutch children born in 1996/1997 recruited mothers from the 
general population during pregnancy. Asthma was defined as an episode of 
wheeze and or a prescription of inhaled corticosteroids. They found breast 
feeding for more than 16 weeks compared to no breast feeding was protective 
up to age 8 (OR 0.57 [95% CI0.41 to 0.80])
90
.  Breast feeding history was 
gathered prospectively, but not weekly, as parents gave a breast feeding 
history at age 3 months and then age 1 year
90
.  
 
 
5.4b) The Western Australian Pregnancy Cohort Study (WAPCS)   
WAPCS was established between 1989-92 and recruited 2979 subjects, before 
birth, by 18 weeks gestation
241
.  Asthma was defined as ‘ever diagnosed by a 
physician and wheeze in the last year’.  At discharge parents were given a 
diary to record episodes of illness, feeding history, and other key events in the 
first year of the child’s life. Children were further assessed at 6 years of age.  
Exclusive breast feeding was defined as using no formula or other milk.  After 
adjustment for sex, gestational age, infection, smoking exposure and maternal 
asthma, exclusive breast feeding for 4 months was associated with a reduced 
risk of current asthma in the children at age 6 (OR 0.74 95% CI0.55-1.00 
p=0.049)
241
.  However, information on the introduction of solid food was not 
collected and therefore those who the researchers judged as having had 
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exclusive breast feeding, may have been weaned early, thereby negating 
exclusive breast feeding.  This was a flaw in the study design.   
 
5.4c) The Childhood Asthma Prevention Study (CAPS)  
This Australian study recruited 601 babies from high risk families.  They 
defined current asthma as any wheeze in the preceding 12 months in subjects 
who either had asthma diagnosed by a doctor or at a hospital at any time 
during the ﬁrst 5 years or had a positive bronchodilator test at the 5 year 
assessment. Breast feeding history was taken when subjects were reviewed at 
1, 3, 6, 9 and 12 months. They defined ‘ever breastfed’ as having ever 
consumed breast milk, even once, and ‘fully breast fed’ as babies whose 
mothers reported at the 3 month and the 6 month visit that the subject had not 
been fed food or breast milk substitute.  However, they did not gather 
information on fruit juice and water consumption, therefore exclusive breast 
feeding for the time stated cannot be confirmed.  A total of 85% were ever 
breast fed and the OR for asthma was:  0.59 (0.30–1.16).  Only 2.3% were 
exclusively breastfed for at least 6 months, the OR was 0.90 (0.58–1.40). This 
study found that prolonged breast feeding and late weaning did not reduce the 
risk of current asthma at age 5 years
242
.        
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5.5 Longitudinal studies with prospective history of breast feeding on weekly 
or monthly basis 
5.5a) Helsinki Birth cohort   
Saarinen et al investigated 236 healthy babies born in the first 3 months of 
1975 in Helsinki
243
. The breast feeding history was taken prospectively at  2 
weeks, then at, 1, 2, 4, 6, 9, and 12 months of age. The outcome they 
investigated was ‘respiratory allergy’ which was defined as one of the 
following: allergic asthma diagnosed at hospital, three or more separate 
episodes of respiratory distress with wheezing" (at 3-10 years only); history of 
wheezing in association with three or more respiratory infections (at 3-5 years 
only); seasonal rhinoconjunctivitis, usually associated with positive prick or 
RAST tests; or a history of wheezing and/or rhinoconjunctival symptoms 
associated with animal contact. A total of 150 subjects were followed up until 
age 17 years.  There were three groups of breast feeding history depending on 
the length of exclusive breast feeding: prolonged (>6 months) 36/150, 24%; 
intermediate (1-6 months) 66/150, 44%; and short or no (<1 month) 
breastfeeding 48/150, 32%.  Those with short or no breast feeding were more 
likely to suffer with respiratory allergy (p=0.01, no OR given)
243
.    
 
 
5.5b) The Melbourne Atopy Cohort Study (MACS) 
The MACS cohort study was a longitudinal study in the 1990s which 
investigated 620 children with a family history of atopic disease
77
.  Breast 
feeding history was ascertained by an allergy-trained nurse phoning the 
nursing mother every four weeks until the subject was age 64 weeks.  During 
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the telephone interview the nurse asked questions related to signs of asthma, 
eczema, food reaction and use of asthma medications.  Skin prick testing was 
undertaken at 6 months and 12 months.   There was a significant relationship 
between signs of early atopic disease and the mother being less likely to stop 
breast feeding.  This was expressed as a lower rate of cessation of breast 
feeding if the baby had any early atopic disease, (HR 0.69 [0.52-0.93] 
p=0.015).  This phenomenon, known as ‘reverse causality’, is a possible 
explanation for the fact that that longer breast feeding was associated with a 
greater risk of risk of atopic disease.   
 
5.6 Comparison of results of longitudinal Studies 
Figure 5.1 shows odds ratios from the major studies on asthma and breast 
feeding; the majority of studies show a protective effect with breast feeding in 
childhood.  In adulthood there are only two studies and only one is represented 
on the graph.    The study by Saarinen with outcomes at age 17 years is not 
included in the figure as no odds ratios were quoted, although that study 
suggested a protective effect from breast feeding on symptoms in 17 year olds.  
The MACS study is also excluded as this gives hazard ratios for cessation and 
atopic features.   
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Figure 5.1 Association of breast feeding and asthma (log scale) 
 
 BAMSE Stockholm age 4 asthma240, Tucson81, The Childhood Asthma Prevention 
Study-CAPS
242
, WAPCS
241
, PIAMA
90
, Dunedin
75
, ISAAC II
20
,  The Tasmanian 
Asthma Study-TAS
239
 
 
Some studies define breastfeeding as any amount of breastfeeding, not 
necessarily exclusive, while other studies only consider exclusive breast 
feeding for 4 or 6 months. This makes it difficult to compare studies.  If we 
choose only the highest quality population studies with prospective data on 
breast feeding, (CAPS, BAMSE Stockholm and WAPCS studies), these give a 
favourable outcome in early childhood for breast feeding and asthma.  On the 
whole the evidence suggests that breast feeding may be protective during 
childhood, but that this protective effect potentially reverses in adolescence 
and adulthood.  
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Table 5.1 Longitudinal studies that report on Breast Feeding and their 
definition of breast feeding 
Study group 
(year initially 
recruited/birth 
year if 
different) 
Age of 
subject at 
time of 
study 
Outcome 
measured 
Prospective 
history of breast 
feeding 
Definition of 
breast feeding 
MACs (1990-
94) 
2 Cessation of 
breast 
feeding 
Prospective Exclusive after 
first few days. 
BAMSE 
Stockholm 
(1994-96) 
4 Wheeze or 
asthma 
Prospective Exclusive for 4 
months 
Tucson 
Children’s 
Respiratory 
Study (1980-
84) 
2, 6, 13 Wheeze age 
2, asthma 
age 6-13 
Retrospective 
age 2 but also 
some cases 
taken 
prospectively 
Exclusive for 4 
months 
Isle of Wight 
(1989-90) 
4 Asthma Retrospective at 
age 1 and 2 
Exclusive for 3 
months 
CAPS (1997-
99) 
5 Asthma Prospective 
history at 1, 3, 6, 
9,12 months 
Ever Breast 
Fed, even once 
WAPCS 
(1989-92) 
6   Asthma Prospective No account 
taken of when 
weaned onto 
solids 
Dunedin 
(1972-73) 
7, 9-26 Asthma Retrospective at 
age 3 
Exclusive after 
first few days 
PIAMA 
(1996-7) 
8 Asthma Prospective at 3 
months and 1 
year 
No history on 
weaning onto 
food therefore 
not exclusive 
TAS 
(1968/1961) 
7, 14, 21 Asthma Retrospective 
age 7 years 
Exclusive for 
first 3 months 
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5.7 Infant diet and outcomes in adults 
Lucas et al showed that early exposure to cows’ milk in the preterm neonate 
was associated with an increased risk of atopic disease in infants of atopic 
parents
233
.  Few longitudinal studies have investigated asthma and early 
consumption of foods. Zutavern et al investigated preschool wheeze and infant 
weaning on to foods.  They found no evidence that late weaning affected the 
risk of preschool wheeze.  Late introduction of egg (late introduction was not 
defined but the median of introduction of egg into diet was 8 months) was 
associated with a non-significant increased risk of preschool wheezing (OR 
1.5, 95% CI 0.92 to 2.4)
244
.  The Childhood Asthma Prevention Study (CAPS) 
also found no reduced risk of asthma in 5 year olds with late weaning. The OR 
of asthma at age 5, comparing children weaned by age 3 months to those not 
weaned at age 3 months, was 0.65 (0.36–1.15).  They did, however, find that 
solid food introduction, by 3 months of age, was associated with a reduced 
risk of atopy OR 0.54 (95% CI 0.33–0.87)242.   
Scott et al reviewed the Isle of Wight birth cohort at age 18 years
212
. A total of 
120 subjects were randomised from birth to have low exposure to allergens, 
for the first year of life or to normal diet and environment.  Those in the 
intervention arm were given a strict anti-house dust mite regime and a low 
allergenic load in their diet including extensively hydrolysed formula in those 
not breast fed, and avoidance of dairy products, eggs, soya, fish, shellfish, 
peanut and tree nuts in the first year of life. Asthma was defined as a positive 
response to ‘Has a doctor diagnosed you with asthma?’ and, either a wheeze in 
the last 12 months or use of inhaled corticosteroids. Atopic asthma was 
deﬁned by the combination of asthma plus atopy, defined as at least one 
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positive skin prick test. The intervention was associated with a lower rate of 
asthma at age 18 years (adjusted OR: 0.23, 95% CI 0.08 to 0.70, p=0.01).  
They statistically tested the hypothesis that the mechanism through which the 
intervention reduced the risk of asthma was by a reduction in atopy, using a 
binary logistic regression model which was run with the interaction between 
atopy and the group as the sole explanatory variable. The interaction term did 
not have a signiﬁcant association with asthma at 18 years, which was 
unsurprising given the small numbers. So although the hypothesis is a 
plausible one, a larger study would be required to test it properly.  In this 
chapter we will examine the association of diet in early childhood with asthma 
in early adulthood.  
 
5.8 Aims and objectives 
The aim of this chapter is to examine the effect of diet in early life and its 
association with asthma, wheeze and atopy in adulthood. 
Objectives 
 To investigate the association between the original randomised groups, 
of  cows’ milk exclusion and  normal diet, and asthma, wheeze and atopy in 
early adulthood. 
 To investigate the association of breast feeding with outcomes in early 
adulthood.   
 As a subgroup analysis we will investigate associations in subjects who 
have asthmatic mothers. 
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 To investigate the association between the age at weaning onto food 
types and outcomes in early adulthood 
 
5.9a) Methods 
Full methods regarding the original randomisation, breastfeeding and 
outcomes up to age 7 are given in chapter 2 and  have been published 
previously
107
.  A total of 487 live births were randomised to the intervention 
group, in which mothers were asked to exclude all cows’ milk protein from the 
infants’ diet for the first 4 months of life, or the control group, which was a 
normal diet.  In order to exclude cows’ milk protein, those subjects 
randomised to the intervention arm of the study were offered free soya protein 
based infant formula.  
 
Mothers were asked to keep a diary and were visited by a dietitian weekly for 
the first 26 weeks of the subject’s life, in which period data were gathered on 
the type of milk and food the subject consumed.  Details of different feeding 
routines are given in the questionnaire appendix 2b.  The feeding regime of 
each subject was categorised into one of: Breast milk only, breast and cows’ 
milk, breast and soya supplement, cows’ milk only and soya supplement only. 
Ever having been breast fed was defined as having had breast feeding for at 
least 1 week.  Information was gathered on the age in weeks when the baby 
first consumed the following foods: beef, cereal, egg, fruit, fish and meat other 
than beef.  
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5.9b) Statistical Methods 
The original randomisation was analysed on an intention to treat (ITT) basis.  
This means that after randomisation even those who did not adhere to the 
proposed diet were analysed in the group to which they were randomised.    
Breast feeding was encoded into a binary variable: ever breast fed or never 
breast fed and was analysed using chi-square tests and logistic regression.  The 
time until weaning on a particular food is a continuous variable, which may 
have been censored in that the time until a child first ate a food may only be 
known to be greater than 26 weeks.  The distribution of the time until weaning 
can be estimated using Kaplan Meier methods and different groups compared 
using the log rank test.  Control for confounders was achieved using Cox’s 
Proportional Hazards model.   We will use Cox’s model to analyse the first 
exposure to cows’ milk, producing an estimate of the hazard ratio, assumed 
constant, essentially comparing the risk of wheezing in different groups while 
adjusting for confounders.   
 
 5.10a) Results 
5.10b) Breast feeding rates and association with outcomes 
A total of 180 out of 477 (37.7%) subjects were ever breastfed for at least one 
week.  There was an association between the randomisation group and the 
prevalence of breast feeding: 78/238 (32.8%) ever breast fed in the 
intervention group and 104/249 (41.8%) ever breast fed in the control group 
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(OR 1.47 (95%1.02-2.13) p= 0.041).   This statistically significant association 
may have occurred because soya milk was provided free of charge to the 
intervention group.   Social class was also significantly associated with breast 
feeding choice: A total of 53 out of 119 (56%) subjects from families in social 
class I and II were breast fed, while  135 out of 358 (32%) subjects from 
families in social class III, IV, V or unemployed were breast fed: OR 2.67 
(95% CI 1.74-4.07) p <0.0001.  Those with parental allergy were more likely 
to be breast fed: OR 2.15 -95% CI 1.29-3.58 p= 0.003.  In addition those who 
were not breast fed were significantly more likely to be lost to follow up at age 
23 years (1.59 95%CI 1.08-2.34 p=0.019).   
 
Table 5.2 shows the results of associations of ever being breast fed or not and 
outcomes in childhood and at age 23 years.  Wheeze at age 1 year was 
significantly less likely in those who were breast fed.  No other associations 
were significant, though in the majority of cases the odds ratio was less than 1, 
suggesting breast feeding may protect against wheeze at other ages and asthma 
at 23 years.  The statistically significant association at age 1 would fit with our 
understanding of the role of breast feeding since it is known that the mother 
gives immune support through the passage of IgA antibodies in breast milk 
which protect the infant against upper respiratory tract infections
245
.  We will 
investigate the effects of breast feeding in different wheeze phenotypes in 
chapter 7 but using the established variables there is no evidence of a 
significant effect after the age of 1 year.   
 
159 
 
Table 5.2 Association of breast feeding with allergic manifestations in 
childhood and at age 23 years 
 Ever breast 
fed†  
Never breast 
fed  
Crude OR 
(95%CI) p 
Adjusted†† OR 
(95%CI) p 
Wheeze age 
23 years 
39/124 
(31.5%) 
59/175 
(33.7%) 
0.90 (0.55-1.48) 
0.68 
0.81 (0.47-1.39) 
0.44 
Wheeze age 
15 
45/142 
(31.7%) 
70/214 
(32.7%) 
0.95 (0.61-1.50) 
0.84 
1.03 (0.64-1.68) 
0.89 
Wheeze age 
7 
42/170 
(24.7%) 
86/276 
(31.2%) 
0.73 (0.47-1.11) 
0.14 
0.71 (0.45-1.13) 
0.15 
Wheeze age 
1 
39/177 
(22.0%) 
119/284 
(41.9%) 
0.39 (0.26-0.60) 
<0.0001* 
0.48 (0.30-0.75) 
0.001* 
Asthma age 
23  
19/122 
(15.6%) 
33/174 
(19.0%) 
0.79 (0.42-1.46) 
0.45 
0.71 (0.36-1.41) 
0.33 
Atopy age 23  28/49 
(57.1%) 
42/70 
(60.0%) 
0.89 (0.42-1.87) 
0.76 
0.82 (0.35-1.91) 
0.64 
Atopy age 7 46/161 
(28.6%) 
63/269 
(23.4%) 
1.31 (0.84-2.04) 
0.24 
1.25 (0.78-2.00) 
0.36 
Atopy age 1 37/178 
(20.8%) 
48/291 
(16.5%) 
1.33 (0.83-2.14) 
0.24 
1.22 (0.74-2.03) 
0.43 
* Significant result   † Breast fed for at least one week. 
††Adjusted for social class age 1, parental allergy, gender and original 
randomisation. 
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In the introduction we presented data from the Tucson study that suggested 
that subjects with asthmatic mothers had an increased risk of asthma if they 
were breast fed.  We have therefore investigated the association of breast 
feeding in the 94 subjects who had asthmatic mothers.  As shown in table 5.3 
there was no statistically significant association between breast feeding and 
wheeze, asthma or atopy at age 23.  The ORs for wheeze and asthma at age 23 
were less than one, suggesting that there may be a protective effect from breast 
feeding, but the small sample size led to wide confidence intervals.   
 
Table 5.3 Association of breast feeding with allergic manifestations in 
childhood and at age 23 years only in subjects with asthmatic mothers 
 Ever 
Breastfed 
Never 
Breast fed 
OR (95% CI) p adjusted§ OR 
(95% CI) p 
Wheeze 1 9/31 
(29.0%) 
24/63 
(38.1%) 
0.67 (0.26-1.68) 
0.39 
0.67 (0.24-1.84) 
0.43 
Wheeze 7 12/28 
(42.9%) 
22/59 
(37.3%) 
1.26 (0.51-3.15) 
0.62 
1.36 (0.51-3.59) 
0.54 
Wheeze 15 10/26 
(38.5%) 
18/45 
(40.0%) 
0.94 (0.35-2.52) 
0.90 
1.24 (0.44-3.53) 
0.69 
Wheeze 23  5/17 
(29.4%) 
13/34 
(38.2%) 
0.67 (0.19-2.35) 
0.54 
0.71 (0.19-2.63) 
0.61 
Asthma 23  2/17 
(11.8%) 
6/34 
(17.6%) 
0.62 (0.11-3.47) 
0.59 
0.90 (0.13-6.19) 
0.92 
Atopy 23 3/6 
(50.0%) 
5/11 
(45.5%) 
1.20 (0.16-8.80) 
0.86 
1.22 (0.15-9.98) 
0.85 
§Adjusted for social class age 1, parental allergy, gender and original 
randomisation.  
 
 
There is no evidence that breast feeding is detrimental in our cohort.   
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5.10c)  Cows’ milk exclusion and soya formula supplementation up to 4 
months- the results of the RCT 
Of the 487 subjects, 249 were randomised to normal diet and 238 to soya 
substitute and cows’ milk avoidance.  Of those assigned to cows’ milk 
exclusion 41 (17.2%) used cows’ milk before 16 weeks of life and of those 
who were randomised to usual diet, a total of 32 (13%) of subjects had soya in 
the first 16 weeks of life.   At age 23 a total of 304 subjects completed 
questionnaires but only 123 were available for skin prick testing.  
The associations between the randomisation groups and wheeze, asthma and 
atopy at age 23 years and atopy and wheeze in childhood were analysed on an 
ITT basis and results are shown in Table 5.4. There was no evidence that 
exclusion of cows’ milk protein was associated with outcomes in childhood, 
but asthma and atopy at age 23 years were both significantly associated with 
cows’ milk exclusion.  The effect was in the opposite direction to that 
expected, i.e. the intervention was associated with a significantly increased 
risk of atopy and asthma at age 23 years. It was not possible to elucidate if this 
result was because the subjects had avoided cows’ milk or because they were 
given soya milk supplement. All we can say is that the substitution of soya 
based formula instead of cows’ milk protein in the first 4 months of life led to 
statistically significantly increased rates of asthma and atopy at age 23 years 
compared to the control group. Later we will use survival techniques to 
analyse time to first use of cows’ milk and outcomes at age 23 years. 
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Table 5.4 Associations between the randomisation groups and allergic 
manifestations 
Allergic 
disease 
intervention 
group 
control 
group 
OR (95% CI) 
p 
Adjusted§ OR 
(95% CI) p 
Wheeze 
age 23 
54/146 
(37.0%) 
44/153 
(28.8%) 
1.45 (0.90-
2.36) 0.13 
1.43 (0.87-
2.37) 0.16 
Wheeze 
age 15 
61/180 
(33.8%) 
54/176 
(30.7%) 
1.16 (0.74-
1.81) 0.52 
1.11(0.71-1.76) 
0.65 
Wheeze 
age 7 
58/215 
(27.0%) 
70/231 
(30.3%) 
0.85 (0.56-
1.28) 0.44 
0.89 (0.58-
1.36) 0.59 
Wheeze 
age 1 
80/227 
(35.2%) 
78/234 
(33.3%) 
1.09 (0.74-
1.60) 0.67 
1.04 (0.69-
1.57) 0.85 
Asthma 
age 23 
33/145 
(22.8%) 
19/151 
(12.6%) 
2.05 (1.0-
3.80) 0.023* 
1.95 (1.03-
3.70) 0.04* 
Atopy age 
23  
41/58 
(70.7%) 
29/61 
(47.5%) 
2.66 (1.25-
5.67) 0.011* 
2.97 (1.30-
6.80) 0.01* 
Atopy age 
7 
58/208 
(27.9%) 
51/222 
(23.0%) 
1.30 (0.84-
2.00) 0.24 
1.41 (0.90-
2.21) 0.13 
Atopy age 
1 
46/232 
(19.8%) 
39/237 
(16.5%) 
1.26 (0.78-
2.0) 0.34 
1.27 (0.79-
2.05) 0.33 
§Adjusted for social class age 1, parental allergy, gender and breast feeding.  
*Significant result 
 
5.11a) Patterns of weaning  
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All subjects apart from one (486/487) had eaten solid food by 26 weeks.  A 
total of 478 (98.2%) had eaten fruit by 26 weeks, 466 (95.7%) had eaten 
cereal, beef was eaten by 436 (89.5%) and other meats by 446 (91.6%).  Egg 
was eaten by 357 (73.3%) and fish by only 86 (17.7%) subjects.   
Figure 5.2 gives a histogram of the age in weeks at weaning with any food 
type.  The one subject who did not wean by 26 weeks of age has been 
excluded from the histogram for ease of illustration. 
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Figure 5.2 Age in weeks when first weaned onto solids 
 
For some subjects and certain foods the age of weaning is known only to be 
greater than 26 weeks. We have therefore presented the median age at 
weaning, rather than the mean in Table 5.5.  This table also shows that 75% of 
subjects had eaten some solid food by 9 weeks.  Despite the fact that the WHO 
current recommendation is for sole breast feeding until the child is 26 weeks, 
in the 1980s the practice, in the MAPS cohort, was for the majority of 
neonates to be weaned by just over 6 weeks.  
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Table 5.5 Age in weeks when weaned onto different solid foods 
 Minimum 25
th
 Percentile Median 75
th
 Percentile 
Any Food 1 4 6 9 
Fruit 1 5 7 12 
Cereal 2 9 12 15 
Meat other 
than Beef 
3 14 16 20 
Beef 3 14 16 20 
Egg 3 15 20 >26 
Fish 3 >26 >26 >26 
 
By age 12 weeks 75% of subjects had been weaned onto fruit and weaning 
started as early as 1 week for some subjects. Those who avoided cows’ milk 
were more likely to avoid egg; this was because there are many foods that 
contain both egg and milk, as has been described in a previous publication 
regarding this cohort
100
.   
 
5.11b) Time to weaning 
Using the Student’s t test to analyse subjects who were weaned before 26 
weeks (all but one subject) it was possible to show that there was a significant 
difference between age at weaning for subjects who were from non-manual 
families (mean age at weaning 8.27 weeks) at age 1 year and subjects who 
were from manual families (mean age at weaning 7.0 weeks) at age 1 year 
(p=0.003).   However we can use survival techniques to analyse the data we 
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have regarding weaning and wheeze.  In this case the event of interest is the 
time to wean the subject.  Figure 5.3 shows the Kaplan Meier estimates of the 
time to weaning, allowing for censoring, subdivided into those who wheezed 
and those who did not wheeze at age 23. This shows the proportion of subjects 
who have not been weaned onto solid food by age.  At most ages the 
proportion not weaned was lower in those who wheezed at age 23, suggesting 
that wheezing was more common in those weaned at an early age. Comparing 
the distributions using the log rank test showed there was a significant 
difference between groups (p=0.039).   
Figure 5.3 Kaplan Meier graph of time to weaning and wheeze status at age 23 
years   
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Figure 5.4 also compares the distributions but this time we have a hazard plot 
comparing the hazard of weaning between those who wheeze and those who 
do not.  The hazard function gives the instantaneous event rate i.e. the 
probability that an individual is weaned at time t, conditional on them  not 
having been weaned up to that point.  The hazard function tends to be higher 
in the wheeze group, consistent with the survival function plot in Figure 5.3. 
 
 
Figure 5.4 Hazard function showing age at weaning onto solids by wheeze 
status at age 23 years.   
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A Hazard Ratio (HR) greater than 1, comparing those who wheeze with those 
who do not,  corresponds to the weaning distribution being shifted earlier in 
the wheeze group, i.e. earlier wean would make wheeze more likely.  
Adjustment for confounders is achieved using Cox’s Proportional Hazards 
model.  This assumes that the hazard functions for the two groups have a 
constant ratio over time; the plot of the survival curves in Figure 5.3 and the 
hazard plot in figure 5.4 suggests that is not unreasonable.  
The results of this analysis are shown in Table 5.7.   For wheeze the 
unadjusted hazard ratio was 1.26.  As this is greater than 1 it suggests that the 
risk of wheeze is greater in those weaned early, but it was marginally non-
significant.  Adjustment for confounders had little effect as can be seen in 
Table 5.7. 
  
169 
 
Table 5.7 Results from Cox’s Proportional Hazards Model of age at weaning 
onto solid food and asthma, wheeze and atopy at age 23 years. 
Outcomes at age 
23 
Asthma  Wheeze  Atopy  
Number 
(censored) 
296  (1) 299 (1) 119 (1) 
Unadjusted 
hazard ratio 
1.23 (0.91-1.67) 
0.17 
1.26 (0.99-1.61) 
0.06 
0.81 (0.56-1.17) 
0.26 
Adjusted Hazard 
Ratio† 
1.27 (0.93-1.74) 
0.13 
1.28 (1.00-1.65) 
0.052 
0.84 (0.56-1.27) 
0.41 
*Significant result 
†Adjusted for social class age 1, randomisation, parental allergy, gender and 
ever breast fed. 
 
The above analysis refers to weaning on to any food; we now consider each 
main type of food. There was a significant association between time to 
weaning on to beef and wheeze at age 23 years, as shown in table 5.8.  
Associations with weaning on to other foods were not significant, though the 
relatively small samples sizes led to wide confidence intervals. The result on 
beef suggests that wheeze was less likely with early weaning onto beef; 
however, in the absence of an obvious mechanism, this may be a chance result 
arising from multiple testing.  
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Table 5.8 Time to wean on foods in those who wheeze and those who do not 
at age 23 years. 
Number  Number/ 
censored (%) 
Hazard Ratio no 
adjustment 
Adjusted Hazard Ratio 
(95% CI) 
Meat not 
Beef  
298/23 (7.7%) 0.90 (0.70-1.16) 0.43 1.01 (0.94-1.09) 0.62 
Fruit  299/6 (2.0%) 1.20 (0.94-1.53) 0.14 1.23 (0.96-1.57) 0.11 
Fish  299/255 (85.3%) 1.18 (0.64-2.19) 0.59 1.13 (0.61-2.10) 0.71 
Egg   298/91 (30.5%) 1.00 (0.75-1.34) 1.00 1.00 (0.74-1.35) 1.00 
Cereal  298/13 (4.4%) 1.12 (0.87-1.43) 0.37 1.05 (0.81-1.35) 0.73 
Beef  299/24 (8.0%) 0.75 (0.58-0.98) 
0.03* 
0.76 (0.59-0.99) 0.05* 
*Significant result 
†Adjusted for parental allergy, gender, social class age 1, original 
randomisation and breast feeding 
 
5.12a) Time to event analysis for first exposure to cows’ milk 
In an earlier section we investigated the results from the two randomisation 
groups.  That analysis was on an intention to treat basis, ignoring the fact that 
some in the intervention group were actually exposed to cows’ milk at an early 
age.  Now we will analyse the data regarding first exposure to cows’ milk 
using Cox’s Proportional Hazards model.  The results are shown in table 5.9, 
and suggest that early exposure to cows’ milk protects against asthma and 
wheeze; the hazard ratio for atopy was comparable to those for wheeze and 
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asthma but the smaller sample size has led to a much wider confidence 
interval. 
 
 
Figure 5.5 Age in weeks when cows milk first consumed by randomisation 
group (log scale) 
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Table 5.9 Age in weeks of cows’ milk protein exposure and association of 
outcomes at age 23  
Outcomes at age 23 Asthma  Wheeze  Atopy  
Number (censored) 296  (128) 299 (128) 119 (52) 
Unadjusted hazard 
ratio 
0.51 (0.31-0.84) 
0.008* 
0.67 (0.47-0.94) 
0.02* 
0.67 (0.41-1.08) 
0.10 
Adjusted Hazard 
Ratio† 
0.51 (0.31-0.85) 
0.009* 
0.66 (0.47-0.94) 
0.022* 
0.63 (0.38-1.04) 
0.71 
*Significant result  
†Adjusted for social class age 1, parental allergy, gender and ever breast fed. 
 
5.13 Discussion  
Neither breast feeding nor late infant weaning onto solid food was 
significantly associated with outcomes at age 23 years.  However, few subjects 
were breast fed for more than 4 weeks and the majority of subjects were 
weaned onto solids within 4 months of birth.  This poor exposure to being 
solely breast fed may explain why the results from the MAPS cohort were 
different to many other studies, in which a much higher percentage of subjects 
had sole breast feeding for much longer .  However we were able to show a 
significant association between breast feeding and wheeze age 1.  The 
protective effect of breast feeding with respect to wheeze at age 1 year may be 
exhibited, fairly quickly, through the passage of maternal IgA to protect 
against infections. Hence we found an association in this study.  However, to 
protect against antigenic foods, or indeed to induce a poor tolerance reaction 
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due to lack of antigenic food, one could speculate that sole breast feeding 
would have to continue for longer and thereby not allow the subject to be 
exposed to antigenic foods.  Prescott et al have demonstrated that the Th2-
skewed responses to common environmental allergens, are present in virtually 
all new-born infants and that it is immune modulation toward a Th1 response 
in the early post natal period that determines the normal (non-atopic) state of 
the individual’s immune system in most cases246.  Since our subjects were not 
breast fed for long enough the results of our study cannot add to this evidence.   
One limitation in our RCT was the fact that a high percentage of those who 
were in the intervention arm did actually have exposure to cows’ milk protein.   
 
There are few longitudinal studies that have outcomes on breast feeding in 
adulthood.  Matheson et al found that exclusively breast fed babies in the TAS 
cohort with a maternal history of either asthma or allergic rhinitis in the initial 
survey in 1968, were less likely to develop asthma before the age of 7(odds 
ratio [OR], 0.8; 95% CI, 0.6-1.0). However, after age 7 years, the risk 
reversed, and exclusively breast-fed children had an increased risk of current 
asthma at age 14 years (OR, 1.46; 95% CI, 1.02-2.07) and 32 years (OR, 1.84; 
95% CI, 1.06-3.3) years
239
.  However this study used a retrospective history of 
breast feeding taken when the subject was 7 years of age, relying on parental 
recall of breast feeding which may be inaccurate. Other studies have found 
much higher rates of breast feeding in their population but no other study to 
our knowledge has taken a weekly prospective diet history for the first 6 
months of the subjects’ life.  We would therefore speculate that other studies 
may not be fully aware of their true prevalence of breast feeding.    
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We have shown that excluding cows’ milk protein for the first four months of 
life did not reduce the risk of wheeze, asthma or atopy at age 23 years. Our 
results showed a significant increase in atopy and asthma at age 23 years in 
subjects who were allocated to the intervention arm.  No other study has 
excluded cows’ milk protein in an RCT and followed up subjects into adult 
life.  When comparing soya based milk formulae to cows’ milk based 
formulae, two early studies suggested that soya milk was not as atopy 
inducing as cows’ milk247, 248.  Lowe et al investigated a 3 group RCT of high 
risk infants fed a conventional cows’ milk formula, extensively hydrolysed 
cows’ milk formula or a soy formula when breast feeding had ceased.  At age 
6-7 there was no evidence of soya or extensive hydrolysed cows’ milk 
formulas providing any protection from allergic disease or asthma specifically 
compared to the usual milk formula
249
.   However the GINI plus study 
followed up children till age 6 and investigated eczema (not asthma) as an 
outcome.  The intervention arm used extensively hydrolysed cows’ milk (eHF-
C) based formula.  Researchers found that predisposed children without 
nutritional intervention had a 2.1 times higher risk for eczema [95% 
conﬁdence interval (CI) 1.6 – 2.7] than children without a familial 
predisposition. The risk was smaller with nutritional intervention even 
levelling out to 1.3 (95% CI 0.9–1.9) in children fed eHF-C formula250. 
However the association between our intervention arm and asthma and atopy 
was not apparent until the MAPS cohort were adults and neither the Lowe et al 
study or the GINI plus study has reported on adult results.   The only other 
study, to our knowledge, that has comparable results is the Isle of Wight study, 
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which reported on their subjects at age 18.  Subjects were enrolled in a single 
blinded, randomised controlled trial. Infants in the intervention arm were 
either breast fed with the mother on a low allergen diet or given an extensively 
hydrolysed formula. Exposure to house dust mite allergen was reduced. The 
control group followed standard advice. Children were assessed at ages 1, 2, 4, 
8 and 18 years for the presence of asthma and atopy.  Children were assessed 
at 18 years for the presence of asthma and atopy. They showed that reducing 
allergenic exposure in the first year of life reduced the risk of asthma at age 18 
years the OR being 0.23 (95% CI 0.08 - 0.70), p=0.01
212
. However this study, 
used a multifaceted approach and did not just remove one allergen; in 
addition, they removed exposure to soya in the treatment arm of their study 
because of its allergenic properties, so they are not completely comparable.  
The reason our study showed that cows’ milk had a reduced allergenic effect 
may be because the control group was given soya based milk formula, which 
could have had an increased allergenic effect.   
 
Our results may not be due to early use of soya in our intervention arm, rather 
it may be that in the MAPS cohort early exposure to cows’ milk protein 
created tolerance in the subjects’ immune systems.  In this case our findings 
would be in keeping with the PIAMA cohort study where researchers found 
that the daily consumption of full fat milk and butter at the age of 2 reduced 
the risk of asthma and wheeze at age 3 when compared with children who did 
not have daily consumption
91
.  Sudo et al investigated the role of intestinal 
bacterial flora in oral tolerance induction in germfree (GF) mice. When they 
tested mice without appropriate bowel flora for tolerance induction, they 
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found Th1 cytokines remained low and Th2 remained high.  However when 
they were inoculated with Bifidobacferium infantis, one of the predominant 
bacteria in the  intestinal flora, tolerance induction was maintained.  However 
this only occurred in neonatal mice.  Older mice were unable to develop 
tolerance
251
.    
 
Studies in mice regarding tolerance induction suggest that the neonatal period 
is critical for appropriate immune-modulation to allow adult Th1 type 
responses to develop in the infant
35, 252
.  It may be that our cohort received 
cows’ milk allergen at that critical period and had the correct bowel flora to 
develop tolerance in their neonatal immune systems.  This is not the only 
example of exposure to an allergen in early life promoting tolerance, as 
already discussed in chapter 4, evidence suggests that babies born in the pollen 
season are less likely to have rhinitis or pollen sensitivity up to age 15 
years
218
.  The mechanism of this must also be through early tolerance 
induction.      
 
Weaning onto solid food has not been extensively studied but two reports 
suggest that late weaning does not protect against wheezing
244
 or asthma
242
.  
In the MAPS cohort there was no evidence that weaning was associated with 
asthma, wheeze or atopy.  There was one significant result using Cox’s 
proportional hazard modelling which showed a protective effect from early 
weaning and wheeze at age 23 years.  However it is not clear if this is a true 
effect or just present due to multiple testing.  
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The investigators did not expect, when the study was initiated, that offering 
free soya formula to mothers of new born subjects might have an influence on 
their breast feeding activities.  However our findings show that breast feeding 
rates were lower in the intervention group and it is possible that this arose 
because of the offer of free formula.  Mothers from this deprived community 
may have decided to use formula rather than breast feed as a good source of 
nutrition or purely for convenience. If such a study was to be planned in the 
future then such possible effects would have to be considered by an Ethics 
panel. 
 
Bias may have arisen from the fact that not all mothers kept rigidly to the 
randomisation group to which they were assigned. Some mothers not in the 
intervention arm did use soya milk for feeding the subjects, presumably 
because they believed it to be beneficial, and many in the intervention group 
were exposed to cows’ milk at an early age. 17.2% of mothers in the 
intervention group  admitted to using to using cows’ milk products while  37% 
tested positive to IgG4 for cows’ milk antigen at age 3 months, suggesting 
some exposure to cows’ milk. The combined effects of these departures from 
protocol would be to lessen any effect of the intervention. 
 
In summary we have found that the intervention (exclusion of cows’ milk 
protein with replacement of soya supplementation in neonatal life) appeared to 
increase the risk of adult asthma and atopy. Further areas of research need to 
be undertaken to investigate the mechanism of this increased risk of asthma 
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and atopy with the intervention arm.  This has not been shown in previous 
studies and may be specific to the population under study.   
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Chapter 6 
 
Environmental factors in the aetiology of asthma.  
6.0 Introduction 
 
A wide variety of environmental influences has been implicated in the rise in 
prevalence of asthma.  These include smaller family sizes
253
; less exposure to 
domestic animals in childhood
254
; and  changes in diet
255
. However, no one 
environmental factor has been shown to be unfailingly protective against, or 
consistently a risk for, the development of asthma.  Often it is difficult to 
determine which factor in the environment influences outcomes and when the 
factor has its effect.  It is likely that both environmental and host influences 
interplay to produce an outcome, which may lead to the development of 
asthma.  A risk factor  can be either primary (i.e. increases the incidence of 
asthma) or secondary (triggers symptoms, exacerbates disease, or increases its 
severity)
256
.  In this study we are investigating primary risk factors in early life 
that may have an effect later in life. 
 
It is likely that there is a close interplay between environmental factors and 
genetic make-up which will become better informed with the research into 
epigenetics.  However a full discussion of the epigenetics of asthma is beyond 
the scope of this work and is reviewed by Miller and Ho
257
.  In this chapter we 
will investigate environmental factors in the prevalence of asthma and asthma 
symptoms in adults. 
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6.1 Evidence from migration studies 
Smith et al investigated a group of school children in Birmingham who were 
first reviewed in 1956 and again in 1968.  They showed an increasing 
prevalence of asthma over the 12 year period. They also showed that children 
from  Asian and African backgrounds born overseas had a lower prevalence of 
asthma than children born in the UK (whether British or African and Asian 
parents)
258
.  In the 1980s Gregg investigated the effect of migration of diverse 
people, such as Tokelauan citizens migrating to New Zealand and Xhosa 
children migrating to Cape Town in South Africa, on the prevalence of 
asthma, and suggested that as subjects moved from less developed to more 
developed communities, their prevalence of asthma increased
259
.    
 
Kuehni et al undertook a random postal questionnaire study of 2380 South 
Asian women and 5796 young white mothers residing in Leicester, UK.  The 
survey showed a lower rate of asthma in the South Asian women (10.9%) 
compared to white women (21.8%) and an even lower rate (6.5%) in the South 
Asian women who had not migrated from India until they were over 5 years 
old
260
.  Those who had migrated to the United Kingdom after the age of 5 
years were less than half as likely to suffer with asthma as those who had been 
born in the United Kingdom or had migrated before the age of 5 years.    This 
study suggests that exposure to Western environmental influences is 
particularly important at a young age. 
 
181 
 
The reunification of Germany in 1989 gave the ideal setting to compare the 
effects of genetic factors and environmental factors in the development of 
asthma and atopy.  Despite the political separation of the two populations, 
their genetic make-up remained comparable.  When the Cold War ended and 
the Berlin Wall came down, there was a lower prevalence of asthma among 
children age 9-11 years in the East compared to the West, despite the fact that 
the East was notorious for high levels of pollution
261
.  Frye et al investigated 
the prevalence of bronchial hyper-reactivity in 8-14 year olds from schools in 
what was previously East Germany firstly in 1992 and again in 1995.  They 
found an increase in bronchial hyper reactivity (BHR) from 6.4% in 1992-93 
to 11.6% in 1995-96 (OR 1.9 95% CI 1.3-2.9) which they suggested was the 
first sign of an increase in asthma that was likely to occur
262
.  
 
 A number of environmental factors had changed for children in the two 
German surveys over the 3 years including a significant change in heating 
from coal to central heating, less sharing of bedrooms, a greater percentage of 
children starting day care at age 6 months (7.3% vs 3.9%) and at age 1 year 
(12.5% vs 5.3%) and there was greater contact with pets.  There is no single 
environmental influence that can be pin-pointed as the reason why these 
children have a greater prevalence of BHR compared with subjects of a similar 
age only three years before but it is suggested that a number of factors, 
increase the risk of BHR and asthma.   
 
6.2 Endotoxin and asthma risk 
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Endotoxin is a lipopolysaccharide that is present within the cell wall of gram 
negative bacteria and can be measured in house dust.   The level of endotoxin 
in house dust increases with greater contact with farm animals
263
 and in the 
presence of domestic cats and dogs in the house
264
 and where livestock are 
kept
265
.  Reidler et al found that those children who had regular exposure to a 
farming environment and who drank unpasteurised milk before the age of 5, 
had a significantly lower risk of developing asthma at age 9-10 years than 
those who did not have this type of exposure
266
. A cross-sectional ISAAC 
study found a significantly lower prevalence of ever having been diagnosed 
with asthma or of having wheezed in the past year with a greater concentration 
of endotoxin in living room dust
267
.   
 
6.3 Domestic pets and asthma prevalence  
Having a domestic pet is associated with increased levels of aeroallergens 
specific to the pet that is kept (i.e. fel d1 for cat and can f1 for dog)
268
.  A 
Swedish study found that living with a cat was inversely related to the 
incidence of physician-diagnosed asthma
269
. De Marco et al in an ECRHS 
cross-sectional study in adults found that pet ownership in childhood resulted 
in protection against childhood asthma
270
.   The ECRHS study found that the 
effects of pet-keeping in childhood varied according to the type of pet, the 
allergic sensitisation of the individual, and the wider environmental exposure 
to allergen. Cats owned in childhood were associated with more asthma in 
sensitised adults who grew up in areas with a low community prevalence of 
cat ownership while dogs owned in childhood seemed to protect against adult 
allergic disease but promote non-allergic asthma
271
.   However one systematic 
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review showed that exposure to pets increased the risk of asthma and 
wheezing in older children
272
, which suggests that studies, so far, have not 
answered the question on whether pet ownership is protective or not.  What we 
may need is longitudinal studies to report on this issue.  ALSPAC has reported 
on pet keeping only in childhood and shown a small but significant increase in 
wheeze up to age 42 months when cats and dogs are kept
93
.  The PIAMA 
study found that although keeping pets at the age of 3 months reduced the 
incidence of sensitisation to aeroallergens, at age 8, there was no evidence that 
there was a reduction in the risk of asthma at this age
73
.  Evidence from the 
Dunedin cohort suggested that owning both a cat and a dog in childhood, was 
associated with a lower risk of atopy at age 13 and further pet keeping 
protected against atopy in adulthood, but they have not reported on asthma or 
wheeze
273
.  The Tucson Children’s Respiratory Health study (TCRS) showed 
that early pet ownership was associated with a lower prevalence of wheeze up 
to age 11 years among children without parental asthma, but they have not 
given results on adult subjects
254
.  However, a more recent study showed that 
subjects with asthma selectively avoid keeping a cat if they are allergic, and 
concluded that at least in part any apparent protective effect of cat keeping 
may be due to avoidance of cat keeping in those with asthma
23
.   
 
 
6.4 Indoor Environment 
People living in urban areas spend most of their time (85–90%) in indoor 
environments
274
, which  have changed enormously over the past few decades 
with the introduction of soft furnishings and ﬁtted carpets. There has been a 
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consequent increase in damp and reduction in ventilation with a subsequent 
increase in indoor allergen levels
268, 275
.  Indoor air has been shown to contain 
increasing levels of indoor aeroallergens due to modern living, i.e. central 
heating and insulated windows
275
.  The other factor in indoor air pollution is 
chemical pollutants from cooking and heating; these have been shown to 
increase asthma symptoms
276
.  Aromatic compounds and carbonyls, in homes, 
oﬃces, shopping malls and schools often have concentrations  2–5 times those 
found outdoors, and can occasionally reach 100 times outdoor levels
277
. In 
addition the rate at which indoor air is changed for fresh air is now lower than 
it was 30 years ago, leading to an increase in humidity, levels of indoor 
pollutants and air-borne allergens
277
.  
 
 
6.4a) Damp and mould in housing  
One German study examined bedrooms both before and 7 months after double 
glazing and central heating were installed and found a significant decrease in 
air exchange rate and an increase in temperature and absolute humidity (water 
content of the air), although relative humidity (the percentage of water vapour 
in the air compared to the maximum for that temperature) did not significantly 
rise
275
.  There was also an increase in house dust mite allergen and fungal 
spores in dust from carpets and mattresses in bedrooms
275
.  The levels of cat 
(fel d1) and dog (can f1) allergens increase with higher humidity and lower 
ventilation
268
.  Fungal spore levels
278
 and house dust mite levels correlate with 
the presence of dampness
279
.   House dust mite levels have been shown to 
correlate with the risk of incident asthma
180
, and so it is no surprise that 
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measured dampness was significantly more frequent in asthma sufferers’ 
homes than in those of age and sex matched controls
280
.   In addition a 
randomised controlled trial of an intervention to remove mould from 
households of asthma sufferers compared to no intervention found a 
significant difference in asthma symptoms between the two groups
281
.  These 
studies suggest that increased levels of allergens are present in damp poorly 
ventilated environments and that reducing dampness and mould may reduce 
asthma symptoms in those who suffer with asthma. However, it is not clear if 
removing damp from the indoor environment reduces the incidence of asthma. 
 
6.4b) Heating and cooking- domestic fuels  
The two most prevalent oxides of nitrogen are nitrogen dioxide (NO2) and 
nitric oxide (NO). These are both indoor air pollutants although NO quickly 
oxidises to NO2 when mixed with oxygen (O2).  Both are toxic gases with 
NO2 being a highly reactive oxidant and corrosive.  The primary sources 
indoors are combustion processes, such as unvented combustion appliances, 
e.g. gas stoves, vented appliances with defective installations, welding, and 
tobacco smoke
282
.  A meta-analysis of studies investigating the respiratory 
effects of indoor NO2 showed that, in children, gas cooking was associated 
with an increased risk of asthma and indoor NO2 was associated with an 
increased risk of current wheeze
283
.  A British study found that gas cooking 
was associated with current wheeze in 14-16 year old children when they were 
investigated using a questionnaire administered to parents
284
.  An association 
between gas stove use and respiratory symptoms (cough and tight chest) was 
found in Australian 7-14 year olds, but there was no association of such 
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symptoms with nitrogen dioxide exposure in this study
285
.  This last study 
suggests that the association of asthma symptoms with gas stove use may not 
be due to an association with raised indoor levels of nitrogen dioxide, but 
rather due to some other factor specific to the indoor use of gas. 
 
The longitudinal Tasmanian Infant Health Survey (TIHS) reported that in 8 
year old children there was an increased relative risk of sensitisation to indoor 
aeroallergens with the use of home gas appliances
286
.   Exposure to fume 
emitting heaters in a cross-sectional study of school children age 8-11 in 
Belmont in NSW Australia showed no association with asthma, if exposure 
was current at the time of questioning.  However, if exposure was in the first 
year of life, there was an association with increased  airway hyper 
responsiveness in 8-11 year olds
287
.   
 
6.5a) Infection and related factors  
The hygiene hypothesis suggests that increased cleanliness should be 
associated with an increased risk of atopic disease.  The ALSPAC study found 
that high levels of hygiene at 15 months of age were independently associated 
with wheeze and atopic eczema reported between 30 and 42 months
288
. 
Korhonen et al investigated children with an atopic disease (defined as having 
sensitivity to a common allergen and one of eczema, asthma or hay-fever) and 
matched controls aged 5-11.  They tested their serum for 12 different 
enterovirus serotypes and found that the controls were more likely to have the 
presence of recurrent enterovirus infections than those with atopic disease
289
.   
The Tasmanian longitudinal study which investigated asthma risk from early 
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life infections, showed that, overall childhood infections, including pneumonia 
reduced the risk of asthma persisting into later life
290
. However other studies 
have not found that early life infections are associated with a reduced risk of 
atopic disease.  A cross-sectional ECRHS study found that a serious 
respiratory infection before the age of five years was associated with a 
significantly increased risk of asthma in adulthood
270
.   An ISAAC study of 5-
7 year olds and 9-11 year olds showed an association of increased risk of 
asthma, especially non-atopic, with repeated episodes of fever and antibiotic 
treatment in early life
291
.   An investigation of maternal infections during 
pregnancy found an association of increased risk of asthma in the child up to 
age 6 if the mother had had a urinary tract infection during pregnancy
292
.     
The evidence regarding infection in early life and protection against allergic 
disease is therefore conflicting.   
 
6.5b) Number of siblings  
The association of older siblings and protection from hay fever at the age of 11 
years and 23 years was the basis of Strachan’s original paper that later became 
the foundation for the hygiene hypothesis.  Other researchers have 
investigated the association of the presence of siblings and the acquisition of 
asthma or wheeze.  The best known studies are presented in table 6.1.  Bodner 
et al undertook a large cross-sectional study of 10-14 year olds in Aberdeen 
and showed that having 3 or more younger siblings was associated with a 
lower risk of asthma
293
.  Similarly a GP database study demonstrated that 
children with increased numbers of older siblings had a lower risk of asthma 
than those with fewer siblings
294
.  Ball et al studied the TCRS longitudinally 
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and showed that the presence of one or more older sibling at home protected 
against the development of physician diagnosed asthma at age 6-13 years
82
.  
However the cross-sectional ECRHS showed that a greater number of siblings 
was associated with a reduced risk of rhinitis in adults but associated with an 
increased risk of asthma
22
. The SIDIRA (Italian Study of Respiratory 
diseases) longitudinal study group found that having siblings was a risk factor 
for transient early wheezing (phenotype of early wheeze not linked to asthma) 
in 5-6 year olds but protective against late onset and persistent wheeze, 
(considered to be precursors to asthma)
99
.  In a study of male conscripts born 
in Sweden between 1973-75, the presence of older siblings was associated 
with a reduced risk of rhinitis, though there was no such protective association 
with asthma
295
.  Pekkanen, however, showed a positive but non-significant 
association with doctor diagnosed asthma and the presence of 3 or more 
siblings in the home.  The relationship between family size and prevalence of 
asthma is not clear and remains controversial. Why there are differing 
outcomes with the SIDRIA and TCRS showing a protective effect for 
persistent wheezing, in children, while the ECRHS shows no protective effect 
in adults, is not clear, but it may be due to the age when the outcome is 
measured or due to the longitudinal nature of the Tucson and SIDRIA studies, 
which means these studies may be more able to record accurately a history of 
asthma.  Although the results of the studies are not noticeably showing a  
benefit of having siblings, overall there does appear to be a lower risk of 
asthma and wheeze in childhood and adulthood in those with more siblings.  
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Table 6.1 studies investigating the association of the presence of siblings and 
asthma prevalence 
Study OR 
(95%CI) 
Outcome variable Variable 
defined 
Study 
design 
Braback
295
 1.31 (0.96-
1.77) with 
rhinitis  
0.92 (0.74-
1.16) without 
rhinitis 
Asthma age 17 years 4 or more 
siblings 
compared 
to none 
Cross-
sectional   
Bodner
293
 0.4 (0.1 - 
0.9)  
Asthma age 10-14 
years 
>=3 
siblings vs 
0 sibs 
Cross-
sectional  
ECRHS
296
 0.31 (0.11-
0.83) 
 
Asthma age 20-44 
years 
>2 sib vs 0 
sibs 
Cross-
sectional  
National 
Study of 
Health and 
Growth 
(NSHG)
133
  
0.87 (0.76-
0.98) 
Asthma attacks or 
wheeze 5-11 years 
>=1 sib vs 
0 sibs 
Cross-
sectional   
Pekkanen 
297
 
1.26 (0.85–
1.88) 
Doctor diagnosed 
asthma ever13-14 
year old children 
0 sibs vs 3 
or more 
Cross-
sectional   
SIDRIA
99
 1.41 (1.21–
1.64)  
Transient early 
wheeze 6-7 year olds 
>=1 sib vs 
0 sibs 
longitud
inal  
SIDRIA
99
 0.83 (0.70–
0.97) 
Late onset wheeze 6-
7 year olds 
>=1 sib vs 
0 sibs 
Longitu
dinal  
Tasmanian 
Infant 
Health 
Survey
298
 
0.36 (0.17-
0.74) 
 
 
Current asthma 
(self- reported ever 
asthma and wheeze 
in past year) 7 year 
old 
>=1 sib vs 
0 sibs 
Longitu
dinal  
TCRS
82
 0.8 (0.7–1.0) Asthma physician 
diagnosis ever and 
symptoms past year 
6-13 year old 
>=1 sib vs 
0 sibs 
Longitu
dinal  
TCRS=Tucson Children’s Respiratory Health study 
 
6.6 Changing response to infection-alteration in immune competence  
A number of factors have been proposed as modulating the immune response 
to infection and therefore these factors may have an effect on the incidence of 
asthma.  Two of these modulating factors are immunisation, which causes a 
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naïve immune system to recognise a harmful microorganism, and caesarean 
section birth, since it has been hypothesised that delivery through the vaginal 
canal arms the new born with healthy maternal bacteria that colonise the gut 
and thereby reduce the risk of atopic disease
299
.   
 
6.6a) Immunisation 
 A study of 13-14 year olds who had participated in the French section of the 
ISAAC study and had vaccination records were found to have a reduced risk 
of asthma and atopy if they had been vaccinated when compared to those who 
had not been vaccinated.  After adjustment for the usual confounders the odds 
ratio was 0.30; 95% CI: 0.10, 0.92. The relationship did not depend on the 
disease against which the vaccine was used as prophylaxis, adherence to the 
observance of the vaccination schedule or the number of inoculations. A 
higher protection was observed in the case of live attenuated vaccines (oral 
poliomyelitis and bacilli Camille-Guerin; OR = 0.26; 95% CI: 0.08, 0.83)
300
.  
However out of a group of 718 only 24 did not have immunisation and they 
are likely to be different in other ways to the children that did have 
immunisation. 
 
Others have found that polio immunisation protects against asthma to age 6 
years, while diphtheria and tetanus immunisation together gave an increased 
risk for asthma at age 6
301
.   A large retrospective Canadian study, in which 
children received at least 4 doses of diphtheria, pertussis and tetanus (DPT), 
reported on the association between delay in first dose of DPT and association 
with asthma at age 7.  If the first immunisation was delayed from before 2 
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months by at least 1 month there was a statistically significant association with 
asthma: OR 0.84 (0.75-0.95).  They found that the risk of asthma was reduced 
to half in children whose first dose of DPT was delayed by more than 2 
months. The likelihood of asthma in children age 7 with delays in all 3 doses 
was 0.39 (95% CI, 0.18-0.86)
302
.    
 
The Tasmanian Longitudinal Health Study (TLHS) investigated the 
association between asthma and childhood vaccination in a population in 
which immunisation against common infections was undertaken by 80-85% of 
the population.  Researchers found no evidence of an association between 
asthma in adulthood and immunisation in childhood
303
. The Melbourne Atopy 
Cohort Study (MACS) found that polio immunisation before the age of 2 
reduced the risk of doctor diagnosed asthma at age 6 in a high risk birth 
cohort
304
.  Overall, it seems that there may be a protective effect from 
immunisation with live attenuated bacteria with in childhood asthma, but this 
is likely to be small.  The effect on adult asthma prevalence is less clear as 
there are few longitudinal studies that have reported on outcomes in adults.  In 
summary there is no clear picture regarding the association of immunisation 
with asthma and wheeze. 
 
6.6b) Caesarean section and risk of asthma 
The rate of caesarean section has risen from 9% of deliveries in England in 
1980 to 24.8% in 2009
305
.  A meta-analysis of studies between 1996-2006 
investigating the association between asthma and caesarean section found  a 
20% increase in the odds of asthma in those born by caesarean section (OR 
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1.20 95% CI 1.14-1.26)
306
.   A further meta-analysis investigating studies from 
1966-2007 found a similar association between caesarean section and asthma 
(OR 1.18  95% CI 1.05–1.32) in all subjects up to adult ages307. The 
Epidemiology of Home Allergens and Asthma longitudinal study found an 
association between caesarean section and rhinitis at age 9 years (OR 1.9 95% 
CI 1.1-3.2 p=0.02) but not with asthma at the same age  (OR 1.1 95% CI 0.6-
2.3 p=0.7)
308
.  The PIAMA study found that children born through caesarean 
section were significantly more likely to have asthma at the age of 8 (OR 1.79 
95% CI 1.27-2.51) than those born with simple vaginal delivery, especially if 
they had allergic parents (OR 2.91 95% CI 1.20-7.05)
309
.  The ALSPAC 
longitudinal study found no association of mode of delivery with asthma at 
69–81 months (OR 1.16 95% CI 0.9-1.5); wheeze 69–81 months (OR 0.95 
95% CI 0.7-1.3); physician diagnosed asthma (OR 1.14 95% CI 0.9-1.4); 
atopy (OR 1.04 95% CI 0.8-1.3)
88
.  Breton et al in a data base study from 
Quebec investigated a cohort of 13 100 and 28 042 single pregnancies in 
women with and without asthma, respectively. The crude OR of perinatal 
mortality was 1.35 (95% CI 1.08 to 1.67), which decreased to 0.93 (95% CI 
0.75 to 1.17) after adjustment for birth weight and gestational age at birth. 
Women with asthma had a higher rate of low birth weight babies and preterm 
delivery than those without asthma
310
.  The authors concluded that the 
increased risk of low birth weight babies and premature delivery in women 
with asthma may partly explain the association between maternal asthma and 
the increased risk of perinatal mortality, i.e. reverse causality.  
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6.7 Environmental tobacco smoke 
A large cross-sectional study of school students in Southern California in 4
th
 
grade (age 9-10 years), 7
th
 grade (age 12-13 years) and 10
th
 grade (age 15-16 
years) was undertaken and based on a questionnaire administered to parents 
The questionnaire asked parents to recall their smoking history during the time 
when the subjects were still intrauterine so there may have been some recall 
bias.  Despite this, the study showed that smoking during pregnancy was 
associated with asthma
311
 and reduced lung function
312
 in the child, however 
they could not show conclusively that environmental tobacco smoke was 
associated with asthma, although it was associated with wheeze
311
.   A 
systematic quantitative review of 25 studies regarding passive smoking in 
school age children (5–16 years) and asthma, wheeze or cough in the child, 
was undertaken in 1997 by Cook et al and revealed a significant association 
for all these symptoms if either parent was a smoker compared to children not 
exposed to environmental tobacco smoke. The pooled odds ratios for either 
parent smoking and association of the following symptoms in the subject were 
1.21 (95% CI 1.10-1.34) for asthma, 1.24 (95% CI 1.17 to 1.31) for wheeze, 
1.40 (95% CI 1.27 to 1.53) for cough
313
.  The association between passive 
smoking and childhood asthma was also shown in a meta-analysis by Tinuoye 
et al, where twenty relevant studies were identified.  The pooled odds ratio 
was 1.32 (95% CI: 1.23 - 1.42, p < 0.001)
314
.  A further meta-analysis of 29 
studies showed that passive smoking increases the risk of asthma by at least 
20% in exposed children
315
.  The SIDRIA group studied two random samples 
of subjects ages 6-7 and 13-14 years in ten areas of northern and central Italy 
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and showed that exposure to smoke of at least one parent was associated with 
an increased risk of current asthma among children [odds ratio (OR) =1.34; 
95% confidence interval (CI) = 1.11-1.62] and of current wheezing among 
adolescents OR = 1.24; 95% CI = 1.07-1.44)
316
. No study has reported on 
childhood exposure to passive smoke and adult risk, although one study 
showed that in utero exposure to tobacco was associated with a higher 
prevalence of smoking in adulthood
317
.  Adult onset asthma has also been 
found to be associated with passive smoking in adults in one study from 
Finland.  The risk of asthma was related to both workplace exposure (adjusted 
odds ratio [OR] = 2.16: 95% CI 1.26-3,72) and home exposure (OR=4.77; 
95% Cl 1.29-17.7) in the past year
318
. 
 
 6.8 Aims and objectives 
The aim of this chapter is to investigate associations between the early life 
environment and asthma and wheeze in early adult life. 
 
Objectives 
1 To investigate the association of outcome variables at age 23 with  
 The possession of household pets in early childhood  
 Housing attributes such as the presence of damp and mould 
 Domestic fuel use for heating and cooking 
 Infection (chest infection in the first year of life) 
 The presence of one or more sibling 
 Immunisation and caesarean section 
 Exposure to environmental tobacco smoke in early 
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6.9 Methods 
In this section the methods were as outlined in chapter 2.  All sections in this 
chapter are based on answers to the questionnaires at different ages.  The 
questions asked with regard to damp housing, mould in housing, older siblings 
and early life chest infections are given in the questionnaires at age 3 months 
and 7 years, reproduced in the appendix (appendix 3b and 7b). 
 
6.10 Results 
6.10a) Domestic pet keeping and outcomes at age 23 years 
A total of 15% of subjects from the MAP study had a domestic cat in the 
family at the age of 1 year and 22% at the age of 7 years.  A total of 30% of 
the cohort had at least one dog in the family at the age of 1 and 42% at the age 
of 7 years.   
 
Table 6.2 shows no significant associations between pet keeping at age 1 or 7 
and any outcomes in adulthood.  However, there is a low OR for wheeze and 
asthma at age 1 and an OR greater than 1 for wheeze and asthma at age 7.  
This suggests that pet keeping at age 1 year may be protective while pet 
keeping at age 7 may increase the risk of asthma and wheeze.  The OR for 
atopy and pet keeping at age 1 and at age 7, are both low suggesting there may 
be some tolerance to sensitisation from regular pet keeping.   
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Table 6.2 Associations between pet ownership at ages 1 and 7 and outcomes at 
age 23  
 Cat or dog 
or mammal  
age 1 
No cat or 
dog or 
mammal age 
1 
Unadjusted OR 
(95%CI) p-
value 
Adjusted† OR 
(95%CI) p-
value 
Wheeze age 
23 
38/124 
(30.6%) 
57/169 
(33.7%) 
0.87 (0.53-
1.43) 0.58 
0.89 (0.53-
1.49) 0.46 
Asthma age 
23 
16/126 
(12.7%) 
37/170 
(21.8%) 
0.52 (0.28-
0.99) 0.047* 
0.54 (0.27-
1.05) 0.07 
Atopy age 
23 
24/49 (49%) 46/70 
(65.7%) 
0.50 (0.24-
1.06) 0.069 
0.59 (0.26-
1.34) 0.21 
 Cat or dog 
or mammal  
age 7 
No cat or 
dog or 
mammal age 
7 
Unadjusted OR 
(95%CI) p-
value 
Adjusted† OR 
(95%CI) p-
value 
Wheeze age 
23 
61/170 
(35.9%) 
31/125 
(28%) 
1.44 (0.87-
2.37) 0.15 
1.64 (0.97-
2.77) 0.065 
Asthma age 
23 
33/172 
(19.2%) 
20/126 
(15.9%) 
1.26 (0.68-
2.32) 0.46 
1.59 (0.83-
3.05) 0.16 
Atopy age 
23 
35/68 
(51.5%) 
35/52 
(67.3%) 
0.52 (0.24-
1.09) 0.08 
0.54 (0.24-
1.23) 0.14 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
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6.11 Home environment 
6.11a)  Damp in housing.   
Table 6.3 shows associations between outcomes at 23 years and damp and 
mould at age 3 months and age 7 years.  There is only one significant 
association, between wheeze at age 23 years and damp and mould at age 7.  
However there are no other significant associations, and this single significant 
result may be by chance. 
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Table 6.3 Damp or mould at age 1 and age 7 years and association with 
outcomes at age 23 years  
 Damp and or 
mould age 3 
months 
Damp and or 
mould age 3 
months 
Unadjusted OR 
(95%CI) p-
value 
Adjusted† OR 
(95%CI) p-
value 
Wheeze age 
23 
40/111 
(36.0%) 
55/183 
(30.1%) 
1.31 (0.80-
2.16) 0.29 
1.36 (0.81-
2.28) 0.24 
Asthma age 
23 
23/112 
(20.5%) 
29/185 
(15.7%) 
1.39 (0.76-
2.55) 0.29 
1.50 (0.80-
2.82) 0.21 
Atopy age 
23 
25/42 
(59.5%) 
45/78 
(57.7%) 
1.08 (0.50-
2.31) 0.85 
1.23 (0.53-
2.85) 0.63 
 Damp and or 
mould age 7 
years 
No damp and 
or mould age 
7 years 
Unadjusted OR 
(95%CI) p-
value 
Adjusted† OR 
(95%CI) p-
value 
Wheeze age 
23 
33/71 
(46.5%) 
63/224 
(28.1%) 
2.22 (1.28-
3.85) 0.004* 
2.39 (1.34-
4.26) 0.003* 
Asthma age 
23 
14/71 
(19.7%) 
39/227 
(17.2%) 
1.18 (0.60-
2.33) 0.63 
1.34 (0.66-
2.72) 0.42 
Atopy age 
23 
20/33 
(60.6%) 
50/87 
(57.5%) 
1.14 (0.50-
2.58) 0.76 
1.04 (0.41-
2.61) 0.94 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
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6.11b) Domestic Fuels for heating and cooking 
Details of the use of domestic fuel at the age of 1 showed that a total of 71 
(14.6%) of subjects used coal at age 1.  No further information was available 
on the use of fuels at that age.   At age 7 a number of household fuels were 
used, including gas for cooking (52.9%), electric fire (8.1%), central heating 
(90.9%), coal fire (4.5%), electric fire (8.1%), gas fire (63.7%) and solid fuel 
heating (18.2%), while 8.1% used some other form of heating.  Table 6.4 
displays the association between outcomes at age 23 years and the presence of 
a coal fire in the home at age 1 or 7 years.  There are no significant 
associations. 
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Table 6.4 Coal fire age 1 and age 7 years and association with outcomes at age 
23 years  
 Coal fire age 
1 years 
No coal fire 
age 1 years 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR (95%CI) 
p-value 
Wheeze 
age 23 
18/41(43.9%) 77/252 
(30.6%) 
1.78 (0.91-
3.49) 0.093 
1.95 (0.94-
4.04) 0.07 
Asthma 
age 23 
9/41 (22.0%) 44/255 
(17.3%) 
1.35 (0.60-
3.03) 0.47 
1.60 (0.66-
3.85) 0.30 
Atopy age 
23 
9/19 (47.4%) 61/100 
(61.0%) 
0.58 (0.22-
1.54) 0.27 
0.65 (0.21-
1.95) 0.44 
 Coal fire age 
7 years 
No coal fire 
heating age 7 
years 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR (95%CI) 
p-value 
Wheeze 
age 23 
6/15(40.0%) 90/280 
(32.1%) 
1.41 (0.49-
4.08) 0.53 
1.48 (0.49-
4.41) 0.49 
Asthma 
age 23 
5/16 (31.2%) 48/282(17.0%) 2.22 (0.74-
6.67) 0.16 
2. 48 (0.79-
7.83) 0.12 
Atopy age 
23 
3/8 (37.5%) 67/112 
(59.8%) 
0.40 (0.09-
1.77) 0.23 
0.57 (0.11-
3.06) 0.51 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
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Table 6.5 shows associations between the use of gas for cooking in the family 
home at the age of 7 and outcomes at age 23 years.  There is one significant 
association between gas as cooking fuel at age 7, and asthma 23 when adjusted 
for confounders.  There is no other association.  
 
Table 6.5 The use of gas for domestic cooking age 7 years and association 
with outcomes at age 23 years  
 Gas for 
cooking  age 7 
years 
No gas for 
cooking age 7 
years 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR (95%CI) 
p-value 
Wheeze 
age 23 
50/154(32.5%) 46/141 
(32.6%) 
0.99 (0.61-
1.62) 0.98 
1.11 (0.69-
1.84) 0.69 
Asthma 
age 23 
33/155 
(21.3%) 
20/143(14.0%) 1.66 (0.91-
3.06) 0.10 
2.02 (1.06-
3.86) 0.033* 
Atopy age 
23 
41/66 (62.1%) 29/54 (53.7%) 1.41 (0.68-
2.94) 0.35 
1.59 (0.70-
3.60) 0.27 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
Table 6.6 shows associations between the use of an electric fire in the home at 
age 7 years and outcomes at age 23 years.  There are no significant 
associations. 
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Table 6.6 The use of an electric fire for heating age 7 and association with 
outcomes at age 23  
 Electric fire 
age 7 years 
No electric 
fire age 7 
years 
Unadjusted OR 
(95%CI) p-
value 
Adjusted† OR 
(95%CI) p-
value 
Wheeze age 
23 
10/26(38.5%) 86/269 
(32.0%) 
1.33 (0.58-
3.05) 0.50 
1.51 (0.64-
3.55) 0.35 
Asthma age 
23 
6/26 (23.1%) 47/272 
(17.3%) 
1.44 (0.55-
3.77) 0.46 
1.66 (0.61-
4.50) 0.32 
Atopy age 
23 
7/11 (63.6%) 63/109 
(57.8%) 
1.28 (0.35-
4.62) 0.71 
2.14 (0.54-
8.49) 0.28 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
Table 6.7 shows associations between the use of central heating in the home at 
age 7 and outcomes at age 23 years.  There are no significant associations. 
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Table 6.7 The use of central heating for heating age 7 and association with 
outcomes at age 23 years  
 Central 
heating age 
7 years 
No Central 
heating age 7 
years 
Unadjusted OR 
(95%CI) p-
value 
Adjusted† OR 
(95%CI) p-
value 
Wheeze age 
23 
90/267 
(33.7%) 
6/25 (24.0%) 1.61 (0.62-
4.17) 0.33 
1.24 (0.46-
3.34) 0.68 
Asthma age 
23 
49/270 
(18.1%) 
4/25(16.0%) 1.16 (0.38-
3.54) 0.79 
0.83 (0.26-
2.67) 0.75 
Atopy age 
23 
62/103 
(60.2%) 
8/15 (53.3%) 1.32 (0.45-
3.93) 0.61 
0.91 (0.25-
3.37) 0.89 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
Table 6.8 shows associations between gas fire as a heating source in the home 
at age 7 and outcomes at age 23 years.  There are no significant associations. 
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Table 6.8 The use of a gas fire for heating age 7 and association with 
outcomes at age 23  
 Gas fire age 7 
years 
No gas fire age 
7 years 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR (95%CI) 
p-value 
Wheeze 
age 23 
56/189(29.6%) 40/106 
(37.7%) 
0.70 (0.42-
1.15)  0.16 
1.15 (0.62-
2.14) 0.66 
Asthma 
age 23 
32/190 
(16.8%) 
21/108(19.4%) 0.84 (0.46-
1.54) 0.57 
0.79 (0.42-
1.48) 0.45 
Atopy age 
23 
48/79 (60.8%) 22/41 (53.7%) 1.34 (0.62-
2.87)  0.46 
1.28 (0.54-
3.06) 0.58 
†Adjusted for Social class 1, gender, breast feeding, original randomisation, 
parental allergy. 
 
Table 6.9 shows associations between the use of solid fuel heating (not 
including coal heating) in the home age 7 years and outcomes at age 23 years.  
There is one significant result with a large effect size.  That is for atopy after 
adjustment for confounders. This result is similar to the result with coal except 
for coal it was not statistically significant.  There may be a suggestion that the 
use of solid fuel for heating in the home during childhood years is associated 
with a reduction in atopy in the adult subject. 
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Table 6.9 Outcomes at age 23 years and association with the use of a solid fuel 
for heating age 7 years 
 Solid fuel 
heating age 7 
years 
No Solid fuel 
heating age 7 
years 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR (95%CI) 
p-value 
Wheeze 
age 23 
19/50(38.0%) 77/245 
(31.4%) 
1.34 (0.71-
2.52) 0.33 
1.30 (0.68-
2.50) 0.43 
Asthma 
age 23 
10/50 (20.0%) 43/248(17.3%) 1.19 (0.55-
2.57) 0.79 
1.09 (0.49-
2.40) 0.84 
Atopy age 
23 
8/20 (40.0%) 62/100 
(62.0%) 
0.41 (0.15-
1.10) 0.61 
0.27 (0.09-
0.82) 0.02* 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
Table 6.10 shows associations between the use of other fuels for heating in the 
home at age 7 years and outcomes at age 23 years. The fuel is likely to be oil 
and may signify other environmental differences since this type of heating is 
often used in farms.  However there is insufficient information for more 
detailed analysis. There are no significant results for these associations. 
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Table 6.10 Outcomes at age 23 years and association with the use of ‘other’ 
fuel for heating age 7 
 ‘Other’ fuel 
heating age 7 
years 
No ‘other’ fuel 
heating age 7 
years 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR (95%CI) 
p-value 
Wheeze 
age 23 
5/27(18.5%) 91/268 
(34.0%) 
0.44 (0.16-
1.21) 0.11 
0.45 (0.16-
1.25) 0.13 
Asthma 
age 23 
4/27 (14.8%) 49/271(18.1%) 0.79 (0.26-
2.38) 0.67 
0.80 (0.26-
2.46) 0.69 
Atopy age 
23 
7/13 (53.8%) 63/107 
(58.9%) 
0.82 (0.26-
2.59) 0.73 
0.75 (0.21-
2.72) 0.66 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
6.12 Infection and related factors  
6.12a) Older siblings in first year of life 
Figure 6.1 shows the number of older siblings for each child.  For 40% of 
families the subject was the first born.   
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Figure 6.1 Frequency of one or more older siblings in MAPS cohort 
 
 
 
Table 6.11 shows associations of the presence of siblings when the subject 
was born and outcomes at age 23 years.  There are no significant associations 
and so no strong evidence for an association between the presence of siblings 
and the risk of wheeze, asthma or atopy.  It is interesting that all odds ratios 
are substantially less than one which suggests that the presence of older 
siblings in the house may have an association with a reduced prevalence of 
wheeze, asthma and atopy. 
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Table 6.11 Outcomes at age 23 years and association with presence of older 
siblings in the first year of life 
 1 or more 
siblings at 
birth 
No siblings 
at birth  
Unadjusted OR 
(95%CI) p-
value 
Adjusted† OR 
(95%CI) p-
value 
Wheeze age 
23 
51/180 
(28.3%) 
45/116 
(38.8%) 
0.62 (0.38-
1.02) 0.06 
0.78 (0.45-
1.33) 0.36 
Asthma age 
23 
28/180 
(15.6%) 
25/119 
(21.0%) 
0.69 (0.38-
1.26) 0.23 
0.83 (0.43-
1.60) 0.58 
Atopy age 
23 
40/72 
(55.6%) 
30/48 
(62.5%) 
0.75 (0.36-
2.58) 0.45 
0.80 (0.33-
1.96) 0.63 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
6.12b) Association of chest infection in first year of life 
Table 6.12 shows the association between having a chest infection before the 
age of 1 year and outcomes at age 23 years.  There was no significant 
association.  
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Table 6.12 Outcomes at age 23 years and association with a chest infection in 
the first year of life 
 Chest 
infection†† 
age 1 
No chest 
infection 
age 1 
Unadjusted OR 
(95%CI) p-
value 
Adjusted† OR 
(95%CI) p-
value 
Wheeze age 
23 
21/58 (36.2%) 73/230 
(31.7%) 
1.22 (0.67-
2.23) 0.52 
1.32 (0.69-
2.51) 0.41 
Asthma age 
23 
15/58 (25.9%) 38/232 
(16.4%) 
1.78 (0.90-
3.53) 0.10 
1.92 (0.91-
4.04) 0.086 
Atopy age 
23 
15/26 (57.7%) 53/91 
(58.2%) 
0.98 (0.41-
2.36) 0.96 
1.17 (0.41-
3.38) 0.77 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
††Chest infection definition at age 1 includes those who wheeze. 
 
 
6.13 Changing immune response 
6.13a) Immunisation 
Table 6.13 shows the frequencies of the different immunisations that were 
given in the first 26 weeks of life.  The rate of diphtheria, tetanus and polio 
immunisation was 78% at 13 weeks but for pertussis immunisation the rate 
was only 46%.  This was because during the 1980s there was some difficulty 
in obtaining the pertussis vaccination in Wales.  We have used the numbers for 
early immunisation (before 13 weeks) as this best approximates the current 
immunisation regime. 
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Table 6.13 Frequency of immunisation to Diphtheria, Pertussis and Tetanus 
and Polio  
Age in weeks <=13 14--26 Total 
immunised 
before 26 weeks 
Number of subjects with Diphtheria 
and Tetanus immunisation at specified 
age  
351 (78%) 82 (18%) 433 (96%) 
Number of subjects with pertussis 
immunisation at specified age 
205 (46%) 42 (9%) 249 (55%) 
Number of subjects with polio 
immunisation at specified age 
348 (78%) 82 (18%) 430 (96%) 
 
 
 
Table 6.14 shows the association of immunisation against Diphtheria and 
Tetanus by 13 weeks and outcomes at age 23 years.  There are no significant 
associations.   
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Table 6.14 Associations of outcomes at age 23 years with diphtheria and 
tetanus immunisation before 13 weeks of age 
 Diphtheria and 
tetanus  
immunisation 
before 13 weeks 
No Diphtheria 
and tetanus  
immunisation 
before 13 
weeks 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR 
(95%CI) p-
value 
Wheeze 
age 23 
65/217 (30.0%) 31/79 (39.2%) 0.66 (0.39-
1.13) 0.13 
0.65 (0.37-
1.13) 0.12 
Asthma 
age 23 
37/291(16.9%) 16/20 (20.0%) 0.81 (0.42-
1.56) 0.53 
0.84 (0.43-
1.67) 0.63 
Atopy age 
23 
55/88 (62.5%) 15/32 (46.9%) 1.89 (0.83-
4.28) 0.13 
1.80 (0.73-
4.44) 0.20 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
 
Table 6.15 shows the associations of immunisation with pertussis and 
outcomes at age 23 years.  There are no significant associations.   
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Table 6.15 Outcomes at age 23 years and association with pertussis 
immunisation before 13 weeks of age 
 Pertussis 
immunisation 
before 13 
weeks 
No Pertussis 
immunisation 
before 13 
weeks 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR (95%CI) 
p-value 
Wheeze 
age 23 
39/125 
(31.2%) 
57/171 
(33.3%) 
0.91 (0.55-
1.49) 0.70 
0.91 (0.54-
1.52) 0.72 
Asthma 
age 23 
24/126 
(19.0%) 
29/173 
(16.8%) 
1.17 (0.64-
2.12) 0.61 
1.21 (0.65-
2.27) 0.55 
Atopy age 
23 
34/52 (65.4%) 36/68 
(52.9%) 
1.70 (0.80-
3.53) 0.17 
1.77 (0.77-
4.09) 0.18 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
 
 
Table 6.16 shows associations for polio immunisation with outcomes at age 23 
years. There are no significant associations.  
 
 
 
  
213 
 
Table 6.16 Outcomes at age 23 years and association with polio immunisation 
before 13 weeks of age 
 Polio 
immunisation 
before 13 
weeks 
No Polio 
immunisation 
before 13 
weeks 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR (95%CI) 
p-value 
Wheeze 
age 23 
64/216 
(29.6%) 
31/79 
(39.2%) 
0.65 (0.38-
1.12) 0.12 
0.64 (0.36-
1.11) 0.11 
Asthma 
age 23 
36/218 
(16.5%) 
16/80 
(20.0%) 
0.79 (0.41-
1.52) 0.48 
0.82 (0.41-
1.63) 0.58 
Atopy age 
23 
54/87 (62.1%) 15/32 
(46.9%) 
1.86 (0.82-
4.20) 0.14 
1.78 (0.72-
4.39) 0.21 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
6.13b) Caesarean section 
Of the 485 subjects for whom we have information on mode of delivery 376 
(78%) had a simple vaginal delivery, 53 (11%) had a caesarean section and 56 
(12%) had a mode of delivery that was not caesarean section and would 
therefore have been through the vaginal canal.  Since our hypothesis is that 
caesarean section does not allow the new born to acquire microorganisms 
through its usual route through the vaginal canal, we will compare caesarean 
section with all other modes, since all others would be through the vaginal 
canal.   
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Table 6.17 shows associations between caesarean section delivery and 
outcomes at age 23 years.  There are no significant results however there is a 
large effect size for atopy.  The number of people who had skin prick testing at 
age 23 was small and therefore the confidence intervals are wide.  Since our 
sample is small we may not have found an association that was present, i.e. we 
may have failed to detect an effect that is present. 
 
Table 6.17 Caesarean section and outcomes at age 23 years 
 Caesarean 
Section 
No Caesarean 
Section 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR (95%CI) 
p-value 
Wheeze age 
23 
10/37 (27%) 86/257 (34%) 0.74 (0.34-
1.59) 0.28 
0.80 (0.36-
1.78) 0.58 
Asthma age 
23 
6/38 (16%) 47/259 (18%) 0.85 (0.34-
2.14) 0.5 
0.88 (0.34-
2.31) 0.80 
Atopy age 
23 
12/15 (80%) 57/104 (55%) 3.30 (0.88-
12.38)  0.06 
2.57(0.63-
10.35) 0.19 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
6.14a) Environmental tobacco smoke exposure 
The environmental smoke exposure rate for our cohort was high.  The mothers 
of the group under study had a smoking rate of 34% while pregnant with the 
subject which was higher than the national average for women in the UK in 
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1984.  The national rate of smoking was 35% (men 38% and women 33%) in 
1982
319
.  The majority of children had a smoker in the home and only 41% of 
children had no smokers in the house at either 1 year or 7 years of age.  
However if one of the parents had allergy, subjects were much less likely to 
have a smoker in the house (i.e. environmental tobacco smoke ETS).  The OR 
for parental smoking and either parent having allergy was 0.59 (95% CI 0.37-
0.94) p=0.03.  Of those with no ETS 50.3% had parents with allergy while 
37.4% had parents with no allergy. 
At age 1, wheeze was present in 26% of those with no smoker in the house, 
33% with a smoker that was not the mother and 47% in those whose mother 
smoked.  This suggests that the greater the exposure to environmental tobacco 
smoke the more likely the subject was to wheeze.  Unsurprisingly there was a 
significant association between environmental exposure to smoke at age 1 and 
wheeze at age 1 year: OR 2.14 (1.44-3.18) p<0.0001.  There was no 
significant association between exposure to environmental tobacco smoke and 
wheeze at age 7: OR 1.33 (0.88-2.01) p=0.18.   
 
Table 6.18 shows there was no significant association between maternal 
smoking during pregnancy and outcomes in adults.  Evidence suggests that 
maternal smoking during pregnancy is associated with an increased risk of 
smoking in the offspring when older
317
.  This fact could bias the results of our 
analysis, since atopic mothers are less likely to smoke.  Therefore the children 
of atopic mothers are less likely to smoke and this could reduce the measured 
effect of maternal smoking on the development of asthma.  Subjects smoking 
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themselves would make wheezing disorder more likely and if this active 
smoking was not taken into account, the effect of maternal smoking on 
wheeze in offspring may be exaggerated.  In the final column of table 6.18 we 
therefore give results of associations controlled for current smoking age 23 
years. 
 
Table 6.18 Outcomes at age 23 years and association with maternal smoking 
during pregnancy 
 Maternal 
smoking 
during 
pregnancy 
No 
Maternal 
smoking 
during 
pregnancy 
Unadjusted 
OR 
(95%CI) p-
value 
Adjusted† 
OR 
(95%CI) p-
value 
Adjusted†† 
OR 
(95%CI) p-
value 
Wheeze 
age 23 
34/89 
(38.2%) 
62/207 
(30.0%) 
1.45 (0.86-
2.43) 0.17 
1.52 (0.87-
2.65) 0.14 
1.34 (0.75-
2.39) 0.32 
Asthma 
age 23 
14/89 
(15.7%) 
39/210 
(18.6%) 
0.82 (0.42-
1.60) 0.56 
0.75 (0.37-
1.56) 0.45 
0.71 (0.33-
1.51) 0.37 
Atopy 
age 23 
23/39 
(59.0%) 
47/81 
(58.0%) 
1.04 (0.48-
2.26) 0.92 
1.30 (0.53-
3.18) 0.57 
1.18 (0.48-
2.91) 0.72 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
†† Additional adjustment for current smoking at age 23 years 
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Table 6.19 shows the association of passive smoking at age 1 and outcomes at 
age 23.  There are no significant results, even when adjusted for current 
smoking at age 23 years.   
 
Table 6.19 Association of outcomes at age 23 years and exposure to passive 
smoke age 1 year 
 Passive 
smoke 
age 1 
No 
Passive 
smoke 
age 1 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† 
OR 
(95%CI) p-
value 
Adjusted†† 
OR 
(95%CI) p-
value 
Wheeze 
age 23 
48/135 
(35.6%) 
47/158 
(29.7%) 
1.30 (0.80-
2.13) 0.29 
1.35 (0.80-
2.28) 0.26 
1.25 (0.73-
2.12) 0.41 
Asthma 
age 23 
26/137 
(19.0%) 
27/159 
(17.0%) 
1.15 (0.63-
2.08) 0.66 
1.18 (0.62-
2.23) 0.61 
1.21 (0.63-
2.30) 0.57 
Atopy 
age 23 
34/56 
(60.7%) 
36/63 
(57.1%) 
1.16 (0.56-
2.41) 0.69 
1.59 (0.68-
3.71) 0.29 
1.59 (0.68-
3.72) 0.29 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
†† Additional adjustment for current smoking at age 23 years 
 
Table 6.20 shows the association of passive smoking at age 1 or 7 and 
outcomes at age 23 years.  There are no significant results although atopy 
gives a large effect size.   
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Table 6.20 Outcomes at age 23 years and association with Passive smoking 
age 1 or 7 years  
 Passive 
smoking age 1 
or 7   
No Passive 
smoking age 
1 or 7   
Unadjusted OR 
(95%CI) p-
value 
Adjusted† 
OR (95%CI) 
p-value 
Wheeze 
age 23 
56/157 
(35.7%) 
39/135 
(28.9%) 
1.37 (0.83-
2.24) 0.22 
1.41 (0.84-
2.37) 0.20 
Asthma age 
23 
29/159 
(18.2%) 
24/136 
(17.6%) 
1.04 (0.57-
1.89) 0.90 
1.05 (0.56-
1.97) 0.88 
Atopy age 
23 
39/62 (62.9%) 31/57 
(54.4%) 
1.42 (0.68-
2.96) 0.35 
1.94 (0.83-
4.53) 0.13 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
Table 6.21 shows that ever having smoked was associated with having a 
wheeze at age 23.  This significant association was present after adjusting for 
class and family history, suggesting that there is a true association of smoking 
with a wheezing disorder.  Although asthma does not appear to be associated 
with a history of smoking at age 23, wheeze does. The association of active 
smoking at age 23 years with wheeze at age 23, after adjustment is OR 2.19 
(1.25-3.83) p=0.006.      
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Table 6.21 Association of smoking among subjects and outcomes at age 23 
years. 
 Ever smoker Never 
smoker 
Unadjusted 
OR (95%CI) 
p-value 
Adjusted† OR 
(95%CI) p-
value 
Wheeze age 
23 years 
54/140 
(39%) 
42/155 
(27%) 
1.69 (1.03-
2.76) 0.02* 
1.79 (1.07-
3.01) 0.03* 
Asthma age 
23 years 
27/140 
(19%) 
25/155 
(16%) 
1.24 (0.68-
2.26) 0.29 
1.29 (0.68-
2.44) 0.43 
Atopy age 23 
years 
28/53 
(52.8%) 
42/67 
(62.7%) 
0.67 (0.32-
1.39) 0.28 
0.74 (0.32-
1.71) 0.48 
†Adjusted for social class age 1, gender, breast feeding, original 
randomisation, parental allergy. 
 
 
6.15 Discussion  
In this chapter we have found some positive sporadic findings on early 
environmental factors and outcomes at age 23 years but on the whole the 
results do not show a consistent association between early environmental 
exposure and outcomes at age 23 years. Pet ownership, however, may have a 
protective effect at least with respect to atopy.   An ECRHS study showed that 
dogs owned in childhood seemed to protect against adult allergic disease but 
promote non-allergic asthma
271
.  The MAP cohort results suggest some 
evidence of an association of wheeze with environmental features which are 
more commonly present in subjects of low prosperity.  One example is damp 
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and mouldy housing at age 7, which was associated with wheeze at age 23 
years but not with asthma at age 23 years in the MAP study.   
 
 Solid fuel use was associated with a reduction in atopy at age 23 years.  This 
may be because houses with solid fuel heating were less likely to have high 
levels of damp and the usual indoor aeroallergens since they would have open 
fires and be more likely to draw air though the house.  However this is 
contradicted by our data which shows that rather than a lower prevalence of 
damp with solid fuel use in the home at the age of 7, there was a greater 
prevalence of damp in homes using solid fuel compared to other forms of 
heating (30.9% vs 23.8% respectively). Unfortunately we do not have data on 
aeroallergen level and solid fuel use, but evidence suggests that high indoor 
humidity, presence of wall-to-wall carpets, and poor ventilation all increase 
the risk for high allergen exposure
268
. 
 
There was no association between chest infection in the first year of life and 
outcomes at 23 years, although there is an association with wheeze at age 7.   
This contradicts other published work such as De Marco et al which was a 
large ECRHS study on subjects age 0-44 years.  They found that respiratory 
infections at an early age are associated with an increased prevalence of 
asthma
270
.  Viral infections are associated with asthma as shown in the 
TCRS
69
.  RSV has long been thought to promote the development of asthma in 
association with genetic factors but this remains controversial and is reviewed 
along with other viral infections by Busse et al
320
.   A review of the effects of 
infectious exposure suggests that the prenatal period and early childhood are 
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likely to be critical for the establishment and maintenance of a normal Th-
1/Th-2 balance, and that viral and/or microbial infections and/or their products 
may have bidirectional effects on the development of allergy and asthma
321
.   
 
Increasing allergen exposure may be the source of the rise in asthma when 
subjects move from low prevalence (eg Tokelauan ) to high prevalence (eg 
New Zealand) areas, since recent evidence has shown that Tokelauan residents 
are exposed to lower levels of indoor aeroallergens compared to residents in 
New Zealand
322
.  However, there is no evidence regarding allergen levels or 
sensitisation in any other population study and therefore it cannot be assumed 
that increased rates of asthma in Westernised communities are related to 
increased allergen exposure.   
 
The relationship between allergen exposure and the incidence of asthma 
shown by Sporik et al
180
  is further complicated by the fact that bacterial 
endotoxins may induce the Th1 immune pathway.  A study examining the 
endotoxin in the house dust of 61 infants with at least 3 physician documented 
episodes of wheeze, reported that there was significantly less endotoxin in the 
homes of those infants who were sensitised to at least one aeroallergen (HDM, 
Cat, Dog and Mouse)
323
, suggesting that endotoxin may be associated with a 
reduction in sensitisation.   However, there is also evidence that a high 
endotoxin level can increase the risk of wheeze and asthma.  The 
“Epidemiology of Home Allergens and Asthma” study found that there was an 
increased risk of wheeze in the first year of life in those with a family history 
of asthma or allergy and a high measured endotoxin level in living room 
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dust
324
.  The Reidler group found a trend to an increased prevalence of non-
atopic asthma and wheeze with increased levels of endotoxin, although this 
was not significant
325
.   These studies suggest that the same environmental 
factor can have different effects in different settings and at different 
concentrations.  Since our subjects were more likely to be from a deprived 
population than other populations in most longitudinal studies they may have 
had high levels of endotoxin which reduced their risk of atopy but also 
increased their risk of asthma and wheeze. 
 
Immunisation may predispose to allergy since it may cause a reduction in 
exposure to infection and therefore encourage T-helper type 2 (Th2) immune 
responses.  Alternatively, vaccination may expose the infant to attenuated 
pathogens and therefore promote a T-helper type 1 (Th1)  pathway
326
.  It is 
therefore unclear what outcome we might anticipate when investigating 
immunisation and prevalence of asthma.  The MAP cohort found no 
conclusive results with immunisation and outcomes at age 23 years.  
Caesarean section was also found to have no association in the MAP cohort 
unlike published research as discussed in the introduction.  
 
The main reason that MAPS showed no definite associations with 
environmental factors is because the sample size was too small to study the 
large number of potential environmental factors that might be responsible for 
incident asthma.  However other factors are likely to be confounders, such as 
the high rate of environmental tobacco smoke (ETS) in this community since 
over 50% of children were exposed to passive smoke before the age of 7.  
223 
 
Smoking among pregnant women in this community was higher than women 
in the UK as a whole for the equivalent period, suggesting that this was a 
community with a very high prevalence of smoking.  It is therefore possible 
that smoking was so common in this community that even those children who 
did not have smokers at home may have been exposed to tobacco smoke at the 
homes of friends and family, this could have reduced the effect size of any 
association we might have found. 
 
In addition smoking is known to have effects on the immune system, some of 
which may be suppressive such as the results of a study undertaken by 
Nymand who investigated pregnant women and found that that 10.4% of non-
smokers developed antibodies during the first pregnancy, rising to 31% after 
the fourth. The corresponding figures in smokers were 7.8% rising to 17.4%, 
which indicates significantly reduced immune  recognition of foreign 
histocompatibility antigens among the smoking population
327
.  Other studies 
have found that smoking can increase the risk of allergic disease as expounded 
in a recent meta-analysis where an association between ETS exposure in early 
childhood and the increased risk of allergic sensitisation was found. In 
addition, subgroup meta-analyses demonstrated that younger children suffer 
the most from detrimental immunomodulating effects of ETS exposure
328
. The 
evidence that tobacco smoke has profound effects on t cell activity and other 
humoral and cellular immune responses in experimental animals has long 
suggested that it also has significant effects on the human immune system, as 
reviewed by Holt et al
329
.  Smoke can cause inhibition of the immune system 
in pregnant women, and enhancement of the immune system in children.  It 
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may also have different effects determined by co factors in the environment or 
genetic factors in the child. This makes it difficult to elucidate a clear picture 
of environmental effects.  Therefore the main finding in this section is that no 
association with early life environment has been proven.  Our study can 
neither refute nor support the work presented in the introduction.   
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Chapter 7 
 
The natural history of asthma and wheeze 
7.0 The course of asthma from birth to adulthood  
The course of asthma from birth to death is variable.  Some asthma sufferers 
appear to recover completely.  Others have long remissions with occasional 
mild relapses. Most seem to continue unchanged for many years, but some 
become more symptomatic and may develop irreversible airway obstruction.  
Rarely some die of acute asthma.  Treatment of patients could be improved if 
we were able to understand the reasons for this variability
330
.  Longitudinal 
population studies are an important way of increasing our understanding of the 
natural history of asthma.  However despite the number of longitudinal studies 
already in place, our understanding of asthma aetiology, progression and 
complication rate is still poor.  There are a number of reasons for this, 
including differing definitions of asthma or other end point used and multiple 
environmental factors that cannot all be controlled for. It is also debateable 
whether asthma is a disease with a single aetiology and many varying 
outcomes or a syndrome with many different factors that cause a variable 
phenotype
330
.   However we know that asthma begins most often in infants as 
wheezing with respiratory infections. If these episodes are mild and 
infrequent, asthma does not usually continue into the school years. If 
wheezing episodes are more frequent and severe, then asthma is likely to 
persist.  If atopy develops before the age of 3 years subjects are more likely to 
develop asthma and have impaired lung function by school age
49
.  Patients 
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with frequent exacerbations have a significantly larger annual decline in 
forced expiratory volume in one second (FEV1)
331
.  
Asthma may remit at any age, especially during adolescent years, as shown in 
the Tucson Children’s Respiratory Study (TCRS) where 42% of subjects had 
remission from asthma around the time of puberty
332
.   However remission 
was based on symptoms of asthma in the TCRS study, rather than objective 
measurements.  Vonk et al defined complete remission of asthma in 5-14 year 
old Dutch asthmatic children in a specialist clinic as having no current 
wheeze, no asthma attacks in the previous 3 years, no use of inhaled 
corticosteroids, normal lung function (FEV1 90% predicted) and absence of 
bronchial hyper-reactivity (BHR).  They found that 22% had complete 
remission after a median of 30 years follow up and a further 30% (total 52%) 
of the group had no asthma symptoms and did not use  steroid inhalers; this 
was termed clinical remission
333
.  Panyhuysen et al found a remission rate in 
Swedish asthmatics of only 11% after 25 years follow up and found remission 
was associated with a younger age and less severe airway obstruction at first 
testing
334
.  The Dutch team also found that more severe disease and continued 
allergen exposure cause the disease to persist and that a persistent decline in 
lung function was retarded, but not completely prevented, by aerosol 
glucocorticoids
335
.  They also found that in subjects with established asthma, 
aged 13-44 years from secondary care clinics, there was evidence of 
irreversible airway obstruction and a low transfer coefficient, even though 
both these features are usually thought of as characteristics of COPD, they 
represented distinct entities in adult asthma 
336
. 
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7.1 Tracking of lung function from childhood into adulthood and risk of adult 
chronic obstructive pulmonary disease (COPD) 
For decades asthma was considered to be a completely reversible obstructive 
airways disease but after a number of pathological investigations it became 
apparent that asthma is not always reversible and the term remodelling was 
used to describe the process of progression of disease
123
.  Remodelling was 
first defined, clinically as asthma that loses its reversible aspect by Rasmussen 
et al studying the Dunedin birth cohort.   In this study they measured lung 
function in their subjects at age 9, 11, 13 and 15 during childhood years and 
then again at age 18 and 26 years in adulthood.  Those subjects who showed 
low post-bronchodilator ratios in childhood also showed a greater decline from 
ages 9 to 26 in the pre-bronchodilator ratio of forced expiratory volume 
divided by vital capacity (FEV1/VC ratio) compared with those with normal 
post-bronchodilator FEV1/VC ratios at both ages. Asthma, male sex, airway 
hyper-responsiveness, and low lung function in childhood were each 
independently associated with a low post-bronchodilator FEV1/VC ratio, 
which in turn was associated with an accelerated decline in lung function and 
decreased reversibility.  They postulated that low lung function tracks from 
childhood into adulthood, with greater loss of function in male than female 
asthmatics at age 26 years
80
. Their findings of irreversible obstruction would 
fit with a diagnosis of COPD. The TCRS also showed that poor lung function, 
measured using maximal expiratory ﬂows at functional residual capacity in 
169 infants by the chest compression technique at a mean age of 2∙3 months 
(SD 1∙9), was associated with low lung function at age 16 and 22 years.  They 
postulated that poor airway function shortly after birth should be recognised as 
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a risk factor for airﬂow obstruction in young adults and that prevention of 
COPD might need to start in foetal life
337
.  
 
Thus far we have presented evidence regarding the natural history of asthma 
from inception to chronic non reversible lung disease.  However it is the 
inception of asthma that is of interest in the understanding of the natural 
history of asthma and now we will present the evidence regarding patterns of 
early childhood wheeze and asthma in late childhood and adulthood. 
 
7.2a) The natural history of early life wheezing disorder and wheeze 
phenotypes 
In 1991 Sporik, Holgate and Cogswell investigated a high risk birth cohort and 
showed a bimodal distribution of wheeze with a peak before the age of 2 years 
and a gradual increase thereafter. Of the 21 children who wheezed before their 
second birthday, most never wheezed again and did not show bronchial hyper 
reactivity (BHR) at 11 years
338
.  This early study was the first to suggest that 
not all early life wheezing was the same and that wheeze after infanthood was 
a significant sign of later childhood asthma, while early childhood wheeze 
might have different aetiology.    In some children wheeze does continue and 
develop into asthma.  Many longitudinal studies have investigated early life 
patterns of wheeze in order to understand which phenotypes predispose to the 
development of asthma. 
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7.2b) Phenotype studies using four phenotypes 
A number of longitudinal studies have investigated the early childhood 
wheeze phenotypes by using variations of the TCRS phenotypes on their own 
cohort.  The modifications from the TCRS phenotype definitions have been 
determined by when subjects were followed up in the particular longitudinal 
studies.  All the phenotype studies are slightly different but generally they 
investigate subjects in early childhood (between 0-3 years old), and later, early 
childhood years (between 3 years old and 6 or 7 years old).  The four 
phenotypes for TCRS are: 
 Never wheeze (NW): no wheeze before 3 years of age and no wheeze 
up to 6 years of age.   
 Transient early wheeze (TEW): wheeze before the age of 3 but no 
wheeze in the year of the 6
th
 birthday.   
 Late onset wheeze (LOW): no wheeze before age 3 years but wheeze 
in the year of the 6
th
 birthday  
 Persistent wheeze (PW): wheeze before age 3 years and wheeze in 
year of 6
th
 birthday.   
The TCRS participants had lung function measured in the first 2-4 months of 
life and those who had infant Vmax FRC in the lowest quartile also had lower 
values for the FEV1/FVC ratio up to age 22, after adjustment for height, 
weight, age, and sex, than those in the upper three quartiles combined. They 
also found that lung function during infanthood was significantly lower with 
the TEW phenotype, when compared to those who never wheeze (p<0.01) 
and when compared to LOW and PW (p<0.05)
92
.   At ages 11 and 16 years 
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subjects who had been defined as having TEW phenotype, had the same risk 
of wheeze in later childhood as those who had never wheezed before the age 
of six.  They also found that both TEW and PW had significantly lower FEV1 
and FEV1/FVC ratio at 11 years and 16 years compared to the other two 
phenotypes
185
. The TCRS study found an association between LOW and PW 
phenotype at age 6 and newly diagnosed asthma at age 22 years
117
.    
 
The German Multicentre allergy study (MAS) followed 1314 children from 5 
centres from birth.  Subjects were reviewed at ages 1, 3, 6, 12 and 18 months, 
then yearly, within 3 months of their birthday, up to 7 years of age. They 
described four phenotypes, similar to those in the TCRS, based on early 
wheeze before the age of 3 and wheeze in the year of their 7
th 
birthday. They 
examined lung function tests at age 7 and the results were expressed as a 
percentage of the predicted value according to internal reference values which 
were determined using statistical methods.  Results of FEV1 for the PW 
phenotype (96.5%+-9.3% predicted) and the LOW phenotype (94.1%+-
12.2% predicted) were significantly different (p=0.01, p=0.001 respectively) 
from the NW phenotype (100.9% +-11.9% predicted).   The TEW phenotype 
(99.3%+-12.3% predicted) was not significantly different from NW. The 
lower lung function tests in LOW and PW were therefore already apparent by 
age 7 years and these were more likely if subjects were atopic or had an 
atopic family history
96
. 
 
MAAS is a longitudinal population-based birth cohort also classified into the 4 
phenotypes, based on the fact the parents were interviewed when the subject 
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was age 3 and also at age 5
98
.  They found poor lung function at age 3 years 
was associated with the subsequent persistence of symptoms in children who 
had wheezed within the first 3 years (i.e. PW phenotype), but was not 
associated with the onset of wheeze after age 3 years in the children who had 
not wheezed previously (i.e. LOW phenotype).   
 
All these three studies have used different measurements for lung function and 
at different ages so they are not necessarily comparable.  Lung function 
measurements in young children are difficult to undertake and the difference 
between the studies may also be explained by this, although finding early 
changes in the TCRS study is due to the very early testing undertaken in this 
study.  In summary, reduction in measures of lung function was present in the 
TCRS cohort in the TEW and PW phenotypes at age 11 and 16 and only in 
TEW in infanthood.  In the German MAS the TEW phenotype did not show 
reduced lung function unless they had been exposed to a lower respiratory 
tract infection or the mother was a smoker; only LOW and PW had lower lung 
function.  The MAAS group just found a reduced lung function at age 3, in 
those who went on to be defined as PW subjects at age 5 years.  From these 
studies we can see that the PW phenotype has universally reduced lung 
function in all the studies.  TEW may only have reduction in lung function 
during infanthood. 
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7.3 Exercise testing 
Mochizuki et al undertook metacholine inhalations tests on subjects age 6 
months and then again 18 months later.  A positive test was defined by a 10% 
drop in transcutaneous oxygen tension.   A positive test was only found in 
those who had established asthma, not in those who went on to develop 
asthma
339
.  Porsbjerg et al showed that both exercise challenge (with 10% drop 
in FEV1) and chemical challenge (20% drop) may be positive in children who 
do not have asthma at the time of a positive result although they may 
subsequently develop it, up to 12 years later
340
.  Jones showed that a positive 
exercise test, defined as a 15% or greater fall in peak expiratory flow rate after 
6 minutes of exercise, in early childhood can predict asthma in later 
childhood
341
, and Rasmussen et al undertook exercise testing in asymptomatic 
children at a mean age of 9.7 years.  They found a percentage fall in FEV1 of 
8.6% or greater was associated with wheeze in adulthood
342
.  This suggests 
that positive exercise testing and chemical testing are associated with asthma 
later in life, although chemical challenge is also associated with established 
asthma. 
 
7.4 Aims and objectives  
 
The aim of this chapter is to investigate the natural history of the MAP cohort 
with regard to wheezing from birth to adulthood.  We will use phenotypes 
based on established classifications in order to investigate if there is an 
association between these phenotypes and outcomes in later life. We will 
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investigate chronic lung disease in young adults and what factors are 
associated with low lung function measurements at age 23 years. 
 
 
 
 
 
Objectives 
 To categorise subjects using modified classifications for childhood 
wheezing phenotypes  
 To investigate the association of a positive exercise test at age 7 with 
outcomes in adult subjects   
 To investigate associations of these childhood wheezing phenotypes 
with the patterns of chronic lung disease commonly seen in adulthood. 
 
7.5 Methods 
Full methods are given in chapter 2.    
7.5a Birthday cards 
The Merthyr Allergy Prevention Study (MAPS) gathered information on 
wheeze and respiratory infections at pre-set interviews with predetermined 
questionnaires, with subjects at 3, 6 and 12 months of life.  Each year between 
the ages of 2 and 6 years, subjects were sent a birthday card with a short 
parental questionnaire attached.  This included a question regarding wheezing: 
‘Have you heard a wheeze coming from his/her chest’.  The questionnaire is 
shown in appendix 6.  Phenotypes in MAPS were coded using only complete 
234 
 
data, i.e. only using the 430 subjects on whom  there was data regarding all 
time points up to age 7.  Subjects with missing data were therefore not 
included.   
 
 
Phenotypes were based on those in the TCRS but modified to take account of 
the data collection protocol: 
 NW was no wheeze at any time point.   
 TEW was wheeze between birth and age 3 years and not between 4 
and 7 years.  
 LOW was wheeze at some age between 4 and 7 but not before this.   
 PW was wheeze at least once before 3 years and at least once between 
4 and7 years. 
   
The differences between definitions in MAPS, TCRS and German MAS are 
detailed in Table 7.1 below. 
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Table 7.1 Definitions of different wheeze phenotypes in TCRS
92
, MAS and 
MAPS 
 Tucson Children’s 
Respiratory Study
92
 
(TCRS) 
German MAS
96
  Merthyr Allergy 
Prevention Study 
(MAPS) 
Never Wheeze 
(NW) 
No Wheeze age 0-
3† or at  age 6 
Never wheeze 
up to age 7 
No Wheeze age 0-3 
or age 4-7  
Transient Early 
Wheeze (TEW) 
Wheeze age 0-3 
but no wheeze in 
previous 12 months 
at age 6 
Wheeze at least 
once before 3 
and not in past 
year at age 7 
Wheeze age 0-3 
but no wheeze age 
4-7 
Late onset 
Wheeze (LOW) 
No wheeze age 0-3 
but wheeze in 
previous 12 months 
at age 6 
No wheeze 
before 3 but 
wheeze in the 
past year at age 
7 
No wheeze age 0-3 
but at least one 
positive record of 
wheezing  age 4-7 
Persistent 
Wheeze (PW) 
Wheeze age 0-3 
and  wheeze in 
previous 12 months 
at age 6 
Wheeze at least 
once before age 
3 and in past 
year at age 7 
Wheeze age 0-3 
and  at least one 
positive record of 
wheezing  age 4-7 
† At least one physician-diagnosed wheezing lower respiratory illness (LRI) in 
the first 3 years of life. 
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7.5b) Exercise test age 7 years 
At age 7 years, each child was invited to undertake an exercise challenge test. 
Peak expiratory flow rate (PEFR) was measured 5 times before exercise 
began.  The children then ran round a room for 6 minutes, and 5 further PEFR 
measurements were taken after 5 minutes' rest.  On each occasion the mean of 
the 3 highest readings was taken as the estimated value. The results of the 
exercise testing have been published and a significant difference was found 
between the mean change in PEFR in those who wheeze and the mean in those 
who do not at age 7 years
107
.   We have taken a drop in PEFR of 15% or 
greater as a positive exercise test. 
 
7.6 Results 
Up to age 7 years, 430 subjects out of a total of 487 (88.3%) gave complete 
information on the presence of wheeze at ages 0-7 years.    There was 
complete data to age 15 on 345 (70.8%) subjects and to age 23 years on 255 
(52.2%) subjects. 
 
As shown in Figure 7.1, wheeze is more common in males than in females up 
to age 7.  The OR for the association between wheeze and gender is more than 
1 in favour of males at each wheeze age. While these results are not always 
significant, there is an obvious pattern towards more wheezing in males.  
However at ages 15 years and 23 years the OR is close to 1 suggesting no 
significant gender difference. 
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Figure 7.1 The Association of gender with age of wheeze (log scale) 
 
 
The association of wheeze at age 23 with wheeze at different ages in 
childhood is displayed in figure 7.2 by plotting the OR measuring the 
association between wheeze at earlier ages with wheeze at age 23.  A 
significant OR is indicated by a star.  The figure demonstrates that in our 
cohort, wheeze from the age of 4 is significantly associated with wheeze at age 
23 years.  This suggests that early wheeze, which occurs before the age of 4, 
may be different in origin to adult wheeze, while late childhood wheeze may 
be a precursor of adult disease. 
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Figure 7.2 The association of wheeze age 23 years with wheeze in childhood 
(log scale) 
 
 
A star signifies a statistically significant result 
 
Figure 7.3 plots the OR for the association of asthma at age 23 years with 
wheeze at different ages in childhood.  This suggests that wheeze before age 3 
years is probably not a prequel to asthma but wheeze in late childhood is.   
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Figure 7.3 The association of asthma age 23 with wheeze in childhood (log 
scale) 
 
A star signifies a statistically significant result 
 
 
7.7 Exercise test results age 7 years 
A total of 202 boys and 188 girls undertook an exercise test, in which 67 
(33%) boys and 55 (29%) girls were positive.    A positive exercise test was 
not associated with wheeze at age 7 (OR1.35, 95% CI 0.85-2.16 p=0.12), 
wheeze at 15 (OR 1.06, 95% CI 0.64-1.76, p=0.46) or wheeze at 23 years (OR 
0.97, 95% CI 0.56-1.68, p=0.52), but was associated with asthma at age 23 
years 2.15 95% CI 1.13-4.08, p=0.02.  These findings suggest that wheeze at 
23 years is different to asthma at 23 years, as has been shown on a number of 
occasions in this thesis. 
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7.8 Childhood wheeze and remission, relapse and late onset  
To determine remission and relapse rates we used only those 255 subjects on 
whom we have outcome data at ages 1-7, 15 and 23 years.  A total of 165/255 
(64.7%) subjects had a wheeze at least once in the first 7 years.  Remission of 
this childhood wheeze was found in just under 50 percent of subjects; 77 of 
the 165 who had a wheeze before the age of 7 (i.e. 30.2% of the original 255), 
did not wheeze again at age 15 or 23- early wheeze with remission.  Of the 90 
who did not wheeze before 7, 29 (11.4% of the original 255) went on to have a 
wheeze at age 15 or 23 years- later onset wheeze.  Adult onset was found in 14 
(5.5% of the original 255) out of the 90 who did not wheeze before age 7 years 
and who had a wheeze for the first time at age 23 years- adult onset wheeze.  
No information was gathered in the intervening years so it is possible that 
subjects did wheeze more frequently but we do not have that information.  The 
early Cogswell group  found that 75% of those who had wheeze onset before 
age 2 did not have wheeze at age 11
338
.  We do not have data at age 11 but do 
have data on wheeze at age 15 and 23 years and asthma at age 23 years.  Of 
those subjects in the MAPS cohort who had wheeze at or before the age of 2 
years, 59.8% were wheeze free at age 15 years and 63.5% were wheeze free at 
age 23 years.  These rates are lower than the Cogswell group at age 11 years.  
However when we investigate subjects with asthma at age 23 years, 77.2% of 
those who had a wheeze at age 2 years or younger were free from asthma at 
age 23 years.   
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7.9a) Childhood phenotypes in MAPS and comparison with other longitudinal 
studies 
The MAP study reported on a greater number of possible observations than the 
other studies. This means there is a greater chance of someone being classed 
as having a wheeze.  The TCRS, German MAS and MAAS have used only the 
ages stated and considered only wheeze in the year before the later observation 
year stated.  This means that the definitions are not strictly comparable.  In 
fact if we use TCRS definitions to analyse the MAP study data i.e. NW: no 
wheeze age up to 3 or at age 6, TEW: wheeze only in first 3 years, LOW: 
wheeze only at age 6 and PW: wheeze in first 3 years and again at age 6 years, 
the percentages of phenotypes are given in table 7.2. The directions of the 
differences in prevalence are all as expected, given the definitions. 
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Table 7.2 The prevalence of different phenotypes in the MAPS cohort using 
MAPS definitions and also TCRS definitions 
 MAPS Definitions TCRS Definitions 
NW 32.1% 38.4% 
TEW 20.7% 33.2% 
LOW 10.9% 4.6 % 
PW 36.3% 23.8% 
 
 
Figure 7.4 shows the differences in phenotype frequencies between a number 
of longitudinal study cohorts. Some of the differences are due to varying 
definitions, as illustrated above, while others may arise from differences in the 
populations. 
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Figure 7.4 Rate of childhood phenotypes for MAPS compared to TCRS, 
German MAS and MAAS. 
 
NW= Never Wheeze, TEW=Transient Early Wheeze, LOW=Late Onset 
Wheeze, PW=Persistent Wheeze 
 
Table 7.3 displays a comparison of the phenotypes for the cohorts from 
MAPS, TCRS, German MAS and MAAS.  The prevalence of atopy in 
childhood in each group for TCRS and German MAS (age 6 years for TCRS, 
age 7 years (at age 6 if age 7 not available) for MAS and age 7 years MAPS) 
is shown.  It was surprising that the MAPS cohort was generally less atopic 
than the TCRS subjects, despite the fact that the MAPS group was recruited 
from a high risk population and therefore might be expected to have a greater 
rate of atopy.  The prevalence of atopy was 51% in the TCRS, 41% in the 
German MAS group and only 34% in the MAPS cohort.  However within each 
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cohort LOW was the most atopic phenotype and PW was the second most 
atopic phenotype.    The prevalence of atopy was not given for MAAS. 
 
Table 7.3 Childhood wheeze phenotype in MAP cohort compared to TCRS 
and MAAS 
Childho
od 
Wheeze 
Phenoty
pe 
MAP study (430) 
High risk population 
TCRS92 (762) 
Unselected 
population 
German MAS96  
‘Nested’ population 
study† 
MAAS98  
(463) 
Unselected 
population 
 Prevalence % Atopic Prevalence % Atopic  Prevalence % Atopic  Prevalence 
Never 
wheeze  
32% 17.3%  53%  33.8%  65% 35.4%  54%  
Transien
t early 
wheeze  
21%  13.3%  19%  38.4%  25%   42.6%  25%  
Late 
onset 
wheeze  
11%  43.5% 15%  55.7%  5%  75.7%  5%  
Persiste
nt 
Wheeze 
36% 34.0%  13%  51.1%  5%   51.1%  17% 
†1314=total population -499 high risk subjects 815 controls. 
 
Gender differences in four childhood wheeze phenotypes are shown in table 
7.4.  Boys are known to wheeze more in childhood than girls and using NW as 
the reference variable, there is an association between male gender and the 
two phenotypes, TEW and PW.  There is no definite association of LOW with 
gender, possibly due to the low frequency of this phenotype. These results 
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confirm that wheezing before three is more common in boys than girls, and 
therefore the prevalence of TEW and PW is higher in boys.  
 
Table 7.4 Gender difference in the 4 early wheeze phenotypes  
All 
subjects 
n=430 
Male 
subjects 
Female 
subjects 
OR (95% CI) p-
value with NW as 
reference variable 
Adjusted† OR (95% 
CI) p-value with NW 
as reference variable 
NW 59/111 
(53.2%) 
79/116 
(68.1%) 
1 1 
TEW  52/111 
(46.8%) 
37/116 
(31.9%) 
1.88 (1.10-3.23) 
0.02* 
2.11 (1.19-3.75) 
0.01* 
LOW  23/82 
(28.0%) 
24/103 
(23.3%) 
1.28 (0.66-2.49) 
0.46 
1.31 (0.66-2.58) 0.43 
PW  93/152 
(61.2%) 
63/142 
(44.4%) 
1.98 (1.24-3.14) 
0.004* 
1.91 (1.18-3.12) 
0.009* 
†Adjusted for social class age 1 year, breast feeding, original randomisation, 
parental allergy. 
 
7.9b) Childhood wheeze phenotypes and outcomes at age 23 years in MAPS. 
The definition of childhood phenotypes can help us to understand asthma in 
early years. However, it is clear that not all childhood wheeze occurs in 
children with asthma.  It is therefore important to investigate which outcomes 
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are associated with different childhood phenotypes in later childhood and adult 
life in the MAP cohort and compare this to other established cohorts.   
These childhood phenotypes are helpful only in as much as they can inform 
our understanding of the natural history of asthma.  To examine the 
association with adult outcomes we have investigated associations between 
phenotypes and wheeze and asthma at age 23 years.  These are shown in tables 
7.5 and 7.6.  TEW does not appear to be associated with either wheeze or 
asthma age 23 years.  Wheeze at age 23 is only associated with PW and not 
with LOW while asthma age 23 is highly significantly associated with PW as 
expected and also there is a non-significant association with LOW. 
 
Table 7.5 Childhood phenotypes and association with wheeze at age 23 years 
All 
subjects 
n=285 
Wheeze 
age 23 
(93) 
No wheeze 
age 23 
(192) 
OR (95% CI) p-
value with NW as 
reference variable 
Adjusted† OR (95% 
CI) p-value with NW as 
reference variable 
NW (100) 25 75 1 1 
TEW (59) 18  41 1.32 (0.64-2.69) 
0.45 
1.61 (0.73-3.55) 0.24 
LOW 
(28) 
10 18 1.67 (0.68-4.08) 
0.26 
1.56 (0.62-3.89) 0.34 
PW (98) 40 58 2.07 (1.13-3.79) 
0.02*  
2.09 (1.09-4.00) 
0.03* 
†Adjusted for social class age 1 year, gender, breast feeding, original 
randomisation, parental allergy. 
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Table 7.6 Childhood phenotypes and association with asthma at age 23 years 
All 
subjects 
n=285 
Asthma 
age 23 
(51) 
No 
asthma 
age 23 
(234) 
OR (95% CI) p-
value with NW as 
reference variable 
Adjusted† OR (95% 
CI) p-value with NW 
as reference variable 
NW (100) 9 91 1 1 
TEW (59) 7 52 1.36 (0.48-3.87) 
0.56 
1.64 (0.52-5.11) 0.40 
LOW (28) 5 23 2.20 (0.67-7.19) 
0.19 
2.09 (0.59-7.38) 0.25 
PW (98) 30 68 4.46 (1.99-10.01) 
<0.0001* 
4.99 (2.09-11.93) 
<0.0001* 
†Adjusted for social class age 1 year, gender, breast feeding, original 
randomisation, parental allergy.  
 
 
7.9c) Aetiological factors and childhood wheeze phenotypes in MAP 
Table 7.7 shows a significant protective association between ever being breast 
fed and TEW and PW and no evidence of an association with LOW. These 
results reflect the earlier findings of a significant association of breast feeding 
with wheeze at age 1 but not with wheeze at age 7.   
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Table 7.7 Childhood phenotypes and association with breast feeding age 1 year 
All subjects 
n=430 
Ever 
breast 
fed 
Never 
breast 
fed 
OR (95% CI) p-
value 
Adjusted† OR 
(95% CI) p-value 
NW (138) 66 72 1 1 
TEW (89) 28 61 0.50 (0.29-0.88) 
0.02* 
0.54 (0.30-0.98) 
0.04* 
LOW (47) 21 26 0.88 (0.45-1.71) 
0.71 
0.87 (0.44-1.72) 
0.68 
PW (156) 50 106 0.52 (0.32-0.83) 
0.006* 
0.55 (0.33-0.92) 
0.02* 
†Adjusted for social class age 1year, gender, original randomisation, parental 
allergy. 
 
Table 7.8 shows environmental tobacco smoke (ETS) exposure gives a 
statistically significant association with both TEW and PW, probably because 
smaller airways are more likely to be affected by the injurious properties of 
tobacco smoke.  Both these phenotypes, TEW and PW, by definition have 
wheeze before the age of 3 years and when airways are small. 
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Table 7.8 Childhood phenotypes and association with environmental tobacco 
smoke (ETS) age 1 year, defined as mother or other person living with subject 
age 1 year being a regular smoker. 
All subjects 
n=429 
ETS age 
1  
No ETS 
age 1 
OR (95% CI) p Adjusted† OR 
(95% CI) p 
NW (138) 52 86 1 1 
TEW (89) 53 36 2.44 (1.41-4.20) 
0.001* 
2.17 (1.23-3.84) 
0.008* 
LOW (46) 22 24 1.52 (0.77-2.98) 
0.23 
1.57 (0.79-3.12) 
0.2 
PW (156) 89 67 2.20 (1.38-3.51) 
0.001* 
1.79 (1.09-2.94) 
0.02* 
ETS = Environmental tobacco smoke  
†Adjusted for social class age 1 year, gender, original randomisation, parental 
allergy and ever breast fed. 
 
Either parent having allergy is significantly inversely associated with TEW, 
possibly due to the reduced prevalence of smoking among atopic parents as 
discussed in chapter 6 section 6.14a.  However when the association of TEW 
and either parent having allergy is adjusted for exposure to environmental 
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smoke age 1 year as well as the other confounders, the OR remains significant: 
0.44 (95% CI 0.23-0.87) p=0.02, suggesting that there is a true inverse 
association between the TEW phenotype and having atopic parents in the 
MAPS cohort.  Table 7.9 also shows a non-significant association of parental 
allergy with LOW.  In our cohort there appears to be no association between 
parental allergy and PW, the phenotype most closely linked to asthma.  This 
suggests environmental attributes may contribute more to the development of 
asthma than genetic characteristics in our cohort. 
 
Table 7.9 Childhood phenotypes and association with parental allergy  
n=430 Either 
parent 
allergy 
Neither 
parent 
allergy 
Unadjusted OR 
(95% CI) p-value 
Adjusted† OR 
(95% CI) p-value 
NW (138) 115 23 1 1 
TEW (89) 61 28 0.44 (0.23-0.82) 
0.01* 
0.42 (0.22-0.83) 
0.01* 
LOW (47) 43 4 2.15 (0.70-6.58) 
0.18 
2.10 (0.68-6.49) 
0.20 
PW (156) 131 25 1.05 (0.56-1.95) 
0.88 
1.07 (0.56-2.06) 
0.83 
†Adjusted for social class age 1 year, gender, ever breast fed, original 
randomisation 
 
In table 7.10 we show the association between atopy at age 7 years and these 
childhood wheeze phenotypes.  It is to be noted that the wheeze phenotypes 
251 
 
are determined before the age of atopy and therefore it is not surprising that 
there is no association with TEW since this early wheeze predates the age of 
atopy.  There is however an association of PW with atopy age 7 years and an 
even stronger association with LOW and atopy at age 7 despite the small 
numbers in the LOW group.   
 
 
Table 7.10 Childhood phenotypes and association with atopy age 7 years 
N=415 Atopic age 7  Not atopic age 
7 
Unadjusted OR 
(95% CI) p 
Adjusted† OR 
(95% CI) p 
NW 
(133) 
23 110 1 1 
TEW 
(83) 
11 72 0.73 (0.34-1.59) 
0.43 
0.76 (0.33-
1.74) 0.52 
LOW 
(46) 
20 26 3.68 (1.76-7.68) 
0.001* 
3.67 (1.73-
7.78) 0.001* 
PW 
(153) 
52 101 2.46 (1.41-4.31) 
0.002* 
2.50 (1.39-
4.50) 0.002* 
†Adjusted for social class age 1 year, gender, ever breast fed, original 
randomisation, parental allergy. 
 
 
7.10 Chronic changes age 23 years and association with childhood variables 
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A total of 14 subjects out of 120 who had spirometry, i.e. 11.7% of subjects 
had an FEV1<80% of the predicted value.  Out of 119 subjects for whom we 
have a valid post bronchodilator FEV1, 8 (6.7%) had a low FEV1 post 
bronchodilator. One subject was excluded because their FEV1 dropped from 
above 80% to below after bronchodilators and therefore only seven subjects 
are included in the assessment of low FEV1 post bronchodilator in table 7.11. 
Those with post bronchodilator FEV1 <80% would fulfil the criteria for lung 
obstruction.  Of these seven subjects only four had wheeze at age 23 years, 
and three did not suffer with wheeze. These seven were defined as having 
irreversible obstructive airways disease or remodelling, using the definition 
expounded by Rasmussen et al
80
.  The other six subjects with low pre 
bronchodilator FEV1 did reverse and therefore were consistent with poorly 
controlled asthma.  These findings suggest a high prevalence of chronic lung 
disease at the early age of 23.  Table 7.11 shows the gender differences 
between males and females for chronic lung disease in our cohort. Males 
appear to have a higher rate of chronic lung disease than females, even when 
results are adjusted for smoking.  The reason for the higher level of chronic 
lung disease in males is not clear, but may be related to early wheeze in males. 
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Table 7.11 Gender differences in chronic lung disease 
Chronic Phenotype Male  Female OR (95% CI) 
p-value 
OR (95% CI) p-
value Adjusted for 
ever smoking  
Low FEV1 pre β agonist 
(Low FEV1)†   
9/50 
(18.0%) 
4/70 
(5.7%) 
3.62 (1.05-
12.52) 
p=0.04* 
4.02 (1.14-14.20) 
p=0.003* 
Low FEV1 post β 
agonist (irreversible 
obstruction phenotype) 
6/50 
(12.0%) 
1/70 
(1.4%) 
9.41 (1.10-
80.82) 
p=0.04* 
12.42 (1.22-
98.03) p=0.02* 
† Group is made up of both the COPD and those with reversible obstructive 
airways 
 
Table 7.12 shows the association between wheeze at different ages and the 
irreversible obstruction phenotype in adults as we have defined it (post 
bronchodilator FEV1 less than 80% predicted).  There were no statistically 
significant results but there was a non-significant association of the 
irreversible obstruction phenotype with wheeze at age 1 year or before.  We 
might speculate that those subjects who wheeze before the age of 1 were 
similar to those subjects in the TCRS study who were in the lowest quartile for 
lung functions at 3 months of age.  There was no other significant association 
between childhood wheeze and the adult irreversible obstruction phenotype 
although some ORs were moderately large.  
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Table 7.12 Association of irreversible obstruction phenotype with wheeze in 
childhood and adulthood 
Age at 
wheeze 
Low FEV1 post β 
agonist -
irreversible 
obstruction 
phenotype  
No Low FEV1 
post β agonist  
 
OR (95% CI) 
p-value 
OR (95% CI) p-
value Adjusted for 
ever smoking  
1 year 4/7 (71.4%) 32/111 
(28.8%) 
3.29 (0.70-
15.54) 
p=0.13 
4.13 (0.82-20.78) 
p=0.085 
7 years 2/7 (28.6%) 31/113 
(27.1%) 
1.06 (0.20-
5.74) 
p=0.95 
1.05 (0.19-5.90) 
p=0.96 
15 years 2/7 (28.6%) 36/104 
(34.6%) 
0.76 (0.14-
4.09) 
p=0.75 
0.69 (0.12-3.91) 
p=0.68 
23 years 4/7 (57.1%) 49/113 
(43.4%) 
1.74 (0.37-
8.14) 
p=0.48 
1.63 (0.32-8.29) 
0.56 
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7.12 Discussion 
We investigated the natural history of wheeze and asthma in MAPS. We found 
that before the age of 7 years, males were more likely to wheeze than females 
and that wheeze between ages 3 and 7 was especially associated with asthma 
and wheeze at the age of 23 years.  We found that more than 50% of 
childhood wheeze sufferers went on to wheeze at the age of 15 or 23 years.  A 
positive exercise test at age 7 was also associated with asthma at age 23 but 
not with wheeze at age 23 or younger.  Both wheeze and asthma at age 23 
years were significantly associated with the PW phenotype suggesting that this 
phenotype may be the precursor for chronic lung disease in this cohort. The 
four phenotypes could be considered to be really just two phenotypes; those 
who wheeze early (TEW and PW) and those who do not (NW and LOW).  
This would explain some of the findings such as the increased male tendency 
to have either TEW or PW phenotypes.  However for some outcomes we 
could divide the group into two phenotypes in a different way. Since PW and 
LOW are both more likely to be associated with asthma and wheeze at age 23 
years and TEW and NW are not significantly different in many of our 
outcome measures, as was found in the TCRS study
185
, we might consider the 
two phenotypes to be NW and TEW  and alternatively LOW and PW together.   
 
Of interest was the comparison between the phenotypes and atopy in MAPS, 
TCRS and German MAS, since MAPS was generally less atopic in all the 4 
phenotypes.  This is probably because MAPS has a low general level of atopy.  
The significance of this is that atopy in childhood has been associated with 
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chronicity of lung disease in the German MAS cohort
49
 but not with 
remodelling in the Dunedin cohort
80
 nor low lung function in the TCRS
337
.  In 
the MAPS study there was no evidence of an association of atopy with the low 
FEV1 phenotype.  In fact there was a non-significant negative association 
between atopy age 7 and low FEV1 age 23 years (OR 0.38 -95% CI 0.04-3.26) 
and also no significant association with atopy at age 23 years and low FEV1 
(OR 0.96 -95% CI 0.21-4.49).  We have found no evidence that atopy is 
associated with chronicity of lung disease in the MAPS cohort.  However 
similar to the Dunedin study
80
 we did find that low FEV1 was more common 
in males than females.  The cause for this worse outcome in some males in the 
MAPS cohort is not clear and may be due to wheeze occurring early in life in 
male subjects.  Our study was not powered to investigate this issue but it does 
require further investigation. 
 
We found that early wheeze was significantly associated with male gender, up 
to the age of 7.  Early wheeze in boys is thought to be related to the relative 
size of airways in male lungs during childhood, which are relatively smaller 
than airways in female lungs
2
.  This relative uncoupling of airway size and 
lung size is known as ‘dysanapsis’343.  In adult humans, the male has relatively 
larger airways than females and the propensity of males to wheeze is lost 
when they reach adulthood.  At age 15 and 23 years there was no association 
with gender in the MAP cohort although other studies have found an increased 
rate of asthma in females in adulthood
296
.  Abnormal spirometry at age 23 
years in the MAPS cohort was significantly associated with gender.  Boys 
were much more likely to have abnormal spirometry.   
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Subjects in the MAPS cohort were less likely to be wheeze free at age 15 if 
they had wheezed at or before the age of 2 years (59.8% wheeze free) than the 
Cogswell group at age 11 (75% wheeze free)
338
.  However the results are 
comparable.  Cogswell’s cohort was also a high risk cohort from the UK 
selected before birth, and although those who had wheeze at 2 or younger and 
were wheeze free at age 15 in the MAPS cohort was lower than the 
Cogswells’ group, it was not especially different.   
 
Breast feeding was associated with an OR less than 1 in the three phenotype 
categories compared with NW in table 7.7.  This suggests some protection 
from breast feeding in the MAPS cohort.  Both TEW and PW were 
statistically significantly associated with breast feeding, which may at least in 
part, be related to the association of breast feeding with wheeze in the first 
year of life, since both TEW and PW are defined by wheeze before the age of 
3 years.  Passive smoking at age 1 was  significantly associated with TEW and 
PW as has been shown in the TCRS longitudinal cohort where TEW was 
associated with parental smoking
92
.  Both these phenotypes are defined by 
wheeze before the age of 3 years and it may be that environmental tobacco 
smoke exposure, which is known to increase the risk of wheeze at age 1 in this 
cohort, is impacting on our phenotype definitions.  However this would not 
explain the differences between TEW and PW with respect to asthma and 
wheeze at 23 years.  The TEW phenotype is closer to NW than PW when we 
consider asthma at age 23 years.   
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The TCRS study showed an association of asthma at age 22 years with LOW 
and PW phenotype at age 6
117
, while MAPS showed an association between 
PW and probably LOW and asthma. The association between LOW and 
asthma was not significant but the effect size was large suggesting there may 
be an association.  We have found that ETS was significantly associated with 
TEW and PW (table 7.8), as has been shown in TCRS study. We found TEW 
was statistically significantly inversely associated with parental allergy. This 
has not been described in other longitudinal studies.   
 
Male gender in the MAPS cohort was more likely to be associated with a low 
FEV1, compared to female gender.  Rasmussen et al
80
 also found lower lung 
function had a propensity for males in the Dunedin cohort.  They found that 
the mean FEV1/ VC ratio was consistently higher among females than males 
and decreased significantly from late adolescence into adult life among males. 
The cause for this is not clear and may be due to wheeze occurring early in 
males more than females.    Our study was not powered to investigate this 
issue but it does require further investigation. 
 
Atopy was associated with LOW and PW in all the cohorts even though atopy 
was much less common in the MAPS cohort than in others.  The rate of atopy 
was lower in every phenotype in the MAPS cohort than in the corresponding 
phenotypes in other cohorts ; despite this the rate of symptoms was high and 
chronic lung disease was also relatively common with 11% of subjects at the 
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age of 23 having a low FEV1, less than 80% of predicted.   Although low 
FEV1 was not significantly associated with wheeze at age 1 there was a 
substantial effect size and a larger study may have given more definitive 
results. The TCRS study found that both the TEW group and the PW group 
were significantly more likely to be in the lower quartile for lung function than 
the other two phenotypes at age 16.  The TCRS paper suggests that the relative 
differences in lung function were present at age 6 years and that there was no 
significant change in any phenotype subset relative to peers from age 6 years 
to 16 years
185
.   This suggests that changes that occur before the age of 6 years 
are carried through to adult life.   In the Dunedin study, Rasmussen et al 
showed there was tracking of poor lung function from age 9 through to age 26 
years of age, suggesting this was due to airways remodelling as seen in 
pathological specimens of subjects with longstanding asthma.  They suggested 
that reduced lung function tracks from childhood to adulthood
80
 and further 
work has recently shown in pathological specimens that remodelling does 
occur early in subjects, sometimes even before the symptoms of asthma have 
begun
344
.  The Dunedin study only recruited children at age 7 so they do not 
have early data like TCRS but their data does support TCRS in that they too 
show that any changes in lung function that are present at the age of 7 track 
through to adult like.  The MAAS study measured lung function at age 3 years 
and they found that subjects who had continued wheezing after the age of 3 
(subjects with PW) did have a reduction in lung function at age 6.   We have 
not undertaken spirometry on our subjects until age 23 years so we are unable 
to comment on tracking of spirometry.  However what the MAPS cohort does 
add to the discussion is that our non-reversible obstruction group at age 23 
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years, although very small, does show a non-significant association with 
subjects who wheeze at 1 year or younger. One might speculate that these 
subjects with low FEV1 at age 23 years in MAPS were similar to  the 
participants  in the TCRS study who had infant Vmax FRC in the lowest 
quartile and then went on to have lower values for the FEV1/FVC ratio up to 
age 22 years.  It was suggested that these subjects were likely to be at higher 
risk of developing COPD than other subjects in the TCRS cohort. This chapter 
suggests, as shown by Stern et al in the TCRS cohort study that paediatric lung 
function is an important predictor in the development of adult lung disease
337
.   
 
The paediatric wheeze phenotypes have allowed us to categorise our subjects 
into groups from which we can further analyse them.  Further research into 
these 4 wheeze phenotypes will help us to understand what childhood 
environmental features may be responsible for the rise in asthma and if there is 
any treatment we can undertake to change the course of one of these 
phenotypes as we currently understand them. 
  
As yet, there is no preventive course of action that can alter the natural history 
of asthma and other paediatric wheeze disorders.  However the MAPS cohort 
has shown that like other longitudinal studies, early life wheeze, is associated 
with low lung function in adulthood. 
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Chapter 8 
General discussion and conclusion 
8.0 Discussion 
The aim of this thesis was to investigate the association of factors in early life 
with wheeze, asthma and atopy in adult years in our subjects.  This included a 
randomised controlled trial of exclusion of cows’ milk protein for the first four 
months of life with a soya preparation when breast feeding was not possible.  
A high risk birth cohort was recruited from a deprived area of the South Wales 
valleys.  The themes considered were: social class, parental allergy and 
asthma, BMI, immunological factors, diet, the original randomisation, 
environmental factors and natural history.   
 
8.1 Principal findings 
 
There was a 62% response rate of the cohort as a whole at age 23 years, 
although there was a higher loss to follow up of subjects with wheeze at age 1, 
subjects from unemployed families at age 1 and male subjects.  There was no 
evidence of an association with social class and any outcome at age 23 years. 
However at age 1 and age 7 there was an increase in wheeze with lower social 
class.  There was an association between paternal allergy and paternal asthma 
and asthma and wheeze at age 23 years.  The risk of wheeze at age 23 years 
increased with BMI at age 1, 7 and 23 years but only in girls.  
 
Atopy, defined as a positive skin prick test, in early life was associated with 
atopy later in life. Total IgE in early life was also associated with the level of 
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total IgE in later life, up to adulthood.   The results showed that childhood 
atopy, defined as a positive skin prick test at age 7 years, was associated with 
a significantly increased  risk of wheeze from age 3 up to age 23 years.  This 
was despite the fact that atopy had a prevalence of approximately 50% in 
those subjects who had wheeze at age 7, and suggests that although the 
prevalence of atopy was low in the MAPS cohort, atopy still had a strong 
association with asthma symptoms in childhood and adulthood.   
 
We were able to use two methods to investigate an appropriate cutpoint for 
total IgE level that would define atopy.  Using these cutpoints we found an 
association between total IgE and wheeze (non-significant) and asthma 
(significant and large effect size).  There was evidence of an association 
between asthma and IgE even after adjustment for atopy based on positive 
skin prick test result, although the association was no longer significant after 
adjustment for skin prick test result.  This relationship between total IgE and 
asthma even in the absence of specific sensitisation, was first reported by 
Burrows et al who suggested that these findings challenged the concept that 
there are basic differences between allergic and non-allergic asthma
41
.  
However we were unable to develop this hypothesis any further as we had a 
small sample size who attended at age 23 years for skin prick test 
investigations and this may explain why our results were not significant.  
 
The low prevalence of atopy at age 7 years in the MAPS cohort was probably 
related to environmental factors that we were unable to measure.  By the age 
of 23 years there was a higher prevalence of atopy especially among those 
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who were asthmatic at age 23 years with only 27% (8 subjects) non-atopic 
asthma sufferers. One may speculate that studying only the non-allergic 
subjects in the MAPS cohort may suggest other possible aetiological factors 
for asthma, but the MAPS cohort was not powered to investigate only those 
subjects without atopy, and therefore we have no evidence on this matter. 
 
There was also a very low level of breast feeding in the group as a whole, and 
this was significantly lower in the intervention arm than the control arm.  
Since the intervention arm was associated with an increased risk of atopy, and 
asthma, we could argue that the two were related but it is not possible to 
demonstrate causality.  
 
Rates of both asthma and atopy were significantly higher in the intervention 
arm of the RCT. This is likely to be due to specific characteristics in our 
cohort as other studies have found benefit from reduced exposure to allergens 
in the first year of life.  Although there is some evidence of soya 
supplementation being inert, other studies have excluded soya when they have 
undertaken an allergen free diet
212
.  So the results may be due to the fact that 
we used soya in our intervention arm.  Alternatively it may be that early 
exposure to cows’ milk in the MAPS cohort was associated with a reduction in 
atopy in later life. 
 
The MAPS cohort showed no pattern of environmental factors affecting 
outcomes at age 23 years.  Many environmental factors were investigated but 
combinations of them could not be investigated easily since the number of 
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subjects was too small.  Few significant associations were found other than an 
association of a lower prevalence of atopy with solid fuel burning. 
 
Early life wheeze was associated with adult wheeze and asthma in the MAPS 
cohort. Phenotyping of early childhood wheeze revealed that a higher 
proportion of subjects in the MAPS cohort had persistent wheeze (PW) than in 
other comparable cohorts.  The MAPS cohort was a high risk one and the 
definitions for each phenotype varied between cohorts.  In the MAPS cohort 
the phenotypes of late onset wheeze (LOW) and PW were both associated 
with asthma aged 23 years.   
 
There was a strong but non-significant association between wheezing in the 
first year and having a non-reversible obstruction at age 23. In spite of the 
small sample size, this may contribute to the body of evidence that suggests 
that COPD is determined early in life, probably in infancy. 
  
8.1 Strengths and limitations of study 
The main strength of this work is that it was a large cohort in a deprived 
community in the South Wales valleys followed up for over 20 years.  A large 
amount of information was gathered at or near birth and we have investigated 
associations of these early factors with outcomes in adults.  Follow up to the 
age of 7 years was high, and annual follow up until the age of 7 years meant 
we have strong data to inform our childhood wheeze phenotypes.  We know 
that early life events have an impact on outcomes in adulthood and so it was 
important to follow up subjects into adult life. Unlike some other longitudinal 
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studies, such as those in Tasmania and Dunedin, our study began before birth 
so the associations with early life events were prospectively gathered.  This 
makes recall bias much less likely.  This has been especially important in our 
evidence on breast feeding. There are only a handful of longitudinal studies 
that have gathered information on breast feeding and diet prospectively on a 
weekly basis and then continued to report outcomes in adults.  Rates of breast 
feeding in this study were very low and it is perhaps not surprising that 
associations were not found with outcomes beyond the age of 1 year.  We 
cannot speculate how the lack of rigour in collecting data in other studies may 
have affected their results.   
 
The main weakness of this study was the loss to follow-up. Only 62% were 
seen at age 23 years, and only 25% were present for spirometry and skin prick 
testing at age 23 years.  A larger cohort study, with higher attendance at clinics 
for testing, would have given us greater power in our calculations of 
associations.  A large birth cohort such as the ALSPAC study in a similar area 
to that of the MAPS cohort would have been an excellent design for our 
study
345
.  With a larger sample size we may have been able to find more and 
stronger associations with the variables we were reviewing. 
 
We might have considered using extensively hydrolysed cows’ milk formula 
for the intervention arm, if we were undertaking a similar study today, 
although, as Lowe et al showed in 2011, there is no evidence of an increased 
risk of asthma up to age 6 or 7 years with early life soya milk supplements
249
. 
However Berg et al have shown a reduction in eczema with the use of 
267 
 
extensively hydrolysed cows’ milk formula in high risk children in the large 
GINI plus study
250
.   
 
In addition we may have considered undertaking serial specific IgE results as 
well as serial skin prick test results.  Julge et al proposed that there may be a 
down regulation of skin prick test positive results compared to specific IgE 
response among children from countries without a market economy (i.e. non 
westernised)
346
.   In a large international ISAAC study Weinmayr et al
347
 
found a pattern of discordance between positive skin prick test and positive 
specific IgE results which was greater in children from countries which were 
considered less affluent determined by gross national income of the country.  
With specific IgE levels we may have been able to obtain a better 
understanding of patterns of discordance in our non-affluent population in 
South Wales.   
 
A useful further addition to the study would have been more consistent lung 
function testing. With childhood spirometry, and regular spirometry in the 
teenage years, we may have been able to have a clearer view of when the 
chronic changes of low FEV1 may have been initiated and if there were any 
environmental factors that made these early changes more likely. 
 
8.2 Interpretation of findings 
The original premise of this study was that the exclusion of allergens early in 
life may protect children at high risk of asthma from developing the disease. 
The underlying hypothesis was that allergens are causally related to the 
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incidence of asthma and therefore the RCT of normal diet against cows’ milk 
exclusion diet was initiated.   In fact those subjects who had cows’ milk early 
in life, had a reduced risk of asthma and atopy.  This result may have been due 
to subjects in the control arm of the RCT receiving soya milk, which may have 
had a higher allergenic effect.  Soya antigen has been shown to be associated 
with epidemics of asthma when soya beans are unloaded in port in 
Barcelona
348
, but there is no convincing evidence thus far that soya is more 
allergenic when taken orally than cows’ milk. 
 
There have been a number of studies both longitudinal and cross-sectional that 
have investigated the natural history of asthma and wheezing disorder.  
However few longitudinal studies have followed subjects from early 
infanthood to adulthood and therefore there are few to compare with MAPS.  
The Melbourne
349
 and Dunedin
116
 studies have both investigated subjects into 
adulthood but neither have investigated subjects from infancy and therefore 
early life histories are based on recall and cannot be relied upon.  TCRS is the 
only other large cohort that has reported on adult outcomes and taken a 
prospective history in infants
337
.   
  
The subjects in this cohort did have a lower rate of atopy in childhood than in 
other comparable cohorts.  Atopy is known to have a higher prevalence in 
subjects of higher social class.   Strachan et al found a prevalence of 
sensitisation to house dust mite of 25% in children from social class I and 
16.5% in children from social class V
128
.  Heinrich et al in Germany 
investigated the effect of social class, based on three groups determined by 
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parental education level.  Those in the highest social class and with the most 
years of education had a sensitisation level of 22.1% (95% CI 19.5%-25.0%) 
N=904 and those from the lowest social group with the lowest level of 
education had a sensitisation level of 11.5% (95% CI 7.1-17.4 %) N=165
350
.    
The reason for the high prevalence of aotpy  in association with high social 
class is not clear but may be related to reduced rates of infection at a young 
age causing changes in the subject’s immune system, as proposed by 
Strachan
50
.  However, an alternative interpretation of this hypothesis is that 
deviations in the composition of gastrointestinal microbiota as a result of 
westernised lifestyles (antibiotic use, diet) have disrupted the mechanisms 
involved in the development of immunological tolerance.  Sudo et al have 
shown that tolerance induction in a murine model is related to adequate 
diversity of gut flora
251
.  Abrahamsson et al showed that low diversity in gut 
microbiata in early infancy precedes the development of asthma at school 
age
351
.   Sjogren et al investigated faecal samples collected up to age 2 months.  
Those subjects who develop allergy at age 5 years were signiﬁcantly less often 
colonised with specific gut bacteria up to 2 months
339
.  These studies support a 
view that a more diverse gut microbiota early in life might prevent allergy 
development. Our cohort may have had a low level of atopy because they were 
from a relatively deprived community and may therefore have been exposed to 
more bacteria early in life giving them greater diversity in gut bacteria.  
However despite the low level of atopy at age 7 years, there is no evidence 
that asthma was less frequent in this cohort.   
 
270 
 
Breast feeding was associated with a reduction in wheeze at age 1 year but  
not associated with outcomes at age 23 years.  The rate of breast feeding was 
very low in MAPS, limiting the likely effect at population level, in spite of 
obtaining a weekly prospective history of feeding of the infant.  The dietitian 
actually went to visit the mother in her home and therefore was able to see, 
first hand, what was being given to the infant.  To our knowledge, no other 
study has been as thorough as this in obtaining a history of early infant feeding 
and therefore it is hard to compare with other studies.  The World Health 
Organisation (WHO) has advised increasing exclusive breast feeding in all 
new-borns from 4-6 months, which was previously advised, to 6 months based 
on the fact that there is no evidence to suggest this will have a detrimental 
effect on the baby
352
.  However, fewer than 1% of mothers exclusively 
breastfed for the recommended time in a 2005 survey
353
.  We would propose 
that mothers are often under pressure to breast feed and therefore are more 
likely to suggest that they have breast fed for longer.  Unless there is 
prospective gathering of breast feeding information it is not possible to 
confirm the accuracy of any study. 
 
8.3 Implications for research and practice 
Unfortunately as so many questions remain unanswered regarding dietary and 
environmental factors and the development of asthma, as yet, the implications 
for clinical practice are difficult to determine.  However from the work 
undertaken we can identify that the early wheeze phenotyping is an effective 
way of categorising children who wheeze early in life and from these 
phenotypes we may be able to suggest prognosis.   There is also the suggestion 
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that adult wheeze associated with abnormal irreversible lung function testing 
may not be only related to smoking and more work is required in this area to 
fully understand the different phenotypes of early onset COPD, which may 
help to deliver new therapies for our chronically disabled respiratory patients. 
 
Further longitudinal studies of birth cohorts from socially deprived areas are 
required in order to investigate environmental factors that might reduce the 
prevalence of asthma.  One of these factors would be the reduced rate of 
atopy.  We may learn more about the aetiology of asthma investigating a large 
population based birth cohort from a less affluent area, where similar to 
MAPS we might expect a higher prevalence of non-atopic children who 
wheeze.  More work is required to elucidate the environmental factors that are 
linked to incidence of asthma in both children and adults and this can best be 
achieved by large longitudinal population based studies.  The key is 
understanding the natural history of wheezing disorder and which infants who 
wheeze will go on to develop adult wheezing disorders, both asthma and 
COPD, and which subjects who do not wheeze in childhood, do go on to 
develop asthma later in life. 
 
As well as the epidemiological studies that have been summarised in each 
chapter of this thesis, we require a better understanding of the immunological 
factors on which the environment impacts.  This means we need to investigate 
more models of early life immunity in the laboratory.  The murine models 
worked on by Prescott et al and by Adkins have suggested that early 
environment can change the way the immune system develops during 
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childhood and therefore create an allergic or tolerant individual but our 
understanding of critical times points and antigen dose for both atopic and 
tolerant status are not clear.  Once they are more fully understood, this will 
help us to look for appropriate environmental triggers in our epidemiological 
studies and will also assist us in developing asthma prevention studies.  Cross-
sectional studies have helped us to develop hypothesis for longitudinal studies 
but these types of studies are always dependent on recall bias, and therefore 
cannot give the detail of those early months of life that are so critical.  These 
murine models may hold the key for hypothesis setting in the future for the 
next generation of longitudinal studies. 
 
Despite this initial progress, fundamental questions remain that need to be 
addressed by well-designed research studies. Cohort-driven epigenetic 
research has the potential to address key questions, such as those concerning 
the inﬂuence of timing of exposure and dose of exposure required to increase 
susceptibility to asthma development. The presumption is that the 
development of asthma is not a foregone conclusion based on genetic makeup, 
and hence modifiable
354
.  In addition asthma is a disease that exhibits a 
notoriously variable phenotype
355
, again suggesting that environmental factors 
may determine phenotype. Epigenetic mechanisms such as-DNA methylation, 
histone modifications, and production of non-coding RNAs are epigenetic 
molecular changes that can alter gene transcription, without changing the 
DNA coding sequence, that occur prenatally or during other susceptible time 
periods and may modify the clinical manifestations and variable nature of this 
complex disease
354
.  Large GP database studies may be another useful method; 
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large numbers of subjects can be included but the approach has limitations. 
Data contained in these databases are routine data and depend on a subject 
attending a GP. Data are recorded using Read codes and their use  
varies between GPs, some concentrating on diagnoses while others on 
symptoms, though  medication use should be recorded in similar ways by all 
GPs.  Despite these limitations, this may be a way forward if undertaken 
carefully. 
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